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Abstract

Data mining techniques have been used widely in many areas such as business, science,
engineering and medicine. The techniques allow a vast amount of data to be explored in
order to extract useful information from the data. One of the foci in the health area is
finding interesting biomarkers from biomedical data. Mass throughput data generated
from microarrays and mass spectrometry from biological samples are high dimensional
and is small in sample size. Examples include DNA microarray datasets with up to
500,000 genes and mass spectrometry data with 300,000 m/z values. While the
availability of such datasets can aid in the development of techniques/drugs to improve
diagnosis and treatment of diseases, a major challenge involves its analysis to extract
useful and meaningful information. The aims of this project are: 1) to investigate and
develop feature selection algorithms that incorporate various evolutionary strategies, 2)
using the developed algorithms to find the “most relevant” biomarkers contained in
biological datasets and 3) and evaluate the goodness of extracted feature subsets for
relevance (examined in terms of existing biomedical domain knowledge and from
classification accuracy obtained using different classifiers). The project aims to generate
good predictive models for classifying diseased samples from control.
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1. Introduction
Recently, mass throughput technologies such as microarrays and mass spectrometry
(MS) have been developed and widely used in the biomedical domain. A large number
of biological datasets involving different types of diseases such as cancer and
Alzheimer’s disease (AD) have been generated using these technologies (Ma & Huang,
2008; Stoeckel & Fung, 2007). Microarrays allow thousands of genes to be measured
simultaneously in a single experiment. MS technology produces enormous amounts of
high-dimensional datasets about cellular functions. Examples of DNA microarray
datasets include gene arrays with up to 500,000 genes and MS datasets with 300,000
m/z (a unit of measure) values (Aliferis, Statnikov, & Samrdinos, 2006).
Typically, biomedical research involving the above mentioned techniques is linked to
prevention, diagnosis and drug development for treatment of diseases; with a focus in
diseases such as cancer and Alzheimer’s disease. According to Cancer Research UK
and American Cancer Society, globally cancer is a leading cause of disease and cause of
death. In 2008, 12.7 million new cancer cases and 7.6 million people died of cancer.
The worldwide trend is predicted to be a significant increase of 22 million new cases
each year by 2030 (American Cancer Society, 2011; Cancer Research UK, 2012), that is
about 286 million people will be diagnosed to have cancer by 2030.
According to the World Alzheimer 2012 Report, globally, about 36 million people have
Alzheimer’s Disease or dementia and this number will increase to 66 million and 115
million by 2030 and 2050 respectively, that is about one new case every four seconds
(Alzheimer's Association, 2012; Alzheimer's Australia, 2012). There are no early
diagnostic tests that are definitive for this disease, with a definitive diagnosis only
possible following a post-mortem examination of the brain for evidence of the disease’s
characteristic neuropathology (MayoClinic, 2013). However, the pathogenic processes
of Alzheimer’s disease are likely to begin years before clinical symptoms are observed.
Therefore, the need for biological markers (biomarkers) defined as “a substance,
physiological characteristic or gene, that indicates, or may indicate, the presence of
disease, a physiological abnormality or a psychological condition” (Biological marker,
n.d.), whose measurable levels are altered prior to clinical symptoms is of paramount
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importance. The need to detect Alzheimer’s disease via an “equivalent pregnancy test “
has been repeatedly stated in the literature (Trojanowskl, 2004). The ideal diagnostic
test is one that is inexpensive, has a high specificity and can be carried out as easily and
accurately as a “pregnancy test”; enabling diagnosis as early as possible (Hooper,
Lovestone, & Sainz-Fuertes, 2008)
While the availability of such datasets can aid in the development of techniques and drugs
to improve diagnosis and treatment of diseases, the nature and the enormous volume of
such mass throughput data challenge the power of data mining (DM) in terms of their
analysis to extract useful and meaningful information. A fundamental problem in
identifying biomarkers from high dimensional data involves a systematic search for
relevant features; to reduce the dimensionality of the dataset to a small, yet highly reliable
and discriminative subset that is representative, improving the classification accuracy and
reducing the computational cost (Hanczar et al., 2003; Somorjai, Dolenko, &
Baumgartner, 2003).
1.1. Statement of the Problem
Analysis of high dimensional data, in general, have problems that arise from ‘the curse
of dimensionality’ (R. Clarke et al., 2008), which relates to a very large number of
attributes (features) and ‘the curse of dataset sparsity’ (Somorjai et al., 2003), which
relates to the small number of samples (e.g. in the case of a prostate cancer dataset
with 12600 features and only 102 samples) in the dataset. These problems result in
overfitting, inaccurate classification and high computational cost in searching through
the feature subspace (Kim, Kim, Lim, & Kim, 2010). Owing to the complexity of the
data it is very important that the number of features be reduced in order to improve
classification accuracy and to perform the analysis with less computational cost (Liu, Li
& Wong, 2002). Additionally, owing to the curse of dimensionality, traditional
statistical approaches and machine learning techniques are not effective in analysing
these types of datasets (Yu & Liu, 2004).
One approach to find biomarkers is to use feature selection (FS) techniques to select the
most relevant feature subsets. “Feature selection can be defined as a problem of finding
a set of minimum number of relevant features that describe the dataset.” (Kim et al.,
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2009, p.2). It is the process of going through the vast amount of data, including a large
number of features in the dataset, to select relevant feature subsets (possibly an optimal
subset), which improve the classification accuracy in terms of sensitivity (a probability
that the prediction is positive when the disease is present, i.e., true positive prediction)
and specificity (a probability that the prediction is negative when the disease is not
present, i.e., true negative prediction) (Dash & Liu, 1997, 2003). In addition the
identification of an optimal subset of features, capable of providing absolute
discriminatory information, can lead to the development of inexpensive diagnostic
assays with a few features (genes) and which subsequently can be widely deployed in
clinical settings.
Another consideration in addressing the problem of finding relevant biomarkers is
related to characteristics typically associated with biological datasets that make the DM
task especially challenging. These include the following:


Noisy data: This can be attributed to differences in experimental setups;
technologies and impression with their associated devices and software; and
variances in biological observations.



Datasets typically are of small sample size but high dimensional: Unlike
traditional domains associated with DM applications, biological datasets
typically have only a small number of samples (at best in the hundreds), while
the number of features, is typically in tens of thousands. This characteristic leads
to the phenomena, curse of dimensionality and over-fitting in classification
tasks. Algorithms developed to carry out DM in traditional domains are not
suitable to be used to analyse these datasets. In addition, this characteristic will
also create a scenario where there is a high likelihood of finding false positives
in classification tasks owing to chance, and robust methods to validate the
classification models are vital.



Complexities of interactions amongst features in a biological dataset.
Features in the biological datasets are not independent; their correlation structure
is not fully understood in many cases. Many data analysis approaches only
involved evaluating each feature separately and do not consider possible
correlations amongst features. However, from a biomedical perspective, groups
3

of features are known to work together as pathway components in a biological
process.


Biological and diagnostic relevance
Another point to note is that data obtained via mass throughput technologies
such as microarray serves 2 functions:
o biological relevance - by providing measurements related to mechanisms
underlying the disease and
o diagnostic relevance - as relevant features in the construction of accurate
diagnostic classifiers for prediction.
It is vital to understand the interplay between diagnostic and biological
relevance -- that the former is neither a necessary nor a sufficient condition for
the latter. First, high correlation between disease status and specific features do
not necessarily imply that they have a causal relationship with the specific
disease. Likewise, in constructing accurate diagnostic classifiers it is highly
unlikely that all biologically relevant features may be utilized. The outcome is
that selected features on the basis of their diagnostic relevance need be validated
for biological relevance by examination of the literature for relevance to the
specific disease and by subsequent experimental analysis. Second, biological
evidence suggest that typically multiple sets, each with a finite number of
features, are responsible for a specific disease (i.e. multiple causes -- features
can be combined in many different ways, all leading to a specific disease). The
outcome here is that identifying multiple sets of biomarkers is important for
discovering correlations among features and to support evaluation of different
combinations in the diagnostic phase.



Validation of results from data analysis and absolute ground truth:
Absolute ground truths are not available in this field for validation of results
associated with the data analysis. In other disciplines, experts can be readily
available to provide ground truths but in the areas of proteomics and genomics,
biomedical knowledge in terms of differential physiological behaviour pertinent
to specific biological states is currently inadequate. The ultimate judge for
validation would involve biological validation (e.g. clinical trials), for which one
will have to focus on some specific subsets of minimal size. Results from data
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analysis are also likely to be useful if they are position in context and can be
subsequently followed up with more focused studies by biomedical researchers.
Many FS algorithms have already been developed and used in various areas such as
business, science, engineering, and in recent times, increasingly applied in the area of
bioinformatics. Cho et al. (2003) used a genetic algorithm (GA) together with a neural
network classifier to select relevant features from Alzheimer’s disease datasets. A
Support Vector Machine (SVM) classifier was used in Mukerjee et al.’s study (1998) to
select features from a Leukemia microarray cancer dataset.
Existing work involving evolutionary approaches include Li, Liu and Bai (2008)
incorporated a GA into filter and wrapper methods to search for feature subsets from a
Prostate MS dataset; Deb and Reddy(2003) incorporated the method of weighted voting
into a multi-objective evolutionary algorithm (MOEA) called non-dominated sorting
algorithm (NSGA2) to search for multiple sets of optimal features for Leukemia, Colon,
Lymphoma, GCM and NCI60 cancer data.
Rough set theory (RST) (Pawlak, 1982) was developed on a mathematical basis and
has been used in DM to analyse vague, uncertain or incomplete data in datasets and to
remove redundant features effectively (Pawlak, 1997). RST has also already been used
to select features for biomedical data in numerous studies (Punitha & Santhanam,
2008). However approaches incorporate RST with an evolutionary algorithm (EA) such
as MOEA (NSGA2) or GA to search for optimal set of features for high dimensional
biological data are limited. For example, Banerjee et al. (2007) proposed an
evolutionary Rough Set based FS technique for analysing gene expression data.
The Nearest Shrunken Centroid (NSC) algorithm (Tibshirani, Hastie, Narasimhan, &
Chu, 2002) with its most well-known software implementation being known as
Prediction Analysis for Microarrays (PAM), has been widely used as a FS and
classification method for high dimensional biomedical data in numerous studies (Ray et
al., 2007). NSC selects features by shrinking a class centroid for each feature toward its
overall centroid for all classes using a shrinkage threshold value.
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Shrinkage threshold values associated with the application of NSC have usually been
selected via 2 approaches, Cross Validation (CV) (Tibshirani et al., 2002; S. Wang &
Zhu, 2007; K. Yeung & R. Bumgarner, 2003) and empirical approach (Klassen & Kim,
2009; Levner, 2005; Ray et al., 2007). With the CV approach, the dataset is divided
randomly equal into k parts, each part consists of approximate proportion of a number
of samples and classes. One part takes turn to be the test set while the other k-1 parts are
used as the training set. The procedure is repeated n times to obtain the prediction error
rate for each time. The overall prediction error rate is then calculated by averaging the
errors from all iterations. The selected optimal threshold value is based on the CV
prediction errors associated with the different threshold values. With the empirical
approaches, the optimal shrinkage threshold was selected based on the lowest
classification error over a range of shrinkage thresholds. However, threshold values
selected using CV and empirical approaches are not precisely tuned for the specific
dataset to obtain optimal classification results. This is due to the fact that these
approaches are limited in terms of exploring the entire search space of threshold values
in relation to the dataset, resulting in threshold values that may not be the optimal.
Optimal shrinkage threshold values used in the NSC algorithm would make a vital
difference in selecting optimal feature sets and subsequently, improving the
classification accuracy.
To address the challenges in the analysis of mass throughput data such as microarray
data, FS is seen as a vital first step to identify relevant features for classification.
Although many FS techniques have been developed and used for analysis of such high
dimensional biological data, most of the existing work typically involved deterministic
approaches, attempting to find a unique set of biomarkers. The development of
techniques capable of extracting multiple potential sets of biomarkers for subsequent
analysis and the incorporation of evolutionary algorithms, especially MOEA in these FS
techniques is limited. Following this direction, this research study aimed to develop
evolutionary based FS techniques for analysis of high dimensional biological data
generated from molecular biology techniques such as microarrays, metabolite profiling
and mass spectrometry and to evaluate these techniques, both in terms of their
performances and the validity of the extracted information.
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1.2. The purpose of the study
The aims of this project are:


to investigate and develop FS algorithms that incorporate various evolutionary
strategies, specifically investigating the use of

evolutionary strategies in

conjunction with RST and NSC;


to evaluate the developed algorithms in terms of finding the “most relevant”
biomarkers contained in biological datasets and



to evaluate the goodness of extracted feature subsets for relevance (examined in
terms of existing biomedical domain knowledge and classification accuracy
form the perspectives of sensitivity and specificity associated with different
classifiers). The project aims to generate sets of features for construction of good
predictive models for classifying diseased samples from control.

1.3. The contributions of this study
The area of bioinformatics is “data rich”, as the breakthroughs in the development of
mass throughput technologies resulted in huge volumes of data being produced.
However, this area increasingly suffers from a situation where biomedical researchers
lack the time and the appropriate tools to complete a sound and comprehensive analysis
of these huge volumes of data in order to make biological sense and to use the data
optimally. The study contributes in the area of bioinformatics, in the development of
FS techniques that aid in the analysis of datasets acquired using mass throughput
technologies. Specifically, the study examines the development of FS techniques that
incorporates evolutionary algorithms, especially MOEA. Unlike existing techniques, the
developed approaches support FS by simultaneously considering tradeoffs between a
number of criteria (e.g. high classification accuracy and a small number of features).
Additionally, the developed techniques is cost and time effective, allowing researchers
to use computer time to analyse realms of data as the output from the techniques are
multiple sets of potential features (biomarkers) that can be further investigated to
explore both diagnostic and biological relevance. The following section details the
contributions of the study.
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A FS technique incorporating the use of GA, K-means and RST for
analysis of high-dimensional biomedical data
Use of RST as a FS technique in bioinformatics has been limited and this study
investigated an approach of combining RST with a GA. The first step in this
approach, RST-GA, employed the k-means algorithm to generate class centroids
from the training data. The class centroids are used as initial seed values for RST
to partition the data that subsequently led to the reduction of a large number of
features. GA was then utilised as a search method to find sets of optimal
features. Unlike deterministic approaches that produce the same set of optimal
features, this approach produced a different set of features from each run of
RST-GA. Identification of multiple sets of biomarkers with high diagnostic
relevance is important as it allows biomedical researchers to examine these sets
using existing biological knowledge to determine sets to validate for biological
relevance in subsequent clinical studies.



Use of evolutionary algorithms for enhancement of the NSC algorithm
The NSC algorithm has been widely used as a FS and classification method for
high dimensional biomedical data in many studies (Bair & Tibshirani, 2004;
Klassen & Kim, 2009; Lee, Lee, Park, & Song, 2005; Ravetti & Moscato, 2008;
Ray et al., 2007; K. Y. Yeung & R. E. Bumgarner, 2003). A shrinkage threshold
value must also be provided to the NSC and this is normally selected via a
manual “trial and error” process which can be very time consuming. The
resulting shrinkage threshold value from this manual process may be limited by
the granularity of the initial pre-determined values. In this study, evolutionary
based approaches, NSC-GA, NSC-MA and NSC-NSGA2 involving GA,
memetic algorithm (MA) and MOEA (NSGA2) respectively, were developed to
find shrinkage threshold values automatically. These approaches eliminate the
need to find the shrinkage threshold value manually and produced more precise
shrinkage threshold values. For NSC-GA described in Chapter 5 and NSC-MA
in Chapter 6, the shrinkage threshold value is determined on the basis of a single
objective function which is an aggregation of 2 separate objective functions (i.e.
evaluation criteria). For NSC-NSGA2 described in Chapter 8, multiple optimal
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shrinkage threshold values are obtained while simultaneously considering
different tradeoffs amongst multiple objective functions.
Unlike approaches (e.g. S. Wang and Zhu (2007)) that attempted to improve the
performance of NSC by modifying it, the original NSC algorithm (Tibshirani et
al., 2002) is used here, thus potentially the proposed techniques can also be
incorporated into any modified NSC.
A point to note with regards to the nature of shrinkage thresholds is that rather
than being an exact value, a narrow range of values maps to the same set of
features. This implies that owing to the stochastic nature of evolutionary
approaches, these approaches produced different results (i.e. different shrinkage
threshold values resulting in different sets of features) from each run of the
technique. However if these shrinkage threshold values are only slightly
different, they mapped to the same set of features, thus in some cases, producing
identical sets of features from a number of different runs. While having less
variability, these approaches still produce multiple sets of biomarkers from the
analysis of a dataset.
Lastly, another advantage associated with the proposed approaches being able to
produce more precise shrinkage threshold values is obtaining better
classification accuracy when the corresponding optimal set of features is
employed in NSC to classify unseen test datasets.


Investigate the impact of using different distance measures in the NSC
algorithm
The study investigated the impact of using different distance measures:
Mahalanobis, Pearson and Mass Distance (MD), in the NSC algorithm
employed in NSC-GA for analysis of high dimensional biological data. In the
NSC (Tibshirani et al., 2002), Euclidean distance is employed as an evaluation
measure in determining the score used to classify sample points. The Euclidean
distance is not an effective nor a robust measure for classification when
compared to other similarity measures such as Mahalanobis, Pearson and MD
(Datta & Datta, 2003; Ding & Peng, 2005; Yona, Dirks, Rahman, & Lin, 2006).
9

This investigation contributes to a better understanding of using the different
distance measures in NSC and the impact these have on the task of finding the
most relevant features that can lead to higher classification accuracy for
biological data.


Identification of a number of subsets of relevant features for Alzheimer’s
disease, Colon, Leukemia, Lung, Lymphoma, Ovarian and Prostate cancer
data.
Approaches developed in this study were evaluated using seven datasets.
Indirectly, each of these datasets was analysed for finding optimal sets of
biomarkers, by considering tradeoffs between high classification accuracy and
minimum number of features. Most existing studies (Banerjee et al., 2007; Fan
& Fan, 2008; Foss, 2010; Tai & Pan, 2007; S. Wang & Zhu, 2007) evaluate their
developed techniques using various datasets and only reported their findings in
terms of the size of the optimal feature sets and associated classification
accuracy. However, besides examining the classification performance of a set of
features, its relevance to its corresponding domain is crucial. Unlike previous
work, this study lists the extracted features from the analysis of each datasets
and where possible, examines the relevance of these features by searching the
literature.

These subsets of relevant features can be used by biomedical

researchers for further clinical investigation to validate their biological relevance
to the specific disease.


Impact of using specific classifiers on sensitivity and specificity
Sensitivity and specificity associated with classification are two measures that
are of great interest to the biomedical community in their efforts to find
biomarkers and to assess them as to how well they can predict relevant
outcomes.

Sensitivity represents the probability of correctly diagnosing a

condition (i.e. the proportion of truly affected (i.e. diseased)) in a sample
population that is identified by the test as being diseased). On the other hand,
specificity represents the proportion of truly non-diseased that the test identified
as such. This study demonstrated that different classifiers constructed using the
same set of features produced different sensitivity and specificity in the
10

classification of test data. In other words, there can be classifier-bias – for
example,

classifier C, constructed using a set of features demonstrates high

sensitivity and low specificity; when in actual fact, there may exists a number
of other classifiers constructed using the same set of features and demonstrating
both high sensitivity and high specificity.
Thus in a DM analysis for finding suitable sets of biological markers, a number
of classifiers should be used instead of just using one. This will avoid cases of
missing out on sets of features with high discriminatory capabilities that should
be further investigated in early diagnostic test developments but were rejected
on the basis of their sensitivity/specificity obtained via a specific classifier.


A set of techniques for comprehensive analysis of biological datasets
As mentioned previously, data from mass throughput technologies typically
consists of a small number of samples where each is composed of thousands of
features. Additionally these features have correlation relationships that are still
not fully understood. From a biomedical perspective, groups of features are also
known to work together as components in a biological pathway. Given these
complexities in the data, manual evaluation to find sets of features would be
intractable.

Many existing data analysis approaches in bioinformatics only

involved evaluating each feature separately (univariate analysis) and do not
consider possible correlations amongst features nor the joint behavior of a
combination of features. The set of techniques developed in this study attempts
to address this limitation where the basis of the selection involved the evaluation
of different combinations of features by simultaneously considering two or more
selection criteria.
Owing to the stochastic nature of the evolutionary based approaches developed in this
study, multiple optimal sets, consisting of a varying number of features, and of high
diagnostic relevance are obtained. While the multiple sets of features obtained via RSTGA (described in Chapter 4) showed a varying degree of overlap (in other words,
different numbers of common features), NSC-based approaches, namely NSC-GA,
NSC-MA, NSC-NSGA2 produced feature sets where a smaller set is always a subset of
a larger set from analysis of a specific dataset.
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An interesting consequence of this characteristic is seen when all these different sets of
features obtained via a NSC-based approach (e.g. NSC-GA) is used to construct
classifiers for classifying unseen test data. The domain expert can make informed
decision based on the tradeoffs between classification accuracy and size of a feature set.
For example, in the event where a set with 6 features produced the same classification
accuracy as a set with 7 features, the domain expert can examine the 7th feature and use
domain knowledge to decide on it potential relevance and make a decision about its
inclusion in subsequent analysis. Equally in another scenario, if sets with 1, 2, 3, 4, 5, 6,
7, 8, 9, 10, 21 and 23 features respectively resulted in classifiers producing the same
classification accuracy on the unseen test dataset, it would then appear that a major
contributing factor relates to 1 feature and the domain expert may validate this in a
subsequent clinical trial. This sort of information from the analysis is important as
reducing the number of features to a smaller promising set, for further investigations,
would reduce costs associated with future experiments and development of diagnostic
toolkits.
In summary, this thesis contributes towards a better understanding of incorporating
evolutionary approaches in the development of techniques for analysing biological data
from mass throughput technologies. The techniques developed here can be used for a
comprehensive analysis of a dataset, extracting information that biomedical researchers
can use to make informed decisions with regards to evaluation of sets of biomarkers for
biological relevance. The thesis also contributed to an increased understanding of the
impact of employing different similarity measure in NSC and demonstrated the need to
be aware of the possibility of classifier-biased when examining the sensitivity and
specificity associated with a specific set of features.
1.4. Significance


The developed techniques improves NSC and allows researchers using NSC to
be able to obtain shrinkage thresholds automatically, thus reducing time and
effort required.
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The developed techniques can be used for a comprehensive analysis of high
dimensional biological dataset, extracting information that biomedical
researchers can use to make informed decisions for subsequent investigations of
sets of biomarkers. Instead of traditional univariate analysis, the developed
techniques allowed biomedical researchers to examine the joint classification
behaviour of different sets of features in the development of diagnostic toolkits.

1.5. Structure of the thesis
The thesis consists of nine chapters. The primary theme in this thesis is the investigation
of evolutionary approaches for feature selection in biological data and this thread of
investigation starts with the pilot study described in Chapter 4, progressing to
investigation of GA for automatically obtaining the shrinkage thresholds for NSC in
Chapter 5, followed by the investigation involving memetic algorithms in Chapter 6 and
culminating in the multi-objective approaches described in Chapter 8. Chapter 7
described the investigations to examine the impact of different the secondary theme
being the impact of different similarity measures in NSC. Some preliminary concepts
and descriptions of the datasets for evaluation of the developed approaches are
described in Chapter 3.
The following section gives an overview of each of the remaining chapters in the study.
Chapter 2 describes a literature review consisting of 2 major sections 1) a review of
DM techniques and algorithms that have been previously developed by other
researchers for FS and classification in the domain of bioinformatics; and 2) technical
descriptions of algorithms that have been employed in the proposed approaches in this
study. These include RST, NSC, GA, NSGA2, MA and different similarity distance
measures (Euclidean, Mahalanobis, Pearson and MD) algorithms are discussed.
Chapter 3 describes 7 biological datasets, Alzheimer’s disease, Colon, Leukemia,
Lung, Lymphoma, Ovarian and Prostate cancer data, used in the study. Data
configurations for training and test sets, 10 fold cross validation (CV) strategy, as well
as general information of how the datasets were used to evaluate the developed
algorithms are also detailed in this chapter.
13

Chapter 4 describes the proposed approach RST-GA, which incorporated RST and GA.
K-means clustering method is used to find the centroid for partitioning data in the
reduction of features using RST approach with a non-deterministic algorithm, GA. The
results of evaluating the proposed are described using Colon and Leukemia cancer data.
Chapter 5 describes the proposed approach of incorporating NSC into GA (NSC-GA)
to automatically search for optimal shrinkage threshold values for NSC. In this chapter,
the details of the proposed approach, NSC-GA that utilised the training dataset for
obtaining optimal shrinkage threshold values for NSC automatically are described. Also
in this chapter, the details of the proposed approach that employed NSC as an evaluator
to evaluate the goodness of the feature subsets and GA as a search strategy to find
optimal shrinkage threshold values for NSC are described.
Chapter 6 describes the proposed approach of incorporating NSC into MA (NSC-MA)
to improve the search for finding optimal shrinkage threshold values for NSC
automatically. The details of a local search implemented in MA are also described in
this chapter.
Chapter 7 describes the proposed approach of incorporating different similarity
distance measures (Mahalanobis, Pearson and MD), into the NSC-GA framework to
improve the search for finding smaller sets of relevant features that lead to higher
classification accuracy.
Chapter 8 describes the proposed approach of incorporating the NSGA2 algorithm as a
MOEA into NSC to find multiple solution sets of optimal shrinkage threshold values
automatically for NSC. In this chapter, the details of the proposed approach, NSCNSGA2 that employed the NSC algorithm as an evaluator are also described.
Chapter 9 summarises the main findings from the thesis and outlined the proposed
approaches that have been developed in the study. Future work is also discussed at the
end of this chapter.
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1.6. Summary
This chapter has provided the background and highlights some important aspects that
lead to the use of FS algorithms and DM as necessary tools to select relevant features
and analyse biological data. The purpose of the study and contributions from the study
were also discussed. In the next chapter, previous studies associated with FS in
bioinformatics are described. Techniques applicable to this study are reviewed.
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2. Literature review
This chapter consists of 3 sections: 1) Review of DM and FS techniques; 2) review of
some existing work which applied FS techniques to select relevant feature subsets and
classify data in the area of bioinformatics; 3) review of techniques which were
incorporated in the implementation of proposed approaches in this study.
2.1. Data mining and feature selection techniques
As mentioned earlier in Chapter 1, microarrays and mass spectrometry techniques
generate massive amounts of high dimensional data. It is good in terms of data
enrichment and availability, but at the same time challenging in terms of selecting the
most relevant features for classifying the data accurately. DM and FS are approaches
that have been widely used for analysing high dimensional data. FS techniques are used
to select optimal (of minimal size) sets of relevant features from a high dimensional
dataset efficiently. The following sections describe the general concepts of DM and FS,
and specially the three categories of FS methods: filter, wrapper and embedded.
2.1.1.

Data mining

The task of automatically finding interesting patterns from large data repositories is
known as DM, and it can be categorized into predictive and descriptive tasks (Tan,
Steinbach, & Kumar, 2006). Classification techniques are associated with predictive
tasks where the aim is to predict the target variable using values of other attributes of
the dataset. This is known as a supervised learning classification technique because the
classification algorithm has to be trained in the training phase to produce the predictive
model which is then evaluated for its performance in the testing phase. For descriptive
tasks, techniques like clustering, also known as an unsupervised learning classification
technique, are used to classify data that do not have class labels. Thus, the classification
model does not need to be trained prior to perform the predictive task. The unsupervised
classification technique classifies data based on their similarity measures into a group
(class), e.g., similar distance measures, similar gene profiles. General concepts of
classification techniques are described in the following section.
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2.1.1.1.

Classification

As mentioned earlier, classification is a type of supervised learning. The classifier needs
to be trained with a training data, and evaluated with test data before being used for the
classification on an unknown data (Tan et al., 2006).

The process of supervised

learning may be illustrated by the following figure:

Training data

Classification Algorithm

Unseen test data

Classification model

Model evaluation

Figure 2-1 A general process of supervised learning for classification
As seen in Figure 2-1, in the process of supervised learning, a dataset is split into a
training set and a test set. The training dataset is used to train the classifier, generating a
classification model, whilst the unseen test dataset (not seen in the training phase) is
used to evaluate the classification model for its accuracy on prediction.
One measure of the performance of the training model is the accuracy of its prediction.
A smaller error rate in prediction indicates better and a more reliable a model. A
confusion matrix table is used to show the number of correct and incorrect predictions
for each class. Classification accuracy and error rates are calculated using Equation
(2.1) and (2.2) (Tan et al., 2006), as follows.

Accuracy

Error rate

number of correct predictions
Total number of predictions

number of wrong predictions
Total number of predictions

(2.1)

(2.2)
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According to Han, Kamber and Pei (2006), Tan et al. (2006) and Witten and Frank
(2005), the performance of a classifier is evaluated by using one of the following:
holdout, random subsampling, cross-validation and bootstrap techniques.


Holdout technique with stratification: the dataset is stratified into training data
and test data (e.g. ½ for training and ½ for testing or 2/3 for training and 1/3 for
testing). Stratification is the process where samples in the dataset are divided
proportionally into the training and test datasets with balance in classes. The
training data is used to build a classification model and the test data is used to
evaluate the accuracy of the model.



Random subsampling: the principle is similar to the holdout method but the
training and test process are repeated a number of times to obtain classification
accuracy accordingly. Each time the data are splitted randomly into the training
set and the test set (Dieterle, 2003). The average classification accuracy over a
number of iterations is the overall result for the classifier’s accuracy.



Cross-validation (CV): is the method to divide the dataset into a number (k) of
subsets, e.g. 10 fold CV where k=10. Each subset consists of a proportional
number of samples with balanced number in classes (stratification). K-1 subsets
are used as training data to train the classification model and the remaining
subset is used as test data to evaluate the model. This procedure is repeated k
times, e.g., for 10 fold CV the procedure repeated 10 times, therefore every
subset, in turn, is used as a test set. The average accuracy over k times is the
overall classification accuracy of the model. K-fold CV methods are normally
used in conjunction with the stratified holdout method as a standard method for
evaluating classification results, e.g., stratified 10 fold CV (Witten & Frank,
2005).



Bootstrap: similar to random subsampling, but samples that have been selected
for the training data still remained in the original dataset, so that they have a
chance to be chosen again. Bootstrap 0.632 is a popular approach used to
evaluate the classifier. With the Bootstrap 0.632 approach, the training set
consisting of 63.2% of the samples and the test set consisting of 36.8% of the
samples (Dieterle, 2003). The calculation of bootstrap .632 is shown in Equation
(2.3) (Tan et al. (2006), as follows.
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2.1.1.2.

)

(2.3)

Feature selection

Generic Steps in FS
According to Dash and Liu (1997) and Hall (1999) FS techniques consist of 3 major
steps:
Step 1: Apply a search strategy to obtain subsets of features. The search strategies
include: evolutionary algorithms, e.g., GAs or MOEAs, greedy, best first search with
forward search selection (FSS) and backward search selection (BSS).
Step 2: Employ evaluation criteria such as distance measures, information measures,
dependence measures or consistency measures. These measures are considered as a
filtering mechanism, because they are independent processes to evaluate the candidate
sunsets. Another measure is classifier error rate if a classifier is involved in the process
of evaluating the candidate subsets.
Step 3: Determine a stopping criterion to stop the iteration process of selecting subsets.
Stopping criteria might be based on a pre-defined maximum number of generations to
run the algorithm or the convergence of the algorithm or a solution is found
(Lancashire, Rees, & Ball, 2008). The following figure illustrates the above steps:
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Dataset
FS algorithm

Feature subsets

Feature Evaluation

No

Stopping
criteria?

Yes

Optimal
solution

Figure 2-2 Steps in a FS process
Many FS techniques have been developed and applied to a variety of fields such as DM,
bioinformatics and health related areas (Portinale & Saitta, 2002; Saeys, Inza, &
Larranaga, 2007). In general, these techniques fall into three categories: filter methods,
wrapper methods or embedded methods, which are described in the following sections.
Filter methods
Filter methods are performed prior to the use of a learning algorithm. Filter methods use
separate independent techniques such as T-test, Kolmogorov Smirnov (KS) test and Ptest to rank individual features (Levner, 2005). Filter methods select relevant features by
calculating scores for each feature. Features with low scores are eliminated from the list.
Thus only a number of high scoring features are retained and considered as relevant
features. At the end of the filtering process, only one feature subset is generated and
used to construct the classifier.
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Wrapper methods
Wrapper methods are different from the filter methods described above. Instead of
finding a relevant feature subset by a separate independent process, the wrapper method
has its own machine learning algorithm (classifier) employed as part of the FS process.
Unlike the filter method, numerous feature subsets are generated in the wrapper method
and each of them evaluated using the machine learning algorithm. The process iterates a
number of times until the best feature subset is found (Guyon, 2007; Guyon & Elisseeff,
2006; Inza, Larranaga, Blanco, & Cerrolaza, 2004; Saeys et al., 2007). The number of
iterations depends on the total number of features in the dataset (i.e., more features,
more subsets generated and thus more iterations are needed to obtain an optimal feature
subset).
According to Kohavi and John (1997), and Hall (1999), the learning algorithm
(wrapper) is considered as a “black box” due to components of the black box, including
FS, feature evaluation and the learning algorithm (classifier) itself, are not known from
the outside. The way the method works is that the “black box” generates feature subsets
using the training dataset and evaluates them using the classifier error or accuracy rate.
The process stops when the termination condition(s) is met and the best feature subset is
selected, and subsequently it is used for constructing the classifier.
Embedded methods
Embedded methods are methods that have a FS algorithm built into their classifiers, so
that the search for relevant attributes can be done within the classifier itself using the
dataset. As a result, a set of features is selected, and then a predictive model is generated
and evaluated by the classifier.
Due to the importance of relevant (optimal) features in classification of high
dimensional data, developing an advanced FS technique that can select the most
relevant features from this type of data is one of the foci of DM community. A large
number of search strategies have been developed by many DM researchers for finding
optimal feature subsets that can be used in the investigations for biomarkers. The
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following sections describe some FS techniques that have been proposed in previous
studies.
2.2. Feature selection approaches have been developed in the area of bioinformatics
The following sections describe some existing work related to FS approaches in the
domain of bioinformatics. This section consists of 4 sub sections that described FS
approaches involving evolutionary algorithms, rough set theory (RST), nearest shrunken
centroid (NSC) and hybrid FS approaches, respectively.
2.2.1.
2.2.1.1.

Feature selection using EAs
Genetic algorithm

The GA has been employed for FS as a standalone approach or as a hybrid approach
which incorporates other algorithms such as SVM, k-Nearest Neighbor (k-NN) for
finding feature subsets for high dimensional biological data. The following section
describes some of these approaches.
The GA was used in the study of Yang and Honavar (1998) to select relevant features
for the Wisconsin diagnostic breast cancer data. The overall fitness of sets of features is
evaluated based on the aggregation of 2 objective functions: classification accuracy
obtained from neural networks and the cost of performing the classification for each
candidate feature subset (solution). The study has demonstrated that GA selected a set
of features which is half the size of the entire feature space and still retained the same
accuracy of 92.1% as to the case of using all the features. In the study of Handels, Rob,
Kreusch, Wolf, & Poppl (1998), GA was also employed to select features for a tumour
skin cancer dataset. Similarly, the fitness of candidate solutions are also evaluated based
the aggregation of 2 objective functions, one for a number of features selected in the set
and another one for its associated classification accuracy. That is, one objective function
is employed for maximizing the minimal set of set features and another objective
function is employed for maximizing the classification accuracy of the selected feature
set. This study also showed GA selected a small subset of 5 features with the resulting
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classification accuracy of 97.7% and GA outperformed other search methods such as
the greedy and the ranking algorithms.
Another approach using the GA in the process of selecting relevant features was carried
out Jourdan, Dhaenens, & Talbi (2001). In this approach, the procedure of FS was
carried out using GA and k-means in 2 steps: 1) The GA was utilized for searching
optimal features with the aim to select a small subset of features from datasets with a
large number of features, 2) selected features from step 1 are used as initial input
features for a k-means clustering algorithm to cluster the data. As a result, the execution
time of the algorithm is much faster than using k-means without GA; from 7500
minutes down to 1 minute, and data were clustered effectively (Jourdan et al., 2001).
In the study of Sun, Babbs and Delp (2005), the GA was compared to Adaptive
Sequential Forward floating search (ASFFS) method for FS. Both methods were
evaluated using a small dataset of images of Breast cancer that consisted of 296 normal
regions and 164 cancerous regions. As a result, ASFFS outperform GA in terms of ROC
(Receiver Operating Characteristic) analysis (Az). ASFFS achieved Az = 0.964 and the
GA achieved Az = 0.917. The study concluded that, the GA application was more
suitable for a large dataset, while ASFFS performed better for a small or medium
dataset (Sun et al., 2005).
The GA was also applied to select a relevant set of features for a prostate protein MS
dataset in the study of Li et al (2008). Multivariate filter and wrapper methods were
used as objective functions in the GA to determine the fittest individual. With the
multivariate filter method, an evaluation criterion is built based on the scatter matrix and
Bhattachayya distance. With the wrapper method, an evaluation function is built based
on classification error rate and the posterior probability. This study achieved 92.7%
classification accuracy for the multivariate filter method and 97.75% for the wrapper
method. These results showed that the GA based multivariate filter and wrapper
methods as its objective functions improved the classification accuracy when compared
to other FS methods such as PCA and sequential selection methods (Y. Li et al., 2008).
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2.2.1.2.

Multi-objective evolutionary algorithms

In the study of Deb and Reddy (2003), a MOEA, called non-dominated genetic
algorithm (NSGA2), was implemented with binary encoding representation to find
multiple optimal feature sets for microarray cancer datasets: Colon, Leukemia and
Lymphoma. Three objective functions, f1, f2, f3, were implemented in their approach. f1
is for the size of gene subsets, f2 is for the number of mismatches (errors) in the training
dataset and f3 is for the number of mismatches (errors) in the test dataset. The proposed
approach, NSGA2, obtained 352 different three-gene sets that gave 100% classification
accuracy. In addition, NSGA2 was employed in an approach where a local search
strategy was incorporated into a MOEA in the study of Mitra and Banka (2006) for
performing biclustering on yeast and human B-cells datasets.
Rough sets and fuzzy set-based approaches for FS have also been combined with
MOEAs to select features and classify high dimensional datasets in the domain of
bioinformatics (Banerjee et al., 2007; S. Mitra & Hayashi, 2006). Banerjee et al. (2007)
proposed an evolutionary rough set based FS technique for analysing gene expression
data. The new FS approach was based on the RST with the application of MOEA to
search for optimal subsets. NSGA2 was employed as a MOEA to optimize 2 objective
functions simultaneously and generated a set of multiple optimal solutions. RST was
employed to generate a distinction table of smaller sets of relevant features and used as
initial inputs for NSGA2 to search for multiple optimal solution sets. This approach was
evaluated using Colon, Lymphoma and Leukemia microarray cancer datasets. As a
result, the number of relevant selected genes was smaller compared when to other
selection methods, such as neural networks, t-test based FS and SVM, and also the
accuracy of the classification was still retained at a very high level. This achievement is
due to the fact that, RST was used to generate reducts in the form of small subsets of
relevant features initially and then NSGA2 optimized the reducts to find the best subset
(minimal reducts) of relevant features with highest classification accuracy (Banerjee et
al., 2007).
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2.2.1.3.

Memetic algorithms (MAs)

Zhu, Ong and Dash (2007) used a MA to search for relevant features for the Colon,
Central Nervous System, Leukemia, Breast, Lung and Ovarian microarray cancer
datasets. They proposed the Wrapper-Filter Feature Selection Algorithm (WFFSA) and
Markov Blanket-Embedded Genetic Algorithm (MBEGA) which involves MA. Both
approaches were based on the traditional GA and a local search (LS) algorithm such as
ranking filter method for WFFSA and Markov Blanket for MBEGA. In these
approaches, binary representation was used for encoding chromosomes and the SVM
classifier was employed to evaluate the fitness of individuals in the population. The MA
based approach outperformed GA in terms of a faster convergence and smaller feature
subsets with higher classification accuracies.
Recently, Kannan and Ramaraj (2010) employed MA with a correlation based filter
ranking method as the LS algorithm and the Naïve Bayes classifier as a fitness evaluator
to evaluate the fitness of feature subsets. In their approach, binary representation was
used for encoding chromosomes, Subset Size-Oriented Common Feature method was
used for crossover and random bit flip method was used for mutation. The proposed
approach outperformed the other search algorithm such as GA and ReliefF-based GA in
terms of obtaining smaller feature subsets and higher classification accuracy.
2.2.2.

Feature selection using RST

An approach incorporating a greedy search algorithm into RST for selecting relevant
features was proposed by Zhong, Dong, and Ohsuga (2001). In their approach, RST was
first used to generate reducts (sets of minimal features), which were evaluated using the
Generalization Distribution Table and the Rough Set theory (GDT-RS) rules discovery
system (Dong, Zhong, & Ohsuga, 1999; Zhong, Dong, & Ohsuga, 1998). GDT is used
to evaluate the goodness of a rule and the RS theory is used to find the best rule. A set
of indispensable features is called “CORE” and cannot be eliminated from the feature
list, and can be also used to classify data. (Zhong et al., 2001). A greedy search strategy
was employed to search for optimal reducts from the reducts generated from the RST
step. Firstly, features (reducts) obtained from the RST step were used as initial feature
inputs for the greedy search algorithm, and then the greedy algorithm finds relevant
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features from the feature list using GDT-RS rules for feature evaluation. Features
selected are then added to the reduct until the set of optimal features are obtained. As a
result, the proposed approach selected the optimal set with 4 features for the Breast
cancer data, and 17 and 19 features for gastric cancer data (Zhong et al., 2001).
Midelfart et al. (2002) applied RST to select relevant feature sets and classify
microarray gene expression data. High dimensional microarray data might contain
irrelevant features that affect RST in terms of generating a large number of reducts of
irrelevant features and therefore less accuracy in class prediction. In order to address
this problem, Midelfart et al. (2002) used t-test statistics to measure features; first by
calculating the centroid of each class for each attribute and then to measure the
difference between them for any significance. Only the features with highest t-test
statistics were selected as significant features and subsequently used as feature inputs
for RST. The approach was applied to the gastric cancer data and the number of features
obtained in the selected subsets are from this approach range from 17-161 features
(Midelfart et al., 2002).
A new RST approach, called roughfication, was proposed to handle real values for
microarray data in the study of Ślezak and Wróblewski (2007). In the traditional RST
approach, real data values must be discretised prior to applying RST to generate reducts
and to classify data. The Roughfication approach creates a new information system (IS)
which based on the original IS. The new system used symbolic values (instead of real
values in the original system) during rule generation processes. The symbols are used to
form decision rules and subsequently used to predict the class for new samples. This
approach was evaluated using the Breast cancer dataset and results obtained were
compatible with other classification approaches (Ślezak & Wróblewski, 2007).
2.2.3.

Feature selection using NSC

One of the popular FS and classification algorithms in bioinformatics is the NSC
algorithm (Tibshirani et al., 2002) (due to its algorithm is simple and effective). It is
also known as Prediction Analysis for Microarrays (PAM) which is a software
implementation of the NSC. The NSC has been used in numerous studies (Arai &
Barakbah, 2007; Klassen & Kim, 2009; Levner, 2005; Ray et al., 2007; Rocha de Paula,
26

Gómez Ravetti, Berretta, & Moscato, 2011; Tibshirani, Hastie, Narasimhan, & Chu,
2003).
Tibshirani et al. (2003) used the NSC to analyse the Small Blue Round Cell Tumours
(SRBCT) and Leukemia datasets and obtained the set of 43 genes and 21 genes,
respectively. The set of 43 genes constructed a classifier that achieved the classification
accuracy of 100% and the set of 21 genes resulted in a higher classification accuracy
when compared to analysis involving the same datasets in Golub et al. (1999) using 50
genes (Tibshirani et al., 2003).
Arai and Barakbah (2007) compared the NSC method with other classification methods
such as Fisher’s Linear Discriminant Analysis (FLDA), Logistic regression
(LOGISTIC), k-NN, SVM, Penalized Discriminant Analysis (PDA) using the SRBCT,
Lung NSCI60 and Yeast datasets they showed that the NSC algorithm outperformed
these other methods in terms of classification accuracy.
In the study of Klassen and Kim (2009), the NSC algorithm was used to select features
for 7 different microarray cancer datasets namely, the SRBCT, Acute Leukemia,
Prostate, Lymphoma, Colon, Lung and MLL Leukemia datasets. From the analysis
involving the application of NSC, 43 features were selected for SRBCT, 21 features for
Acute Leukemia, 6 features for Prostate, 25 features for Lymphoma, 16 features for
Colon, 5 features for Lung, and 52 features for the MML Leukemia datasets with 100%,
94.11%, 90.91%, 86.6%, 75%, 93.7% and 95.4% test classification accuracy,
respectively.
Levner (2005) used the NSC algorithm to classify Ovarian (OC-H4, OC-WCX2a, OCWCX2b) and Prostate (PC-H4, PC-IMAC-Cu) MS cancer datasets. The study
experimented with the use of 20 different shrinkage threshold values ranging from 0.5
to 10 in increments of 0.5 to find the optimal shrinkage threshold. From their analysis,
the average classification accuracy for the five datasets were 62.1% for OC-H4, 94.4%
for OC-WCX2a, 97.2% for OC-WCS2b, 73.6% for PC-H4, and 76.4% for PC-IMACCu. The study also experimented with 200 different shrinkage threshold values ranging
from 0.5 to 10 in increments of 0.05 and obtained the same classification results.
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Ray et al. (2007) used PAM to analyse their Alzheimer’s disease dataset. From this
analysis, a set of 18 proteins were selected from 120 proteins. The set of 18 proteins
were used in the classification of test samples (Alzheimer’s disease, Non-demented
control (NDC), mild cognitive impairment (MCI)). The result from the analysis was an
overall 89 % classification accuracy. The performance of PAM was better than other
algorithms such as GA-ANN by Cho et al. (2003) (Ray et al., 2007). Following the
discovery of the 18 protein biomarker from Ray et al.’s study (2007), Ravetti and
Moscato (2008) and de Paula, Ravetti, Berretta, and Moscato (2011) also used the NSC
algorithm to perform classification on the same Ray et al.’s Alzheimer’s disease dataset
(2007).
Many approaches have also been proposed for modifying the NSC algorithm with the
aim of improving its performance. For example, Yeung and Bumgarner (2003)
developed the uncorrelated shrunken centroid (USC) and the error-weighted,
uncorrelated shrunken centroid (EWUSC) algorithms which are based on the NSC
algorithm. The proposed algorithms removed redundant, correlated genes which
reduced the number of features needed for classification. These algorithms were applied
to different types of cancer datasets such as Colon, Leukemia and Ovarian. The results
showed improvements in the classification accuracy and also in a smaller number of
relevant features. S. Wang and Zhu (2007) proposed 2 methods, Adaptive L∞-norm
Penalized NSC (ALP-NSC) and Adaptive Hierarchically Penalized NSC (AHP-NSC)
with 2 different penalty functions. ALP-NSC method penalizes the maximum absolute
relative difference (|dik|) between the class centroid and overall centroid for the ith gene,
if the maximum absolute |dik| is shrunken to 0 then all dik are automatically shrunken to
0. ALP-NSC also penalizes each gene differently by using a pre-defined weighting
scheme (wj); wj is small (i.e. less penalty applied) for genes that distinguishes different
classes, and wj is large (i.e. more penalty applied) for genes that are similar and do not
distinguish different classes. AHP-NSC penalizes the relative difference (dik)
hierarchically, i.e., within ith gene, different levels of dik are applied. The proposed
methods were used to analyse the Leukemia. Their study showed ALP-NSC and AHPNSC outperformed NSC in terms of selecting smaller sets of features with similar
classification accuracy.
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Although there is extensive work involving the NSC, both from using it to analysis and
from modifications for improvements, a major drawback is the determination of the
shrinkage threshold value. This value is still being manually selected using CV or
empirical methods. In addition, this value impacts on FS and classification in NSC. This
drawback limits the NSC algorithm to perform its best, owing to the fact that if
incorrect or sub-optimal shrinkage threshold values are provided to NSC, then the
algorithm does not perform fully at its best in selecting optimal feature subsets and
subsequently can lead to a lower classification accuracy. Thus, it is essential to develop
methods that can automatically find the shrinkage threshold values for NSC. That is, the
process of selecting the shrinkage threshold value is carried out automatically using the
respective training data. Subsequently, the optimal shrinkage threshold value obtained
from the automated process is used in the NSC algorithm to perform FS and
classification. This would overcome the existing drawback of the NSC algorithm. The
following section describes some of the hybrid approaches that incorporate a classifier
and an EA for selecting relevant features.
2.2.4.

Feature selection using hybrid approach

A hybrid approach that has been used to optimize the search for feature subsets is to
incorporate an EA (e.g. GA) with another algorithm (e.g. SVM) (Pujari, 2001). The
following section describes some studies that used hybrid EA approaches in FS and
classification.
In Peng, Xu, Ling, Peng and Du’s study (2003) study, GA was used in conjunction with
SVM to select features from 2 datasets, namely the NCI60 and GCM cancer datasets.
Unlike other search strategies that search for the best feature one at a time, GA searches
for subsets of features in high dimensional data, hence the algorithm is able to select a
small feature subset with a high accuracy of classification. The results of applying the
approach to 4 cancer datasets (Colon, leukemia, NCI60 and GCM) has shown that, the
algorithm is able to find a smaller subset of relevant genes that produces a higher
classification accuracy than previous methods such as rank-based gene selection and all
paired binary SVM (AP-SVM) (Peng et al., 2003)
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Cho et al. (2003) proposed an approach that incorporated GA and ANN for selecting
relevant features to classify an Alzheimer’s disease dataset of 32 samples with 118
features. An initial feature subset was generated, each feature in this subset was
evaluated using ANN to determine their fitness. GA performed FS based on the fitness
of the individuals. Only dominant features from each generation were selected. These
selected features were used as a relevant feature subset to input for the neural network,
which increased the network efficiency. Experimental results showed that 35 features
were selected from 118 features, and the classification accuracy was 81.9% on the test
data. GA was able to select relevant features to classify Alzheimer’s disease data from
non- Alzheimer’s disease data, which was very useful for early detection of the disease
(Cho et al., 2003)
Jirapech-Umpai and Aitken (2004) proposed a hybrid EA approach for multiclass
classification. The approach combines GA and k-NN with the use of 6 ranking methods
(Information gain, Twoing rule, Gini index, Sum minority, Max minority and Sum of
variances) as fitness selection method to determine best features for GA. In the study,
binary representation was used for chromosomes in the GA population, k-NN was
employed as a measure function between samples using Euclidean distance. The
proposed algorithm of GA and k-NN was evaluated using 2 microarray datasets:
Leukemia and NCI60. The approach selected sets of features with 92% - 98% and
76.23% classification accuracy on the 2 datasets, respectively (Jirapech-Umpai &
Aitken, 2004).
In the study of Li Li et al. (2005), the combination of GA and SVM (GA-SVM) has also
been implemented to select an optimal subset of genes. The proposed GA-SVM used
the power of GA for searching relevant features, and the SVM classifier to evaluate the
goodness of feature subsets. The approach was applied to a diffuse large B-cell
lymphoma (DLBCL) microarray dataset. From the analysis, 99% classification accuracy
was obtained, which outperformed other FS methods such as the combination of GA
and k-NN (GA-kNN), and filter methods (t-test, non-parametric scoring) (Li Li et al.,
2005)
Lu, Tian, Neary, Liu, and Wang (2008) proposed a hybrid FS approach, incorporating
GA to improve FS on 2 microarray datasets: Colon and Prostate cancer dataset. The
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hybrid algorithm uses the features selected from other selection methods: 2 from filter
based methods (entropy-based and T-statistics) and 1 from a wrapper method (SVMRFE). The features selected from these three methods are combined together to form a
feature population. GA uses this feature population as an initial population to start with
and to produce an optimal (or near optimal) subset with a smaller size, but more
accurate in prediction. The result from the study shows that, hybrid FS with GA is more
effective, efficient and accurate in selecting small subsets than the other FS methods
mentioned above. The study also found that top-ranked features do not necessarily give
more accuracy than the lower-ranked features because interaction, correlation and
redundancy between features are to be considered when classifying the data (Lu et al.,
2008)
2.3. Techniques related to the implementations of proposed approaches in the study
for FS and classification
2.3.1.

K-Means

The k-means clustering algorithm was proposed by MacQueen (1967) . It is one of the
most commonly used clustering algorithms for grouping data into different clusters for
large datasets (Huang, 1998). The following figure illustrates a basic k-means
algorithm.

1. Generate initial cluster
centroids randomly
2. Allocate data points to clusters

3. Re-calculate cluster centroids

No

4. Cluster
Convergence?

Yes

Final
Clusters
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Figure 2-3 Basic k-means algorithm
As seen in Figure 2-3, step 1 is to generate initial centroids randomly for the k clusters,
i.e., one centroid for one cluster; in step 2, each data point is placed into the cluster that
has a closest centroid to the data point; step 3 is to re-calculate the new centroid for each
cluster using the new data points and step 4 is to check for cluster convergence. Step 2
and 3 are repeated until the cluster centroids do not change, i.e., convergence takes
place.
2.3.2.

Rough Set Theory

It is common for datasets to contain decision variables (classes) which cannot be used to
differentiate the samples. For example, two or more samples have the same attribute
values but belong to different classes and therefore the samples cannot be assigned
correctly to the class they belong based on values for these types of variables. This
causes problems in classification when the classifier tries to classify data to a certain
class. A rough set (RS) approach was proposed by Pawlak (1982). This approach was
developed on a mathematical basis and could be used to classify indiscernible data. The
RS approach has also been used effectively in FS (Hu, Yu, Liu, & Wu, 2008; Pujari,
2001; Swiniarski, 2001). According to Han, Kamber and Pei (2006), the RS is based on
equivalence classes containing samples that are identical in terms of attributes
describing the data. The RS classifies a class by using a lower approximation and an
upper approximation for the class. The lower approximation for the class consists of all
the samples that can be described as definitely belonging to the class, “positive cases”,
whilst the upper approximation for the class consists of all the samples that are
described as possibly belonging to the class, “possible cases” (Pujari, 2001, p. 57).
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A given class, C

Universe U

Lowe

Lower approximation of C
(positive region)
Upper approximation
(possible region)

Upper approximation of C

Negative region

Figure 2-4 Rough set with lower and upper approximation of a given class, C, adapted
from Han, Kamber and Pei (2006, p. 352) and Hu et al. (2008, p. 3582).
The circle in Figure 2-4 represents a given class (C) that consists of the outlined cross
hatched rectangular region (positive region) as a lower approximation, shaded
rectangular region (boundary region) as an upper approximation. Each rectangle of the
positive and boundary region represents an equivalence class. The samples of the
positive region are identified as belonging to C; whilst the samples of the boundary
region partly covered by C (i.e., samples with similar feature values which belong to
more than one class) are possibly belonging to C, but that status cannot be verified with
certainty. All the samples outside the boundary in the white rectangular region (negative
region) are definitely not belonging to C.
The lower approximation of class C:

={

} where

is an equivalence

class. Thus all the samples in the equivalence classes are in C. The upper approximation
of class C:

={

}. Thus not all the samples in the equivalence classes

are in C. The result of the intersection between equivalence classes and C is a nonempty set. The boundary region is the region of the difference between lower and upper
region and is calculated as Boundary AC =

-

. The boundary region indicates the

roughness of C. The smaller boundary region has the better confidence in classification.
The negative region is the region outside the upper approximation region, NC = U-

.
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The accuracy of the rough set is calculated by dividing the lower approximation by the
upper approximation (lower/upper).
Rough set can also be used to as a pre-processing approach to eliminate a number of
redundant attributes for a high dimensional data based on the equivalence classes, lower
and upper approximation (Jaaman, Shamsuddin, Yusob, & Ismail, 2009), prior to
applying a FS or/and classification technique to select optimal feature subsets to classify
data more effectively.
2.3.3.

Nearest Shrunken Centroid algorithm

As mentioned earlier, the NSC algorithm has been used widely in bioinformatics as a
FS and classification technique to select the most relevant features and to classify high
dimensional biomedical data, e.g., Leukemia data. The following section describes the
NSC algorithms in details.
The NSC algorithm shrinks the class centroid for each feature (gene) toward the overall
centroid for all classes by an amount of shrinkage threshold, ∆. The class centroid ̅
for class k for gene i is calculated using Equation (2.4).
∑
̅

where

(2.4)

is a gene expression value for gene i =1...p and sample j = 1...m, Ck is an

index of nk samples in class k.
The overall class centroid ̅i for gene i is calculated using Equation (2.5).
̅i
The relative difference,

∑

(2.5)

i

is the difference in class centroid, ̅

and the overall class

centroid, ̅i , standardized by the within class standard deviation of gene i, si. The
formula for calculating relative difference

, is defined by Equation (2.6).
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̅i - ̅i

(2.6)

(si so )
1

1

k

n

where mk = √n

s0 = median value of si over all genes
The relative difference, dik is evaluated to 0 if it is equal to 0 or smaller than the
threshold, ∆, else reduce dik by the threshold, ∆. The updated dik is called a shrunken
relative difference, d’ik. The calculation for d’ik is shown in Equation (2.7).
|

|

if |

|

. Otherwise 0

Class centroid for gene i is updated by using the new value of

(2.7)
as shown in

Equation (2.8).
̅

i

̅i

(si

so )

(2.8)

If a gene is shrunk to zero for all classes, then it is considered not different from the
overall centroid (i.e. irrelevant genes from a classification point of view) and is
eliminated from the gene list (Klassen & Kim, 2009) Genes with at least one positive
shrunken relative difference (over all classes K) are retained as relevant attributes
(K. Yeung & R. Bumgarner, 2003). Selected attributes are then evaluated by calculating
the discriminant score for class k for a new sample X* ={x*1, x*2 ,…, x*p}, as shown in
Equation (2.9).

( )

∑pi

- 2 log

(2.9)

The first part of Equation (2.9) is the standardized squared distance of x* to the kth
shrunken centroid, and the second term of Equation (2.9) is a correction based on the
class prior probability

, where

= nk /n.

Based on the discriminant score for each class, sample x* is classified to the class k that
has a minimal discriminant score defined by Equation (2.10).
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(2.10)
where C( ) is an assigned class of sample x,

( ) is a class discriminant score,

( )

is a minimal class discriminant score.
The general steps of NSC algorithm are shown in the following figure.
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Step 1. Calculate class centroid for attribute (gene) i of class k
̅

∑

Step 2. Calculate overall centroid for all classes ( ̅i
̅i

∑

i

Step 3. Calculate the relative difference (dik)
 Calculate class standard deviation of attribute (si)
∑
∑
si 2 =
( ̅
̅ )


Calculate so, median value of si over all attributes



Calculate



Calculate relative difference

√
̅ - ̅

Step 4. calculate the shrunken relative difference (
if | | > threshold (∆)
while | |>threshold (∆)
| | = | |-∆
= sign( ) (| |)
else
=0

)

Step 5. Update class centroids for attribute i
̅
̅
Step 6. Repeat step 1 to 5 until all attributes are processed
Step 7. Select relevant attributes with at least one positive shrunken relative
difference ( ) over all classes
Step 8. Evaluate the set of relevant attributes selected
 calculate discriminant score for class k for a new sample ( )

∑
where


̅

-

is a sample with attribute values
=
/

Assign sample
scores:

..,

to the class k that has a minimal discriminant

Figure 2-5 Steps of the NSC algorithm
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2.3.4.

Evolutionary Algorithm

Evolutionary algorithm (EA) is a search method, based on the principle of survival of
the fittest which was borrowed from the evolution of biological nature. Basically, a
number of generations are iterated through EA; each generation consists of a numerous
individuals. The later generations contain fitter individuals which maybe a subset of
previous generations. Only individuals which survive as the fittest are retained from
generation to generation, and the fittest individual subset is selected at the end of the
process. GA and MOEA are the 2 typical types of EA which are described in the
following section.
2.3.4.1. Genetic Algorithm
GA was proposed and developed by Holland (1975) and is based on Darwin’s theory of
survival of the fittest. GA consists of components such as population representation,
objective function, evaluation of population, selection, crossover, and mutation
operators. Figure 2-6 shows the steps in a GA.

Figure 2-6 Basic steps of GA
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Initial population

Individuals in the population are randomly generated.


Fitness evaluation

The algorithm uses an objective function (s) to evaluate the fitness of individuals in the
population.


Selection

Once the process of ranking the fitness of individuals is done then the selection of
individuals is carried out in order to find which individuals will be combined to produce
offspring. Many selection techniques have been used in the area of GA and these
include: Ranking selection, Roulette Wheel selection and Tournament selection.
According to Miller and Goldberg (1995), an ideal selection technique is the technique
that would be simple in implementation, efficient in performance and adaptable in
different domains. Tournament selection has been widely used in GA because of its
usefulness and robustness, and it satisfied all the criteria mentioned above (Miller &
Goldberg, 1995).
Tournament selection is also known as a random tournament selection that selects k
number of individuals randomly from the population pool to form a tournament group
of size k and the fittest individual from the group is then selected for crossover
(Goldberg & Deb, 1991; Hoefsloot, 2013; Miller & Goldberg, 1995). A binary
tournament selection is a special case of random tournament selection in which, the size
of the tournament group is 2. That is, two individuals are selected randomly from the
population to form a tournament group of size 2 and the best individual of the group
(i.e. the best of the two) is selected (Deb, Pratap, Agarwal, & Meyarivan, 2002; Suzuki,
Takahashi, & Shibahara, 1995). The following figure describes the general process of
selecting individuals using tournament selection.
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Input:
Chromosome population (p)
Fitness population (Fp)
Output:
Selected parent chromosomes (Cparents)
Steps:
1. Set k = size of tournament
2. Set Tournament (Tk) = { }
3. Set n = max number of parents to be selected
4. For counter from 1 to n
a. For counter from 1 to k
 Select chromosomes randomly from p
 Store selected chromosomes into Tk
b. Compare fitness of individuals in Tk using Fp
c. Select a chromosome with the best fitness (Cbest)
d. Store Cbest into Cparents
Figure 2-7 Tournament selection procedure


Crossover (recombination)

The crossover process combines two or more selected parents from previous steps to
produce offspring. This method depends on the type of chromosome representation,
e.g., binary crossover (crossover with single, double, multi points, uniform and
arithmetic) is used for binary representation. Generally, the steps in crossover involve:
1) two parent candidates are selected for crossover, 2) a crossover parameter is used to
determine whether the crossover operation will take place, 3) a random number is
drawn, i.e., for one point crossover, in the case of multi points crossover then more than
one random number need to be drawn, to determine the position (s) where the crossover
take place on the parents, 4) the parents are crossed over at the randomly selected
position(s) to produce the new individuals (offspring). The following figure illustrates
one point binary crossover between two parents which is related to the study.
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Figure 2-8 Example of a one point binary crossover
As seen in Figure 2-8, two parents are split into ‘head’ (in blue) and ‘tail’ (in green) at
the cross position (Cp), the ‘tails’ of 2 parents are inter-changed to produce 2 offspring.


Mutation

After the crossover process, offspring are mutated to produce new individuals with
different features which are not present in their parents. According to Eiben & Smith
(2007), mutation operators can be applied for binary, integer, real and permutation
encoding representations. The following section describes the bit flip mutation
procedure for binary representation and uniform mutation procedure for real-value
representation, both of which are used in this study.
Bit flip mutation for binary representations:
A bit flip mutation is the type of mutation where each bit in the chromosome is allowed
to change its value independently with a small mutation probability (Pm). That is, if the
random number generated for the bit is less than Pm and if the bit is 1 then it changes
(flips) to 0 or if the bit is 0 then it changes to 1 (Eiben & Smith, 2007).
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Input:
Chromosome (chrom)
Mutation probability (Pm)
Output:
Modified chromosome (chromMod)
Steps:
1. Set len = length of chrom
2. Generate a random number (Rn) in the range [0, 1] using a
random number generator (RNG)
3. If Rn < Pm
For counter =1 to len
Generate a random number (Rn) in the range [0, 1] using RNG
If Rn ≤ Pm
Do bit flip on chrom [counter]
chromMod = chrom
4. Else
No mutation
Figure 2-9 Bit flip mutation procedure
The algorithm for Uniform mutation for real-encoding representations is shown in
Figure 2-10.
Input:
Chromosome (chrom)
Mutation probability (Pm)
Output:
Modified chromosome (chromMod)
Steps:
1. Set len = length of chrom
2. Generate a random number (Rn) in the range [0, 1] using RNG
3. If Rn < Pm
Find the lower bound value of chromLb
Find the upper boundary value of chromUb
For counter =1 to len
Generate a random number (Rn) in the range [0, 1] using RNG
If Rn ≤ Pm
Calculate chrom[counter] =chromLb + (Rn * (chromUb - chromLb))
chromMod = chrom
4. Else
No mutation

Figure 2-10 Uniform mutation procedure
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New population generation:

Best offspring from selection, crossover and mutation process is placed into the new
generation. The process of selection, crossover and mutation are repeated until the new
generation of the population is completed.


Termination:

The process of fitness evaluation, crossover, mutation and new population generation
are repeated until a stopping condition is met. For example, such as a solution is found
after a pre-defined number of iterations.
2.3.4.2. Multi-objective evolutionary algorithms
In the real world, tasks are normally associated with multiple conflicting objectives such
as the conflict between performance, cost, fuel efficiency, reliability, etc., For example,
a car that performs well but consumes less fuel and is of a reasonable price. There is no
single best solution that satisfies multiple conflicting objectives simultaneously, rather a
set of solutions with trade-offs between conflicting objectives. Multi objective
algorithms use more than one objective functions to optimize a problem. MOEA solves
the problem effectively by dealing with multiple conflicting characteristics represented
by the objective functions, and generates a set of optimal solutions, e.g., Pareto front of
optimal solutions, which are the set of all non-dominated solutions (Ayala & Coelho,
2008).
MOEA is classified on the basis of its selection approach. There are three different
types of MOEA (Coello & Lamont, 2004):


Aggregating function approach which combines all the objective functions into a
single objective function. The weighting (w) of each objective function, which
indicates the importance of one objective function over the others, is used in this
approach, e.g., F= w1f1 +w2f2 … wnfn. The limitation of this approach is that it
does not give a set of different possible best solutions to satisfy all objectives, rather
than one general solution for all objectives.



Population based approaches which use the population to improve the diversity of
the search but not incorporating the concept of Pareto front in the selection process.
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Vector Evaluated Genetic Algorithm (VEGA) (Schaffer, 1985) is a typical example
for this type of approach. At each generation, sub-populations are created based on
objective functions, i.e., each objective function is used in turn in the selection
process to generate a subpopulation of size of the total population size (M) over a
number of k objectives. A new population of size M is then created from these
subpopulations. Genetic algorithm evolves the new population with the use of
selection scheme, crossover and mutation operator. The drawback of this approach
is that if an individual has a good overall fitness for all objectives but is not the best
individual for any individual objective, then it is discarded.


Pareto based approaches which incorporate the concept of a Pareto front into
MOEA. The objective function used to search for a Pareto Front which is a set of
optimal solutions is defined by Ayala and Coelho (2008), as follows.
Optimized F( ) = (f1 ( ), f2 ( ), … fn ( ))

where n= 1, 2,.., k; decision variables x = ( 1,

2,

…,

n)

X; X = feasible solution set;

fn are objective functions. The concept of a Pareto front is discussed in Chapter 8.
NSGA2 incorporates the concept of Pareto front into MOEA (Deb et al., 2002). This
study uses NSGA2 in the approach of incorporating NSGA2 into NSC for finding
multiple optimal shrinkage thresholds. NSGA2 will be described in Chapter 8.
2.3.5.

Memetic Algorithms (MAs)

MAs are similar to evolutionary algorithms such as GA. A common definition of MA is
“A memetic is an Evolutionary Algorithm that includes one or more local search phases
within its evolutionary cycle” (Krasnogor & Smith, 2005, p. 2). Gene values in GA are
known as memes (Dawkins, 2006) in MA. The term, meme, is referred to a unit of
culture evolution or transmission where the local improvement for chromosomes takes
place using local search (LS) algorithms such as hill climbing (Elbeltagi, Hegazy, &
Grierson, 2005; Wu, 2001a). Thus MA is a hybrid of EAs which combines an EA and a
local search (LS) to improve the fitness of chromosomes (Krasnogor & Smith, 2005;
Wu, 2001a).
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MA has additional steps of LS for improving the fitness of chromosomes in the
population by finding local optimum neighbours in chromosomes prior to the normal
process of crossover and mutation operations. Each new population is evolved locally
using LS and then globally via GA. This cycle repeats until the stopping criteria such as
global convergence takes place or the pre-defined number of generations has been
executed.
The combination of GA and LS makes MA more efficient and effective in terms of
processing time for converging to optimal solutions, finding smaller sets of features,
and improving classification accuracy when compared to other traditional EAs such as
GA (Elbeltagi et al., 2005; Zhu et al., 2007). Different LS strategies such as pair-wise
LS (Merz & Freisleben, 1999), improvement first strategy LS and greedy LS (Zhu et
al., 2007) can be incorporated into GA in different ways. A LS strategy can be applied
to


only elite chromosomes or



the entire population, or



either after the crossover and/or mutation operation

The following section describes some strategies of implementing MA with different LS
methods.
Elbeltagi et al. (2005) described a LS using pair-wise swapping proposed by Metz and
Freislenben (1999). A swapping strategy to interchange 2 memes (genes) was applied to
chromosomes in order to find the best local neighbour in the chromosome. Figure 2-20
illustrates the use of this pair-wise swapping strategy.
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Chromosome before LS (a)
Meme1

Meme2

Meme3

Meme4

Meme5

Meme6

Meme7

Meme8

Meme6

Meme7

Meme8

LS
Pair Swapping

Pair-wise
swapping

Meme2

Meme1

Meme3

Meme4

Meme5

New chromosome after LS (b)
Figure 2-11 An example of LS using pair-wise strategy
As seen in Figure 2-11, the pair of ‘Meme1’ and ‘Meme2’ of chromosome (a) is
swapped to form a new chromosome (b). The process of swapping between the pair
continues for the remaining pairs, e.g., pair of Meme1 and Meme3, Meme1 and Meme4,
...., Meme1 and Meme8, pair of Meme2 and Meme3, Meme2 and Meme4, ...., Meme2
and Meme8, and so on. The number of pairs (N) to be swapped is calculated using
Equation (2.11).
N = ½ (n (n-1))

(2.11)

where n is the length of chromosome.
For example, let chromosome A has the length, n = 1000, then N = ½ (1000(1000-1)) =
499500. That is, LS needs to process 499500 pair-wise operations. This could involve a
large computational time when using this LS strategy. According to Elbeltagi et al.
(2005), in order to reduce the cost of computational time, the swapping between pairs
stops as soon as the fitness of the chromosome is improved (Merz & Freisleben, 1999).
This is known as an improvement first strategy (Zhu et al., 2007), i.e., no need to
continue performing the swap for the remaining pairs once the first improvement of the
chromosome has been found. The procedure of pair-wise LS with improvement first
strategy is described below.
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Input
Chromosome (chrom)
Fitness of chrom
Output
Improved chromosome (chromImp)
Steps
1. Calculate the number of pairs of memes, N=1/2 (n (n-1))
2. For counter =1 to N
Swap the positions of the pair to create a new chromosome (chromnew)
Evaluate the fitness of chromnew
If the fitness of chromnew > fitness of chrom
chromImp = chromnew
Stop swapping pairs and exit
Process the next chromosome
Figure 2-12 Pair-wise LS with improvement first strategy used in Elbeltagi et al. (2005)
The adding subtracting LS strategy involves searching for a better chromosome in
terms of fitness by adding or subtracting a small random value to a meme (gene) value
in the chromosome to create a new chromosome. The fitness of the new chromosome is
then evaluated, if an improvement is obtained then the new chromosome is retained
otherwise discarded. The process continues for the rest of the memes in the
chromosome (Elbeltagi et al., 2005). This is called a greedy search strategy (Zhu et al.,
2007) or a hill climbing search strategy where the search progresses from the current
chromosome to the one that has a better fitness (Kohavi & John, 1997; H. Wang, Wang,
& Yang, 2009). According to Elbeltagi et al. (2005), MA using the adding and
subtracting LS with a greedy strategy outperformed GA in terms of a better
classification accuracy and processing time. The procedure of adding and subtracting
LS with a greedy strategy (Elbeltagi et al., 2005) is described in Figure 2-13.
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Input
Chromosome (chrom)
Fitness of chrom (chromfit)
Population size (S)
Chromosome length (len)
Output
Improved chromosome (chromImp)
Steps
1. Generate a random value, Rn
2. For counter1 =1 to S
For counter2 =1 to len
Add Rn to chrom[counter2] to create a new chromosome (chromnew)
Evaluate the fitness of chromnew
If fitness of chromnew > chromfit
chromImp = chromnew
update chrom = chromnew
Else
subtract chrom[counter]from Rn to create chromnew
evaluate the fitness of chromnew
if fitness of chromnew > chromfit
chromImp = chromnew
update chrom = chromnew

Figure 2-13 Procedure of greedy search strategy using adding and subtracting LS
(Elbeltagi et al., 2005)
According to Zhu et al. (2007), the improvement first strategy LS outperformed the
greedy strategy LS. Their study also found that when applying the improvement first
strategy LS on a few of elite chromosomes, results obtained were better than those
obtained from applying LS on all chromosomes.
Elbeltagi et al. (2005) proposed another MA approach where the LS is applied to
offspring after the crossover or mutation process. In the Guided Local Search (GLS)
Based Memetic Algorithm (Krasnogor & Smith, 2005), the LS is applied to offspring
after the crossover and mutation operations.
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2.3.6.

Similarity distance measures

From the literature, it can be seen that different similarity measures have been used to
cluster gene expression data into groups of similar genes and in classification. A
similarity measures is used in the process for grouping genes into clusters, whereby
genes in the same cluster are as similar as possible, and are very different from genes in
another cluster. For example, Pearson correlation measure considers the correlation
between two genes for measuring the similarity between genes. Similar genes have a
positive correlation and are related (Leale et al., 2013). Genes that similar in expressions
(i.e. close in similarity distance measure) are grouped into a cluster (class) (Deshpande,
VanderSluis, & Myers, 2013). Genes in the same cluster are likely to be involved in the
same cellular processes and biological functions (Paul & Maji, 2014). The set of
selected features from a biological perspective implies that the level of expressions
associated with the selected biomarkers differ significantly between disease and nondisease. There’s little existing evidence as to which measure is most effective but
previous studies have shown that the use of different similarity measures have an impact
on the clustering/classification results. The following sections describe some commonly
used similarity distance measures. These include Euclidean, Mahalanobis, Pearson
correlation and Mass distance.
2.3.6.1.

Euclidean distance

Euclidean distance satisfies the triangle inequality and is the most commonly used
distance measure. It is the method of measuring the distance between 2 points based on
Pythagoras’ theorem (A2 = B2 + C2). For example, points with 2 dimensions A { ,
and B { ,

}, the squared distance between A and B is the total of squared differences
–

of coordinates between A and B. Hence the distance is the square root of
–

}
2

2

, as shown in Equation (2.12).

EucliDAB = √

–

2

Points in multi-dimensional space, e.g., A{ ,

–

, ..,

2

} and B{ ,

(2.12)

, ..,

}, the

Euclidean distance measure is calculated as follows:
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EucliDAB = √∑

)2

(

(2.13)

Euclidean distance have also been used in classification to classify a sample with
multiple features, { ,

, ..,

} to a class. In this case, a sample is assigned to a class

based on the distance between the sample and its class centroid. The Equation (2.13) is
re-written as follows.

√∑

Where

(

)2

(2.14)

is the mean of class k of jth feature
is the sample of jth feature
n is a number of features.

2.3.6.2.

Mahalanobis distance

Mahalanobis distance is a popular method that has been used widely as a distance
measure in clustering and classification (Wölfel & Ekenel, 2005). Mahalanobis distance
(Mahalanobis, 1936) is the method of measuring the distance between the centroids of 2
classes or the distance between a variable and a class centroid. Unlike Euclidean
distance, in which the different class densities are considered to be equal and only the
distance from a data point to a class centroid is a criterion for classification, in
Mahalanobis distance, the different class densities are taken into account when
classifying data (McLachlan, 1999).

Figure 2-14 illustrates Mahalanobis distance

measure.
Data density

Class A

x

Data density

Class B

Figure 2-14 Mahalanobis distance measure
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Variance of each variable and the co-variance between variables are taken into
consideration in the Mahalanobis distance calculation. It handles problems associated
with poorly and highly correlated features in a dataset.
Mahalanobis distance measure is calculated as follows.
MahaD ² = (x - µ)T Σ-1(x - µ)

(2.15)

where µ: class centroid
superfix T: matrix transpose
Σ-1: inverse covariance matrix
2.3.6.3. Pearson distance
Pearson correlation (Pearson, 1895) is a method for measuring the correlation between 2
variables. The correlation is measured in the range of -1 to +1. +1 means the correlation
is a perfect positive linear relationship, 0 implies an uncorrelated relationship and -1 is a
perfect negative linear relationship. Pearson correlation is calculated as follows.

(r) =

∑ (x- ̅ ) (y- ̅ )
√(x- ̅ )2 √(y- ̅ )2

Pearson Distance (PD) = 1- r

(2.16)

(2.17)

where x is variable value
̅ is class centroid
According to Equation (2.17), when r approaches 1, PD approaches 0, i.e., the distance
is 0, thus attributes have a linear relationship; when r approaches to 0, PD approaches to
1 (PD = 1-0), i.e., the distance is 1, thus attributes have an uncorrelated relationship;
when r approaches to -1, PD approaches to 2 (PD =1-(-1)=2), i.e., the distance is 2, thus
attributes have negative linear relationship.
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The problem of using the Pearson distance as defined by Equation (2.17) is that the
relationship between the distance and correlation coefficient is not mapping
appropriately for measuring the correlation distance between variables. To address this,
D. Wang, Wang, Lu, Song and Cui’s study’s (2010) used the absolute Pearson’s
correlation coefficients, | r | to measure the similarity for microRNA, PD is calculated
using | r | instead of r. Thus Pearson correlation distance is now calculated as follows.
PD = 1 - | r |

(2.18)

According to Equation (2.18), when r approaches to 1 or -1 then | r | = 1, PD
approaches to 0 (PD=1- |-1|), that is the distance is 0 and attributes have a positive or
negative linear relationship; when r approaches to 0, PD approaches to 1 (PD = 1 - 0),
that is the distance is 1 and attributes have an uncorrelated relationship.
2.3.6.4. Mass distance
Euclidean, Mahalanobis and Pearson distance do not consider the background
distribution of attributes while calculating the distance (Yona et al., 2006).
MD measure is a method that has been used for evaluating gene expression similarity
and takes into account the background distribution of attribute values in the calculation
of the distance (Yona et al., 2006). Unlike the other measures such as Euclidean,
Mahalanobis and Pearson, MD calculates the distance between two variables by
measuring the relative difference between the variables and by measuring their
probability mass (volume). Two variables are more similar (closer) when they have
smaller volume (Yona et al., 2006).
The equations used to calculate MD for 2 variables (a, b) are taken from Yona, et al.
(2006).
Calculation of probability mass for 2 variables a and b for sample i:

∫

(2.19)
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Where

)

√

=(

is the normal distribution for

sample i.
(

Where

√

)

(2.20)

is a class centroid
is a standard deviation of the class

(2.21)

max and min are the maximum and minimum value of the variables
Hence

can be re-written using Equation (2.20) and (2.21) as follows.

(∫

(

√

)

) (

)

(2.22)

Mass Distance (MD) of variable a and b is obtained by first calculating the total volume
of measurement values bounded between the 2 variables and followed by taking the
product over all samples, as shown in Equation (2.23).
∏

(2.23)

where d is the number of samples.
2.4. Discussion and Summary
From the review of the literature, it can be seen that the biomedical area is data rich
through the development of high throughput technologies such as microarrays, mass
spectrometry and from the international genome projects. Development of new
computational techniques to analyse these data is vital for progress to be made from
bio-information to in the bio-knowledge and followed by drug discovery. One approach
involved feature selection and techniques involved evolutionary approaches, rough set
53

theory, various machine learning techniques and hybrids of some of these approaches.
However given the characteristics associated with biological datasets, approaches
involving traditional statistical approaches and machine learning techniques as
described in Section 2.2 may not effective in their analysis.
From a biomedical perspective, groups of features are also known to work together as
components in a biological pathway. However, as seen in the review, many existing
data analysis approaches in bioinformatics may only involve evaluating each feature
separately (univariate analysis) and do not consider possible correlations amongst
features nor the joint behavior of a combination of features. There is an increasing need
for development of techniques that attempts to address this limitation and where the
basis of the selection involved the evaluation of different combinations of features by
simultaneously considering two or more selection criteria.
In summary, this chapter has briefly described fundamental concepts associated with
DM and FS methods. Existing work related to FS and classification approaches for
analysing high dimensional biological data were also outlined. Lastly Section 2.3
presented a review of the various techniques associated with the proposed approaches in
this study.
The next chapter describes common elements in this study. These include the seven
datasets used to evaluate the approaches in this study, the CV strategy, the process of
checking for the state of convergence and termination conditions for the GA.
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3. Datasets, Evaluation strategy, Convergence and Termination
criteria
This chapter has four main sections that described common elements employed in this
study. The first section described the datasets used for evaluating techniques developed
in this study, the second section outlined the CV approach, and Section 3 and 4 detailed
the process of checking the state of convergence and termination conditions for the GA,
respectively.
3.1. Datasets
This section describes 7 biomedical public datasets associated with various diseases,
ranging from Ray et al. Alzheimer’s Disease (AD) (Ray et al., 2007), Alon et al. Colon
cancer (Alon et al., 1999), Leukemia cancer (Golub et al., 1999), Lung cancer (Gordon
et al., 2002) Lymphoma cancer (Alizadeh et al., 2000), Ovarian cancer (Petricoin et al.,
2002) and Prostate cancer (Singh et al., 2002).
Table 3-1 showed a summary description of these seven datasets.
Table 3-1 Summary of seven public datasets used in the study
Dataset

Type of data

Ray et al. AD

Protein

(Ray et al., 2007)

immunoassay

Alon et al. Colon
(Alon et al., 1999)
ALL-AML Leukemia
(Golub et al., 1999)
Lung
(Gordon et al., 2002)

No

of No

of No

features

classes

samples

120

2

259

2000

2

62

7129

2

72

12533

2

181

4026

2

47

Cancer
microarray

of

Data type

Continuous

Lymphoma
(Alizadeh

et

al.,

2000)
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Prostate
(Singh et al., 2002)
Ovarian (Petricoin et Proteomic
al., 2002)

spectra

12600

2

136

15154

2

253

These datasets have already been used in the evaluation of FS and classification
techniques in previous studies associated with bioinformatics (Banerjee et al., 2007;
Cao, Lee, Seng, & Gu, 2003; Klassen & Kim, 2009; Ravetti & Moscato, 2008; Ray et
al., 2007; Rocha de Paula et al., 2011; Yeung, Bumgarner, & Raftery, 2005). All
datasets (except the AD dataset) are taken from Kent Ridge Bio-medical Dataset
Repository (J. Li & Liu, 2002). Each dataset is a publicly available dataset. Details of
data collection techniques for each dataset can be referred to the original author’s paper.
One of the seven datasets (AD) in Table 3-1 is from Alzheimer’s disease domain and
generated using protein immunoassay technologies, and 5 datasets are associated with
cancer, namely Colon, Leukemia, Lung, Lymphoma and Prostate cancer, all of which
are generated using microarray technologies. Lastly, the Ovarian cancer dataset is
generated using proteomic spectra technologies. The AD dataset consists of a relatively
small number of attributes (120 attributes), while each of the remaining seven datasets
has a large number of attributes ranging from 4026 to 15154, with the number of
samples in these datasets being extremely small in comparison to the number of
attributes. For example, the Prostate cancer dataset consists of only 136 samples, with
each sample having 12600 attributes. This is a typical example of datasets in the
biomedical domain. The samples in all these datasets are classified into 2 classes,
diseased versus non-diseased. The attributes are continuous variables and the format of
the data files is either in Excel or text format. The following sections describe each of
these datasets.
3.1.1.

Ray et al. Alzheimer’s Disease (AD) datasets

The assay dataset used in Ray et al.’s experiment (2007) consists of 259 plasma samples
from 6 categories, namely Alzheimer disease (AD), Non-demented control (NDC),
Other Dementia (OD), Mild Cognitive Impairment (MCI), Other Neurological Disease
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(OND) and Rheumatoid Arthritis (RA). Each sample is characterized by measurements
associated with 120 known signalling proteins (attributes), saved in a Microsoft Excel
file format. Table 3-2 showed the breakdown of information for this dataset. This study
used the same training set and test sets as determined in the Ray et al.’s study (2007).
Table 3-2 Description of subsets associated with the Ray et al.’s dataset (2007)
Dataset: 259 samples
120 attributes

Type of data &
Number of samples
Training set (83)
AD: 43
NDC: 40

Alzheimer disease (AD) (85)

AD test set (92)

Non-demented control (NDC) (79)

AD: 42

Other dementia (OD) (11)

NDC: 39

Mild cognitive Impairment (MCI) (47)

OD: 11
MCI test set (47)
MCI -> AD: 22
MCI -> OD: 8
MCI -> MCI: 17

Other neurological disease (OND) (21)
Rheumatoid arthritis (RA) (16)



Not used for AD classification

Of the 259 samples, 85 samples belong to the AD group and 79 samples
belong to the NDC group. Samples from these two groups are allocated into
2 sets: training and test set. The training set consists of 43 samples
belonging to AD group and 40 samples from the NDC group.



There are two additional test sets used in this study: the AD test set consists
of 42 AD, 39 NDC and 11 OD making a total of 92 samples and the MCI
test set consists of 47 cases of MCI. In the case of MCI, after 2-6 years of
follow-up diagnosis, 22 cases developed to AD, 8 cases developed to OD
and 17 cases still remained as MCI, i.e., not developed to AD or OD (Ray et
al., 2007).
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According to Ray et al. (2007), an additional set, consisting of 21 OND and
16 RA from the 259 samples, was not used for classification.

For more information regarding the methods used to produce the data and the
description of the 120 proteins in the dataset, please refer to Ray et al. (2007)
3.1.2.

Alon et al. Colon cancer data

The Colon cancer dataset consists of 62 samples that was analysed using Affymetrix
oligonucleotide arrays. Samples were taken from tumours and normal tissues. Each
sample has 2000 attributes with continuous values obtained from the microarray
analysis. Data is saved in text file format. Table 3-3 shows the detailed breakdown of
the dataset.
Table 3-3 Description of subsets of Colon data
Dataset: 62 samples
2000 attributes

Type of data &
Number of samples
Training set (46)
T: 30
N: 16

Tumour colon cancer (T) (40)
Normal tissues (N) (22)

Test set (16)
T: 10
N: 6

As seen in Table 3-3, two groups consisting of 40 tumour (T) tissue samples and 22
normal (N) tissue samples are distributed into a training set consisting of 46 (30 T and
16N) samples, and a test set consisting of 16 (10T and 6N) samples. This distribution of
samples in this dataset into the training and test sets followed the same configuration as
used in the study conducted by Klassen and Kim (2009).
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3.1.3.

Leukemia cancer data

Leukemia dataset contains 72 bone marrow samples from acute leukemia patients. It
includes samples from Acute Lymphoblastic Leukemia (ALL) and Acute Myelogenous
Leukemia (AML), with each sample having 7129 attributes with continuous values. The
data is stored in text format. A summary of this dataset is shown in Table 3-4. This
study used the same training set and test sets as determined in the study conducted by
Golub, et al. (1999), J. Li & Liu (2002) and Klassen and Kim (2009).
Table 3-4 Description of subsets of Leukemia data
Dataset: 72 samples
7129 attributes

Type of data &
Number of samples
Training set (38)
ALL: 27

Acute Lymphoblastic Leukemia (ALL) (47)
Acute Myelogenous Leukemia (AML) (25)

AML: 11
Test set (34)
ALL: 20
AML: 14

As seen in Table 3-4, the groups of 47 ALL samples and 25 AML samples from a total
72 samples are allocated into a training set consisting of 38 (27 ALL and 11 AML)
samples and a test set consisting of 34 (20 ALL and 14 AML) samples.
3.1.4.

Lung cancer data

The Lung cancer dataset contains 181 samples from adenocarcinoma (ADCA) and
malignant pleural mesothelioma (MPM) patients. Each sample has 12533 attributes that
are continuous values. Dataset is stored in text format. A summary of this dataset is
shown in Table 3-5. This study used the same training set and test sets as determined in
J. Li and Liu’s study (2002)
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Table 3-5 Description of subsets of Lung data
Dataset: 181 samples

Type of data &

12533 attributes

Number of samples
Training set (149)
ADCA: 134
MPM: 15

Adenocarcinoma (ADCA) (150)
Malignant Pleural Mesothelioma (MPM) (31)

Test set (32)
ADCA: 16
MPM: 16

As seen in Table 3-5, the groups of 150 ADCA samples and 31 MPM samples from the
total 181 samples are distributed into a training set consisting of 149 (134 ADCA and
15 MPM) samples and a test set consisting of 32 (16 ADCA and 16 MPM) samples.
3.1.5.

Lymphoma cancer data

Lymphoma cancer dataset contains 47 samples of Diffuse large B-cell lymphoma
(DLBCL), including Activated B-like DLBCL (ACL) and Germinal Centre B-like
DLBCL (GCL). Each sample has 4026 attributes of continuous values. Dataset is stored
in text format. A summary of this dataset is shown in Table 3-6.
Table 3-6 Description of subsets of Lymphoma data
Dataset: 47 samples
4026 attributes

Type of data &
Number of samples
Training set (34)

Germinal Centre B-like (GCL) (24)
Activated B-like (ACL) (23)

GCL: 17
ACL: 17
Test set (13)
GCL: 7
ACL: 6
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As seen in Table 3-6, the distribution of samples in this dataset followed the same
configuration as used in the study conducted by L. Li, Weinberg, Darden and Pedersen
(2001) whereby the groups of 24 GCL samples and 23 ACL samples from a total 47
samples are allocated in the following manner: a training set consisting of 24 (17 GCL
and 17 ACL) samples, and a test set consisting of 23 (7 GCL and 6 ACL) samples.
3.1.6.

Prostate cancer data

Prostate cancer dataset contains 136 samples from tumour and normal tissues. These
samples were analysed using Affymetrix oligonucleotide microarrays resulting in each
samples having 12600 attributes with continuous values. Dataset is stored in text
format. A summary of this dataset is shown in Table 3-7. This study used the same
training set and test sets as determined in J. Li and Liu’s study (2002)
Table 3-7 Description of subsets of Prostate data
Dataset: 136 samples

Type of dataset

12600 attributes
Training set (102)
T: 52
Tumour tissues (T) (77)

N: 50

Normal tissues (N) (59)

Test set (34)
T: 25
N: 9

As seen in Table 3-7, the groups of 77 tumour (T) samples and 59 normal (N) samples
from the total 136 samples are allocated in the following manner: a training set consists
of 102 (52 T and 50 N) samples, a test set consists of 34 (25 T and 9 N) samples
3.1.7.

Ovarian cancer data

The Ovarian cancer dataset contains 253 samples of cancer and normal tissues. Each
sample has 15154 attributes (continuous values) was analysed using mass spectroscopy.
Dataset is stored in text format. A summary of this dataset is shown in Table 3-8.
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Table 3-8 Description of subsets of Ovarian data
Dataset:

253 samples

Type of dataset

15154 attributes
Training set (126)
Cancer disease (D) (162)

N: 45
D: 81

Normal control (N) (91)

Test set (127)
N: 46
D: 81

As seen in Table 3-8, the distribution of samples in this dataset followed the same
configuration as used in the study conducted by J. Li and Liu (2002) whereby the
groups of 91 normal control (N) samples and 162 cancer samples (D) from the total 253
samples are allocated in the following manner: a training set consisting of 126 (45 N
and 81 D) samples and a test set consisting of 127 (46 N and 81 D) samples.
This section described the various datasets used to evaluate the techniques developed in
this study and the next section will describe the evaluation method for assessing the
performance of the developed techniques in this study.
3.2. Evaluation Strategy
Predictive DM is one branch of DM where a model formulated using some existing data
is used to predict future behaviour/outcomes. There are a number of ways to measure
the performance of these models, namely: classification accuracy, error rates, lift charts
(charts are used to measure the performance of the prediction model by plotting the
number of true positive predictions against the total number of samples) and ROC
curves (charts are used to measure the performance of the prediction model by plotting
the number of true positive predictions against the total number of negative predictions)
(Witten & Frank, 2005). However, an issue associated with the use of these models for
prediction is that while they perform effectively on classifying training data, they may
perform badly on future unseen data. Evaluation of these models then becomes
important in terms of the reliability of the predicted results, with CV being the most
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widely used approach for evaluating these models (i.e., the generalization ability of the
models) (Witten & Frank, 2005). Other methods which also have been used for model
evaluation include holdout and bootstrap 0.632 (Wood, Visscher, & Mengersen, 2007).
Cross validation (CV) is a statistical approach that consists of iterations where subsets
of the data (training data) are first used to fit a model and followed by the testing of the
performance of that model using the rest of the data (validation data). However, if the
approach is not carried out properly, selection bias can occur and the resulting
classification results can be optimistically biased (Ambroise & McLachlan, 2002).
Typically in mining mass throughput data such microarray data, the first step involves
employing FS techniques to reduce the number of attributes to a small number.
Selection bias occurs if the whole dataset is first used in the FS process and then
followed by the CV process. This is due to the fact that the selection of these features
already incorporated information on the test set. Thus in order to avoid the selection
bias in the process of selecting the training model, “the test set must play no role in the
feature-selection process for an unbiased estimate to be obtained” (Ambroise &
McLachlan, 2002, p. 6566).
Other issues that must be considered as part of the evaluation strategy are stratification,
and the number of folds in the CV process, number of repetitions of a CV process and
computation resources and lastly, simulation of prediction of new data. Stratification is
a process for ensuring that each class associated with the dataset is properly represented,
with samples of each class being in the right proportion in both the training and test sets.
According to Witten and Frank (2005), a 10-fold is sufficient to obtain the best error
estimate. If stratification is incorporated into a 10-fold CV procedure then the
evaluation approach is known as a stratified 10-fold CV. In addition, consideration must
also be given to the number of repetitions of the CV process as a single 10-fold
stratified CV will not be able to guarantee a reliable error estimate. Repetitions of CV
need considerations of computation resources and lastly, simulation of prediction of
new data implies having an untouched validation dataset as this is the only way to
simulate prediction of new data. The following section outlines the evaluation strategy,
that addressed the issues discussed above and, is used in this study.
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Unseen test dataset (U)

Training dataset (T)
Fold 1
Fold 2
Fold 3
Fold 4
Fold 5
Fold 6
Fold 7
Fold 8
Fold 9
Fold 10

Figure 3-1 General mining structure: the breakdown of a dataset into an unseen test
dataset (U) (brown colour) and a training dataset (T) (green colour), in which (T) is
further split into 10 folds for 10 fold CV.
The evaluating strategy consists of 3 major steps: 1) partitioning the dataset into a
training dataset (T) and an unseen test dataset (U), 2) performing evaluation of 10 fold
CV on the training data (T) and 3) performing test classification on the unseen test data
(U). The following section describes these steps in details.
Step 1. Partition the full dataset into a stratified training dataset and a stratified unseen
test dataset.


Randomly assign each sample from the dataset into one of two groups: training
(T) and unseen test dataset (U). As part of this allocation process, ensure that
each class associated with the dataset (e.g. disease and healthy control) is
appropriately represented in both the training and unseen test dataset, thus
incorporating stratification. In this study, the split ratio (into training and unseen
test datasets) and the proportion of samples for each of the classes, e.g., Cancer
and Normal in Ovarian cancer dataset, into the training set and unseen test set
respectively, from each of the full dataset, followed the configurations used by
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either the original authors or authors who have also used the same datasets in
their subsequent studies.
Step 2. Perform 10 fold CV using the training dataset (T).


Randomly assign samples from the training dataset (T) into 10 folds to obtain 10
stratified subsets.



Select 1 subset (fold) as the validation set and use the remaining 9 subsets as a
training set. For example, in Figure 3-1, fold 1 may be set to be the validation set
and the training set then consists of fold 2 to fold 10.



Using a selected approach developed in this study and 9 folds, generate the
classification model and evaluate its performance using the validation set. This
process is repeated 10 times (i.e. 10 folds), with each subset in turn being the
validation set and the remaining subsets (9 folds) being a training set. Calculate
the performance of 10 fold CV by averaging the classification error rate over the
10 folds.

Step 3. Perform classification on unseen test dataset (U).


Using the selected approach used in Step 2 and the training data (T), generate
the classification model and evaluate its performance on the unseen test dataset
(U) to obtain the unseen test classification accuracy. This stage may also be
seen as simulating the prediction of new data as the unseen test dataset has been
kept totally separate from the training dataset.

The entire classification process (Steps 2 and 3) is repeated 15 times (15 independent
runs) which means including 15 times of 10 fold CV. The final training classification
accuracy of 15 times of 10 fold CV and classification accuracy of the unseen test dataset
are calculated by averaging their respective accuracy rates over the the15 independent
runs. Running multiple times is also essential for evaluating the quality and
performance of evolutionary algorithm such as GA (Alba, Garcia-Nieto, Jourdan, &
Talbi, 2007). For example, 5 independent runs were used in Huerta, Duvalm and Hao’s
experiment (2006), 10 runs were used in studies (Alba et al., 2007; Bala, Huang,
Vafaie, DeJong, & Wechsler, 1995; Kenneth A DeJong & Spears, 1990; Sharpe &
Glover, 1999); and 20 runs (Stein, Chen, Wu, & Hua, 2005; Zhang & Sun, 2002). Thus
65

in this study,

15 runs are considered as a sufficient number for estimating the

classification accuracy and the performances of the proposed approaches, bearing in
mind the tradeoffs – the need for sufficient number of runs

for evaluating the

performance of proposed techniques and the computational overhead associated with
the analysis of high dimensional biological datasets.
3.3. Termination criteria
According to many researchers (Safe, Carballido, Ponzoni and Brignole (2004),
Koumousis and Katsaras (2006), Milton (2009) and Ong and Fukushima (2011)), the
most common criteria used to terminate GA are: full population convergence to a single
solution, fitness of the population has not improved over a pre-define number of
consecutive generations, a pre-defined maximum number of generations (or fitness
evaluations) have been executed, or the best fitness values found over a number of
generations. The following section describes the stopping criteria employed in this
study for terminating GA. An additional check using the strategy of detecting the
convergence status as described in the previous section 3.3 is also conducted after the
GA is deemed to have converged.
The termination criteria employed here for terminating the GA consists of a
combination of two conditions: executing for a predefined maximum number of
generations and that the fitness of the population did not change over a pre-defined
number of consecutive generations. In order to implement this termination approach, for
each of generations in the GA, the following calculations are carried out, 1) fitness of
each chromosome/individual in the entire population, 2) the maximum fitness of the
population, and 3) the average fitness of the population. Whilst a pre-defined maximum
number of generations are not reached, the average fitness of the population is checked
for any changes (improvement), if it does not change (improve) over a pre-defined
number of consecutive generations (100 generations), then the population is considered
as having converged and the GA terminates . The choice of 100 consecutive generations
for termination is based on the results of parameter tuning that has been completed for
all the datasets in this study, as described in Section 5.3. The number of 100 consecutive
generations is large enough for avoiding a pre-mature convergence. This termination
approach not only avoids premature convergence but also reduce the total
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computational time because there is no need to keep executing the algorithm when the
population in question has already converged (Kumar & Rockett, 2002; Ong &
Fukushima, 2011).
The following algorithm describes the procedure of terminating GA.
Input





Individual fitness in population (Find)
Population size (s)
A pre-defined maximum number of generations (Gmax)
A pre-defined maximum number of consecutive generations of
convergence
(Cmax)

Output
 Maximum population fitness (Fmax)
 Average population fitness (Favg)
Steps
1. Set counter = 0
2. For 1 to Gmax
a. Calculate total population fitness (Ftotal) = ∑
b. Calculate Favg = Ftotal / s
c. If Favg does not change then
 Increase counter by 1
 If counter = Cmax then
Terminate GA
d. Else
 Reset counter back to 0

Figure 3-2 Termination procedure for GA
To minimize the likelihood of premature convergence, this study has incorporated the
following:


Selection of parameter settings from one of the four sets of “standard parameter
values” for GA from the literature and these have been described in Section
5.3.1. This study has also used tournament selection, elitism and an appropriate
crossover probability to ensure a balance between diversity and selection
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pressure, so as to avoid premature convergence. Details are shown in Table 4-1
and Table 5-2.


In addition, this study instituted a mechanism consisting of three parts for
checking for the occurrence of premature convergence: an approach proposed by
Srinivas and Patnaik (1994) for checking for

premature convergence and

checking that the maximum fitness, at the point of convergence, approaches the
theoretical maximum fitness value associated with the different fitness functions
and the termination criteria described in Section 3.3 and 3.4 of the thesis
respectively. In this check, the function defined by

Srinivas and Patnaik

approaches zero and the maximum fitness, at the point of convergence,
approaches the theoretical maximum fitness value associated with the different
fitness functions and termination condition (that is, the fitness of the population
did not change over a pre-defined number of consecutive generations).
3.4. Genetic Algorithm and state of convergence
The GA is incorporated in a number of approaches developed in this study. It is
important to ensure that the GA has achieved convergence as a premature convergence
will result in a local optimal solution instead of a global optimum. To check the
algorithm is converging to the global optimum, this study used an approach proposed by
Srinivas and Patnaik (1994) to check for premature convergence. This can be done by
checking the difference between the average fitness (favg) and maximum fitness value
(fmax) of the population after the GA has converged. A plot of the values for fmax – favg is
used to detect the state of convergence of GA. That is, the smaller the difference
between fmax and favg, the better the global convergence and a better optimal solution
obtained from the algorithm, thus avoiding premature convergences (M. Srinivas &
Patnaik, 1994).
Figure 3-3 shows an example of the convergence plot for one GA execution over 300
generations. The blue line shows the plot of the maximum fitness of the population for
each generation and the red line shows the plot of the values of (fmax – favg ). The vertical
axis on the left-hand side indicates maximum fitness of each generation and the vertical
axis on the right hand side indicates the values for (fmax– favg ). Note that (fmax – favg)
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approaches to values approximately close to zero around 211 generations. This
coincides with the max fitness having a value of 0.954 (1 is maximum). Figure 3-2 also
shows a local optima that occurred in the execution of the algorithm over 300
generations. The 2 vertical green lines in Figure 3-2 illustrate the local optimum (a1)
found prior to the algorithm reaching global convergence (the vertical blue line). If the
algorithm stopped when this local optimum found, then it was a premature convergence,
where (fmax – favg) approaches to values not so close to zero (a2) and it coincides with the
maximum fitness having a smaller value of 0.938 (a1), compared to 0.954 (b1) and (fmax
– favg) is close to zero (b2) in the case of the global convergence.

Global
convergence

Max
fitness
1

Local
optimum
(a1)

0.95

fmax-favg
fitness
0.35

(b1)

0.3
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Figure 3-3 An example of a convergence status plot
3.5. Summary
This chapter has described the details of common elements associated with this study.
These include: 1) the dataset of AD, Colon cancer, Leukemia cancer, Lung cancer,
Lymphoma cancer, Ovarian cancer and Prostate cancer dataset in terms of the training
and unseen test sets, 2) the evaluation strategy used to evaluate the proposed
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approaches, 3) check the state of convergence for GA, and 4) GA termination criteria.
These common elements are applied to the evaluation of proposed approaches
developed in this study.
In Chapter 4, the proposed approach of incorporating RST into GA for searching
optimal feature sets is described. Chapter 4 is the pilot study in this thesis and involved
modifying Banerjee et al.’s (2007) approach for generating the distinction table.
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4. Rough set theory and GA approach (RST-GA)
Chapter 3 described the seven datasets used in this study. It can be seen that these
datasets belongs to the category of “binary classification” problems, specifically, normal
versus diseased or two variants of diseased samples. Common characteristics of these
datasets are very high dimensionality and small number of samples. The challenge when
classifying this type of data arises from the limited availability of a small number of
samples in comparison to the large number of features associated with each sample. With
a large number of features, of which, some maybe redundant or irrelevant, the
classification process can be computationally intensive. Furthermore, with a small
number of samples, over-fitting in training is likely to occur and can lead to higher
classification errors when the trained classification model is used to classify unseen test
data (data not used as part of the training).
Chapter 4 is the pilot study in this thesis and involved modifying Banerjee et al.’s
(2007) approach for generating the distinction table. This chapter is an extended version
of the paper “Incorporating genetic algorithm into rough FS for high dimensional
biomedical data” (Dang, Lam, & Lee, 2011). It describes the first investigation that was
carried out in this study to explore EA-based approaches for FS and classification of
such high dimensional biological data. In Section 4.1, a hybrid approach, incorporating
GA and RST, for searching for the best subset of optimal features is described. A
description of a parameter tuning process for the GA is then outlined in Section 4.3.
Using optimal sets of features generated from the proposed approach, classification was
carried out using k Nearest Neighbour (k-NN) classifiers to evaluate their performance
in classifying unseen test data. Classification results involving classifiers from WEKA
(Waikato Environment for Knowledge Analysis) (Hall et al., 2009) are also shown in
Section 4.4, and followed by a discussion in Section 4.5.
Please note that in this thesis the term “feature” and “attribute” are used interchangeably
and represent the same thing.
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4.1. The proposed approach, RST-GA

Figure 4-1 Framework of the proposed approach, RST-GA
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Figure 4-1 illustrates the framework of the proposed approach, RST-GA, incorporating
k-means clustering, RST and GA. As shown in the figure, the proposed approach uses a
3-phased process, consisting of:
Phase 1: This phase carries out the feature reduction step. Owing to k-means being
employed to find threshold values associated with each feature, a normalization step was
first carried out on all the features. The normalized values are then used to partition each
corresponding feature in the process of generating a reduced attribute table.

The

objective of this step is to do an initial cull, completing a preliminary coarse reduction in
redundancy amongst the features.
Phase 2: In this phase, a distinction table (Wroblewski, 1995), which is a variant of the
discernibility matrix, is constructed using the reduced feature table generated from Phase
1. The distinction table is in the form of binary matrix.
Phase 3: GA was employed in the third phase as an optimization method to search for
the optimal set of features based on the distinction table that has been generated from
Phase 2.
RST-GA, is an initial attempt to explore approaches for analyzing high dimensional
biological data and is based on Banerjee et al.’s approach, using RST and incorporating
GA as a search algorithm However, the proposed approach makes improvements by
using quartile statistics and K-means clustering to obtain optimal centroids for
partitioning data in the first phase.
The steps associated with each of these three phases are described in the following
sections.
4.1.1.

Phase 1: Feature reduction

K-means is employed in this phase to generate centroids of each attribute which are
subsequently used for its partitioning step. K-means is one of the most popular
clustering technique and widely used in the DM community to cluster high dimensional
data (Yedla, Pathakota, & Srinivasa, 2010). K-means clustering groups data into
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separate clusters based on the Euclidean distance between the data points and the
centroids (Nazeer & Sebastian, 2009). According to Nazeer and Sebastian (2009), there
are 2 steps associated with k-means. The first step is to determine the value of k (i.e. the
number of clusters) and to initialize each of these cluster centres to a random number.
The second step involves the use of a similarity measure (e.g. Euclidean distance
measure) to calculate the respective distances of each data point to these centroids and
assignment of the data points to the closest centroid. The new centroid for each cluster
is re-calculated and the respective distances of each data point to the updated centroids
are also re-calculated, and subsequently, data points are re-assigned to the clusters based
on the new values of the re-calculated distances of the data points to each of the updated
centroids. The process of updating cluster centroids, re-calculating the distance between
data points and centroids, and re- assigning data points to the clusters continue until the
convergence of clusters takes place, i.e., when there is no more changes to the cluster
centroids.
In addition, Visalakshi and Thangavel (2009, p. 168) have also stated that “the
clustering results can be greatly affected by differences in scale among the dimension
fro , which the dista ces are co puted”. Thus to address this issue, a normalization
process needs to be carried out to transform raw data consisting of attribute values to a
specific range such as [0, 1] prior to employing k-means clustering. In this proposed
approach, min-max normalization is first used to normalize the data.

a) Normalization
The min-max normalization method (Han & Kamber, 2006) is applied to the training
and test datasets, converting attribute values into the range of [0, 1] using Equation
(4.1).
a'j = (aj (xi) – minj) / maxj - minj

(4.1)

where maxj and minj are respectively, the maximum and minimum expression value of
attribute aj from all samples.
The following figure illustrates an example of normalization.
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(a) Raw data
Attributes

(b) Normalized data
min-max normalization

Attributes

Figure 4-2 Example of part of normalized data using min-max normalization
As seen in Figure 4-2, each attribute (column) shown in the table of Raw data (Figure 42 (a)) consists of values with differences in a wide range (blue box), which are
normalized to values between 0 and 1 (red box) shown in the table of Normalized data
(Figure 4-2 (b)). Thus, after normalization, values of each attribute are standardized in
the same scale (i.e. between 0 and 1).
K-means is also very sensitive to the starting points (i.e. initial centroids) and these
subsequently impact greatly on its ability to achieve global versus local optimum in
terms of accuracy (i.e. clustering results) and efficiency (i.e. computational time spent to
perform clustering) (Bradley & Fayyad, 1998; Nazeer & Sebastian, 2009; Yedla et al.,
2010). In this study, a quartile statistics technique is first employed to find more
appropriate initial starting centroid values for k-means rather than using random values
for initial centroids. The following section describes the quartile statistics procedure for
calculating the initial starting centroids for each attribute.
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b)

Quartile statistics

As seen in Chapter 3, the datasets used in this study are from the bioinformatics domain
and belongs to the category of “binary classification” problems, specifically, normal
versus diseased or two variants of diseased samples. Values associated with attributes of
such datasets typically falls into a number of categories: a normal range where it is
considered to be associated with a “non-diseased condition” and a value that’s too high
or too low may indicate abnormality and that it is associated with a “diseased
condition”. For example, a measurement associated with blood glucose level that’s
below 70mg/dl (milligrams per decilitre) is considered to be associated with a low
blood glucose condition and a measurement above 180mg/dl is considered to be
associated with a high blood glucose condition (hyperglycemia) – a condition which is
known to be associated with diabetes, while a measurement between 70mg/dl and
180mg/dl is considered to be associated with a normal blood glucose level (Euglycemia)
(W. L. Clarke et al., 2005).
On the basis of the above characteristic, the approach employs quartile statistics to find
three values associated with each attribute: 25th percentile, 50th percentile and 75th
percentile; with the value at 50th percentile being used to reflect a value associated with
the normal range and the remaining two to reflect values associated with conditions
considered to be either too low or too high. These three values are then used as
initialization values for centroids of three clusters in the third step – the application of
K-means algorithm. The steps used in the calculation of quartile statistics are shown
below (Banerjee et al., 2007).
 Sort values associated with each attribute in ascending order.
 Partition the sorted values for each attribute equally into small class intervals (δ).
 Calculate quartile statistics for each attribute to obtain the lower threshold value
(Thl), middle threshold value (Thm) and upper threshold value (Thu) using the
formula defined in Banerjee et al. (2007), and shown as follows.

(4.2)
where Lc is the lower limit of the Cth class interval
Rk is the rank of the kth interval value
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Rk

N k

with p = number of partition

p

N is a number of objects
k = kth partition value, k=1, 2, 3 for 4 partitions
is the cumulative frequency of the immediately preceding class interval
such that
is the class frequency
δ is the class interval width

Quartile statistics
Normalized data (a)

Thresholds (b)
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Figure 4-3 Example of partial table of Thl, Thm andThu threshold values generated as
initial starting points for k-means using the quartile statistics method.
As seen in Figure 4-3, each attribute with its values shown as a row in the table of
Normalized data (Figure 4-3(a)) is partitioned into 3 levels of thresholds, lower (Thl),
middle (Thm) and upper (Thu) shown as a row in the table of Thresholds (Figure 4-3(b)).
The three threshold values associated with each attribute are used as initial centroid
points for the K-means clustering step for partitioning each attribute.
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c)

K-means

The k-means algorithm employed here has been described in Section 2.4.1. Figure 4-4
shows the refinement of the cluster centroids before (initial) and after k-means (final)
for one attribute. The initial centroid value (red square) in each cluster (C1, C2, and
C3) shifts towards the centre of the cluster, i.e., red squares move to the green triangles
which are closer to the centre of the clusters. Subsequently, the final centroids obtained
from the k-means step are used in the RST process to produce a distinction table.
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Figure 4-4 Example of cluster centroid positions before and after k-means
d)

Partition data

Attributes are considered to be “of interest” if their values have a decisive role in
differentiating between individuals belonging to different classes (e.g. diseased vs. nondiseased). Using the previous example, blood glucose level can be an attribute of
interest if the task is to decide whether an individual is suffering from diabetes –
specifically in the case where the blood glucose level is either very high or very low.
This implies that this value associated with this attribute differs between the diseased
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and non-diseased individuals, with diseased individuals having values outside the norm.
Using this rationale, the attributes in the datasets are processed in the following manner:
Using the final centroid values obtained in the k-means clustering step, thresholds Thl
and Thu are assigned as the lower and upper attribute thresholds respectively. These
values are subsequently used for transforming the values of each attribute into 0, 1 and
“ ”, with “ ” is considered as a “do ’t care” condition (Banerjee et al., 2007, p. 625).
The implication here is that the range of interest is when the attribute value is at the
extreme ends. The following rules are used to process each attribute:
1. If an attribute value is less than or equal to its associated Thl then assign the
value of 0.
2. If an attribute value is greater or equal to its associated Thu then assign the
value of 1.
3. If an attribute value is greater than its associated Thl and less than its
associated Thu assigned it to “ ”
As seen in Figure 4-5, values in each attribute (blue box) are compared to its respective
Thl and Thu threshold value and has been converted to 0 or 1 or “ ” (red box) based the
conditions as specified above. As a result, a table of 0, 1 and “ ” values are created.
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‘01*’ table
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Figure 4-5 Example of a “01*” table
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e)

Generate reduced attribute value table

Based on the “ ” values in the “0 *” table generated from the previous step, the
average frequency of “ ” is computed from the whole dataset (table) and then used as a
“ ” guided threshold value (Th

avg)

to eliminate attributes. As mentioned earlier,

attributes with a majority of “ ” are considered as not being significant in separating the
different classes. Therefore, attributes with a total number of “ ” greater than or equal to
Th*avg are eliminated from the attribute list. As a result, a large number of attributes are
eliminated and a reduced attribute value table (Ar) is produced.
4.1.2.

Phase 2: Generate a distinction table

In this phase, the reduced attribute table, Ar, is then used to create a distinction table.
The distinction table is a variant of the discernibility matrix which is based on the
indiscernibility relation approach. Objects are divided into equivalence classes based on
equivalence relations such that two objects are in the same class (equivalence class) if
and only if they have the same attribute values (equivalence relation). A discernibility
matrix (Dm) is defined as a matrix of m rows by n columns of an information system (S)
of N samples and A attributes. A discernibility matrix of an information system, Dm (S),
with the ith, jth entry (Eij) is defined as

{

( )}

(Hoa & Son, 1996). According to Banerjee, et al. (2007), a distinction table created
based on the following criteria is greatly reduced in dimension and the computational
time involved is shorter. This distinction table is called a “d-Distinction” table, the same
name used here as in Banerjee, et al (2007, p. 626).
The following rules are used for generating a d-Distinction table:
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1. Insert 1 for object pairs of different classes having different values (e.g., {0,1}
or {1,0}).
(

) = 1 if ai(xk) ≠ ai(xj)

2. Insert 0 for object pairs of different classes having the same value (e.g., {1, 1}
or {0,0}).
(

)= 0 if ai(xk) = ai(xj)

3. Insert 0 for either object of the pair has “ ”.
4. Object pairs of the same class are ignored.
5. Rows with all 0s are not allowed.
A d-Distinction table created using the above criteria has a smaller dimension of m1 *
m2 in comparison to a discernibility matrix of (m*(m-1))/2, where m = m1+m2, and m1,
m2 = the number of samples in class 1 and 2, respectively. For example, let m1 is 22
and m2 is 40, therefore m1 * m2 = 22 * 40 = 880 rows (sets) of objects, which are much
less than ((22+40) * (22+40)-1))/2 = (62*61)/2= 1891. Therefore, in terms of search
space, it would reduce computational cost when using GA to find the optimal feature
subset. The following figure shows an example of a cut down version of d-Distinction
table.
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Figure 4-6 An example of d-Distinction table
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4.1.3.

Phase 3: Feature selection via GA search optimization

The first task of phase 3 is to determine the representation of chromosomes. There are
different types of chromosome representations. These include binary, integer, real
numbers, single character, and permutation representation. One of key components in
application of GA is the representation of the solution using chromosomes (Qin, 1999).
This is due to the fact that GA searches for solutions (chromosomes) to solve a problem,
so it is very difficult for GA to find an optimal solution with an unsuitable chromosome
representation for the specific problem. In fact “the use of different chromosome
encoding schemes would lead to different search performances.” (Chaiyaratana,
Piroonratana, & Sangkawelert, 2007, p. 3).
The aim here is to process the d-Distinction table for sets of relevant features associated
with high dimensional biomedical data using GA. In the studies of Felix and Ushio
(1999), Duval & Hao (2010) and Perez and Marwala (2012), strings of n binary bits
(binary chromosomes), e.g. {0 1 0 1 0 1 0 1 1 1 0 0}, were used to represent solutions
for GA. The length n is the number of features (genes) in the dataset. That is, a binary
chromosome represents a set of features and binary bits (gene values) of 0s in the
chromosomes indicate features are not present (not selected for classification), and
binary bits of 1s indicate features are present (selected for classification) in relation to
the dataset (Banerjee et al., 2007; Deb & Reddy, 2003; Duval & Hao, 2010; Liu & Iba,
2002; Perez & Marwala, 2012; Vafaie & De Jong, 1992). For example, a chromosome
{0 1 0 1 0 1 0 1 1 1 0 0} represents a total of 12 genes in the dataset and genes with
value of “1” (2nd, 4th, 6th, 8th, 9th and 10th genes) are used for classification, whilst genes
with value of “0” are not used. The following sections detail the steps associated with
the application of GA.
a) Population initialization
The population of chromosomes is initialized by randomly selecting sets (rows) of
objects from a d-Distinction table generated from the RST step. The number of sets of
objects selected randomly from the distinction table equals the population size. That is,
the number of sets of objects are randomly selected depending on the size of the
population, e.g., if the size of the population is set to 100 (100 chromosomes) then 100
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sets of objects are selected randomly. The following figure describes the algorithm used
to initialize the population.
Input:
d-Distinction table (Td) of m rows and n columns
Size of population (p)
Output:
An initialized population of p rows and n columns
Steps:
1. Set chromosomes as strings of binary of length n
2. Set initial population of size p (Ip) = { }
3. For counter from 1 to p
a. Generate an integer random number (Rn) in the range [1, m] using a
RNG
b. Search indexes of rows (sets of objects) in Td using Rn
c. Select row[Rn] in Td
d. Store the selected row to Ip
Figure 4-7 Algorithm for initialisation of population using d-Distinction table
b) Fitness evaluation
Fitness function in RST-GA,

of a chromosome is defined using the formula shown in

Equation (4.3).
= w1 *
Where w1 and w2 are the weightings for
and

+ w2*
and

(4.3)
, respectively, with w1 + w2 =1

are the objective function 1 and 2, respectively

is an overall objective function
The fitness of a chromosome,
and

is defined as an aggregation of two objective functions,

. The objective function

is for maximizing the fitness of chromosomes (sets

of features) with the least number of “1”s (features), whilst objective function

is for

maximizing the fitness of chromosomes that discerns the most number of objects, i.e,
maximizing accuracy. Thus, the objective function, , guides GA to find an optimal
subset of relevant features that has the least number of features but gives higher
accuracy in discerning between objects .
Since the objective function is an aggregation of 2 objective functions, f1 and f2,
associated weightings, w1 and w2, are assigned to

and

, respectively. These

weightings of f1 and f2 would affect the search optimization process for finding optimal
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chromosomes (solutions). Therefore, an empirical experiment for obtaining the
appropriate values of w1 and w2 was conducted in this study. Different combinations of
w1 and w2 values were applied, e.g., w1 = 0.1 and w2 = 0.9 or w1 = 0.2 and w2 = 0.8, etc.
As a result, w1 = 0.9 and w2 = 0.1 were found to work best for the 2 datasets used in this
study. Coincidentally, these two weighting are the same as those used in Banerjee et al.
(2007)’s experiment and allowed a comparison with results from Banerjee et al.’s. As
RST-GA incorporated quartile statistics and K-means methods to partition data, an
approach different from Banerjee et al., this comparison of results allows an
examination of the effectiveness of using quartile statistics and K-means for partition
data in phase 1 of the approach.
Equation (4.4) and (4.5) define objective functions f1 and f2, respectively (Banerjee et
al., 2007).
→

→ =
→ =

→

(4.4)
(4.5)

where
N is the length of the candidate chromosome
→ is a number of “1”s in the candidate chromosome
are the number of objects belonging to class 1 and 2, respectively
→ is a number of objects distinguished by the candidate chromosome.

The following Figure 4-8 describes the algorithm used to calculate the fitness of
chromosomes.
Input:
d-Distinction table (Td) of m rows and n columns
Initial population (p)
Output:
Fitness of chromosomes as an array of p rows and n columns
Steps:
1. Set Size = size of population, p
2. Set weighting for w1 and w2 with w1+w2=1
3. Set f = fitness of chromosome
4. Set fitness population (Fp) = { }
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5. For counter from 1 to Size
a. Calculate objective function f1 using Equation (4.4)
b. Calculate objective function f2 using Equation (4.5)
c. Calculate fitness of chromosome f using Equation (4.3)
d. Store f into fitness population (Fp)
Figure 4-8 Algorithm for fitness calculation using f1, f2 and f objective functions
c) GA operators
Selection, crossover and mutation operators for binary-value encodings are used in the
proposed approach. Tournament selection is a simple but efficient operator that has
been commonly used in the GA (Miller & Goldberg, 1995). In the proposed approach,
the tournament selection is employed to select 2 chromosomes from the population for
crossover operation. Two chromosomes are selected randomly from the population of
size k, a fitter chromosome is then selected for crossover. The tournament selection has
been described in Section 2.3.4.1.
Single point crossover (Back, Hoffmeister, & Schwefel, 1991) is a technique that can be
applied to binary value encodings to exchange parts of two chromosomes at a randomly
selected crossover position. That is, 2 selected parents are split into 2 parts at the
crossover position and then the second part of the 2 parents is inter-changed to produce
2 offspring. Single point crossover has been described in Section 2.3.4.1 and is
employed in this study to recombine the chromosomes using the probability rate (Pc) as
listed in Table 4-1.
Bit-flip mutation is the most common mutation operator used for binary encoded
chromosomes. The bit value of a gene is flipped, i.e., if the bit value is 0 then change it
to 1 and vice versa, independently based on a predefined mutation rate, (Eiben & Smith,
2007). As a result, mutated offspring are produced by the process of mutation. The bitflip mutation has been described in Section 2.4.4.1 and is employed in this study to
modify the chromosomes using the mutation rate (Pm) as listed in Table 4-1.
d) New population generation
The 2 best chromosomes are selected from the pool of parents and resulting offspring
obtained from the previous step involving selection, crossover and mutation. These are
then placed into the new population. Also a single elitist strategy is employed in this
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study to allow the best candidate solution in the previous generation to be retained and
placed into the new generation to improve the search in evolutionary algorithms (Ahn &
Ramakrishna, 2010). The process of selection, crossover and mutation continue until the
generation of the new population is completed. The following figure describes the
procedure to generate a new population.
Input:
Chromosome population (p)
Fitness population (Fp)
Crossover probability (Pc)
Mutation probability (Pm)
Elite chromosome (Elite)
Output:
New population (Np)
Steps:
1. Set Size = size of population, p
2. Set new population (Np) = { }
3. Store Elite into Np
4. For counter from 1 to ½ Size
a. Select 2 parent chromosomes from p
 Perform tournament selection to select parent1, parent2
b. Create 2 offspring chromosomes using parent1 and parent2
b1. Generate a random number (Rn) in the range [0, 1] using RNG
b2. If Pc ≥ Rn
 Perform one point crossover on 2 parents to produce 2 offspring
b3. If Pm ≥ Rn
 Perform bit-flip mutation on each bit of offspring
b4. Evaluate fitness of parent and offspring chromosomes
c. Store the best 2 chromosomes into Np
Figure 4-9 Algorithm for generating a new population
e) Checking for convergence in NSC-GA
The process of fitness evaluation, selection, crossover, mutation and new generation is
repeated until the convergence of population in fitness takes place or a predefined
maximum number of generations have been executed. The procedure of verifying the
convergence status and terminating the GA have been described in Section 3.3 and 3.4,
respectively. Upon the convergence the fittest chromosome (optimal solution) is
selected.
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In order to evaluate the proposed approach, a suitable set of parameter values are needed
for all the parameters associated with GA. The following section describes the parameter
tuning process to obtain the best parameter set for GA.
4.1.4.

Parameter tuning for the GA

Convergence of fitness in the GA is important as premature convergence will result in a
local optimal solution. Parameter tuning for the GA is necessary to ensure that the
algorithm has executed using the best parameter setting, owing to the fact that the
crossover probability (Pc) and the mutation probability (Pm) are vital for the optimal
performance of the GA (M. Srinivas & Patnaik, 1994). Parameter tuning for Pc and Pm in
this study is completed using the approach proposed by Srinivas and Patnaik (1994).
This process involves varying different values of Pc and Pm, and observing the difference
value between the average fitness (favg) and the maximum fitness value (fmax) of the
population to verify the convergence status for GA (i.e. local or global convergence). As
a result of this parameter tuning, the best parameter values of Pc and Pm are found to be
0.7 and 0.03, respectively. The complete set of parameter values used to run RST-GA in
this study is shown in Table 4-1.
Table 4-1 A set of parameters used to run GA
Parameters

Values / Methods

Population Size

100

Chromosome length Binary Encoding

The number of reduced
attributes (genes)

Pc

0.7

Pm

0.03

Generation

1000

Selection

Tournament

Crossover

Single point

Mutation

Bit-flip

Elitist

Single
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4.2. Experiment results
The proposed approach was evaluated using both the Colon and Leukemia cancer
datasets described in Chapter 3. For each dataset, 15 independent runs of the proposed
approach were executed using the respective training data. The optimal set obtained for
each run was used to construct corresponding k-NN classifier with k = 1, 3, 5, and 7. The
selected optimal set of features is evaluated using 10 fold CV strategy described in
Section 3.2 and then further evaluated using unseen test datasets.
Steps in conducting one run of the experiment involved:
-

Invoke the algorithm using an input training file and parameter setting file. The
training dataset and unseen test dataset are prepared based on the procedure
outlined in Section 3.1 and 3.2.

-

Use the optimal feature set, to construct corresponding k-NN classifier with k =
1, 3, 5, and 7. Record results. Repeat this step using another training fold until 10
fold CV has been completed.

-

Use the optimal feature set, to construct corresponding k-NN classifier with k =
1, 3, 5, and 7 to classify the unseen test dataset respectively.

The classification results for classifying the unseen test data using each of these k-NN
classifiers were recorded and shown in Table 4-2. The following sections detail the
results obtained from applying the approach on each of the two datasets.
4.2.1.

Alon et al. Colon cancer data

Banerjee, et al. (2007) split the colon cancer dataset, with 50% for training and 50% as
the unseen test dataset. Each of these two datasets consists of 20 Cancer (C1) samples
and 11 Normal (C2) samples. In this study, the Colon cancer dataset was partitioned in
the same way as that of Banerjee, et al.’s (2007).
Using the parameter settings in Table 4-1 and the training data for the Colon cancer
dataset, the optimal subset of features from each of the 15 independent runs of RST-GA
were obtained, evaluated using 10 fold CV evaluation strategy described in section 3.2,
as well as tested on the unseen test set. The k-NN classifier with different k values of 1,
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3, 5 and 7 were used to classify the Colon unseen test dataset. The classification results
obtained using the optimal set from each of the 15 independent runs on the unseen test
data are shown in Table 4-2.
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0.93
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0.92
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fmax-favg
Max fitness
Figure 4-10 A typical convergence plot for maximum fitness and (fmax – favg) associated
with the Colon dataset
A convergence plot from one of the typical runs is shown in Figure 4-10. As seen in this
figure, the algorithm converged to a global optimum with the maximum fitness of 0.99
(approaching the theoretical maximum fitness of 1). The values of (fmax – favg) was
relatively high (values shown on the right-hand vertical axis) in the earlier generations
(<5) and it decreases to values very close to zero after 17 generations. This value
coincides with the maximum fitness value of 0.99. Note that the convergence after 17th
generations is due to the initial population of individuals being selected from the dDistinction table, which consists of chromosomes (binary strings) that have already been
processed for redundancy reduction of features.
Premature convergence occurs when the evolutionary algorithm (e.g. genetic
algorithms) gets stuck in local optima and returns suboptimal solutions (Vanaret,
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Gotteland, Durand, & Alliot, 2013). On achieving global convergence, the population is
genotypically very similar, thus individuals in the population has very similar fitness
value. The state of convergence of each of the 15 runs of RST-GA is evaluated using
the check mechanism outlined in Section 3.4, and typically, a plot like the graph in red
in Figure 4-10 is obtained for fmax - favg. In addition, to gain a understanding of the
behaviour of RST-GA across the 15 run, a whisker plot for the maximum fitness value
of all 15 runs is shown in Figure 4-11 . At the point of convergence, the fitness value
approaches the theoretical maximum fitness of 1 and the spread of the fitness value is
very small across the 15 runs for each of those generations, thus showing global
convergence.

Max fitness
1

0.98
0.96
0.94
0.92
0.9
0.88
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51

Generations

Figure 4-11 A whisker plot for maximum fitness for 15 runs
The fitness maximum value obtained at convergence for each of the 15 run of RST-GA
for the Colon cancer dataset are 0.9907, 0.9917, 0.991, 0.992, 0.9907, 0.9914, 0.9914,
0.9922, 0.9929, 0.9917, 0.992, 0.9898, 0.9896, 0.9902 and 0.9836 respectively. The
first value of 0.9907 is associated with Set 1 in Table 4-3, 0.9917 with Set 2, and the
mapping of the sets following this order until with Set 15 being mapped to 0.9836.
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Table 4-2 Results associated with RST-GA (proposed approach) and from Banerjee, et
al. (2007) using k-NN classifiers, with k=1, 3, 5, and 7 on the Colon unseen test set

Table 4-2 shows the results obtained via RST-GA and those obtained in Banerjee, et
al.’s study (2007). The column headings C1 and C2 in the table stand for classification
accuracy (%) on the Colon unseen test dataset for the Cancer class and Normal class,
respectively. The column heading “Net” stands for the overall classification (%) for all
classes on the Colon unseen test dataset and “Net” is calculated using Equation (4.3).
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Net (%)

where

(4.3)

is true positive for correct prediction to C1 class
is true negative for correct prediction to C2 class
is false positive for incorrect prediction to C1 class
is false negative for incorrect prediction to C2 class

From 15 independent runs, RST-GA found 15 sets of features consisting of 1 set of 10
features, 3 sets of 7 features and 11 sets of 6 features. Each of the 15 sets is used to train
a k-NN classifier with k = 1, 3, 5, and 7 and each row of Table 4-2 is associated with the
classification results obtained on the unseen test dataset. The row highlighted (in blue)
in Table 4-2 shows the highest classification accuracy obtained for classifying the
unseen test set. It can be seen that the proposed algorithm found a smaller set with 6
genes that gave a higher classification accuracy in comparison to those involving the
larger set of 15 features reported by Banerjee, et al. (2007). It is not possible to evaluate
whether there are any commonality in the sets of features found by RST-GA, with the
set obtained by Banerjee et al. (2007) as the list of their 15 features is not listed in their
paper.
In addition to examining the importance of the classification performance of a set of
features, its relevance to its corresponding domain is crucial. Table 4-3 lists the selected
genes by accession numbers for the 15 sets found by the proposed approach. As seen
from the table, some genes are common across a number of these sets (e.g. H08393 are
found in set 1, 3, 5, and 12). These are coded in the same colour in the table for ease of
identifying them in the different sets.
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Table 4-3 List of genes associated with the Colon Cancer dataset for each of the 15
optimal sets of features obtained from 15 independent runs of RST-GA

As seen in Table 4-3, the feature set obtained from each of 15 runs of the RST-GA is
different, with only a small number of features in common across the different sets. This
is due to a characteristic associated with feature selection methods, namely, the stability
of feature selection methods. Stability is a term used to describe the sensitivity of a
feature selection algorithm to small variations in the training data and in the settings of
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the algorithmic parameters, resulting in different feature sets being produced by the
algorithm. Small variations in the training data include using a different partition of data
samples, reordering of samples and adding/removing a few samples. In addition, in
stochastic algorithms, using different random seeds and different parameter values will
also result in different results from the algorithm. Both Rough Set theory and the GA
are algorithms known to have feature selection instability.
An important point to note is that each execution of the RST-GA approach consists of
three phases, and the application of GA is only in the third phase. The first two phases
of RST-GA involved application of Rough Set Theory to generate the d-Distinction
table, used as input,

in the third phase (i.e. the GA phase). The initialization of

population in the third phase (i.e. GA phase) involved 100 individuals randomly
selected from the d-Distinction table (e.g. in the case of the Colon Cancer dataset, size
of the d-Distinction table = 480). Thus the input to the GA phase is different in each of
the 15 runs (besides having the random seed being different). Given that the GA is a
feature selection instability method, different results is obtained in different runs since
the input data is different. Other potential causes for the feature selection instability here
is due to redundancy of features in high dimensional biological datasets, where multiple
features contribute to the same diseased effect and with the availability of only a small
number of samples in relation to the high number of features as exemplified by
microarray datasets.
Set #3 (“Set #3” column highlighted Table 4-3) is one of the 15 sets selected using the
proposed approach which gave the highest classification accuracy on the unseen test
data. This set consists of 6 genes which have been reported in biomedical literature as
being associated with cancer and other diseases. U31248 (Human zinc finger protein
(ZNF174) mRNA) is related to the expression of colon tissues (Williams, Khachigian,
Shows, & Collins, 1995). L08069 (Human heat shock protein, E. coli DnaJ homologue
mRNA ) is not only “shown to increase tumorigenicity in rat colon cancer”
(GSAEmulator, n.d.), but also associated with tumour development in human
(Diesinger et al., 2002). H49870 (yo24h10.s1 Soares adult brain N2b5HB55Y) is
involved in the detection of over-expression for olon cancer disease (Laping, 1999). The
M18216 (Human nonspecific crossreacting antigen mRNA) is considered as a major
component of Carcinoembryonic antigen involved in expression of lung cancer, tumour
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specimens, and tumour cell lines at mRNA levels (Hasegawa et al., 1993), and also
increasing level of expression in Colon cancer (Hinoda et al., 1997). H08393
(yl92a10.s1 Soares infant brain 1NIB) is involved in the process of degrading activity
of Colon cells. It is also one of 66 differently expressed genes for Colon cancer data
(Shaik & Yeasin, 2007). M22538 (Human nuclear-encoded mitochondrial NADHubiquinone reductase 24Kd subunit mRNA) is involved in schizophrenia, bipolar
disorder, and Parkinson disease (Nishioka et al., 2010) and is the only feature of this set
that has not been shown to have an established linked to some form of cancer. This
result may be the trigger for biological studies to include this feature for subsequent
investigations.
Sensitivity and specificity associated with classification are two measures that are of
great interest to the biomedical community in their efforts to find biological markers
(also known as biomarkers) and to assess the utility of these biomarkers as to how well
they can predict relevant outcomes. Sensitivity represents the probability of correctly
diagnosing a condition (i.e. the proportion of truly affected (i.e. diseased) in a sample
population that is identified by the test as being diseased). On the other hand, specificity
represents the proportion of truly non-diseased that the test identified as such. Ideally, a
biomarker should have high sensitivity and high specificity – resulting in the majority of
the truly at-risk cases being correctly identified, and the majority of the truly not-at-risk
cases also correctly identified as not having the diseased condition.
From Table 4-2, the k-NN classification results associated with each of the 15 sets of
features mostly showed high sensitivity but low specificity, implying the majority of the
truly at-risk cases will be correctly identified, but the majority of the truly not-at-risk
cases will also be incorrectly identified as at-risk. For example, in the case of the
highlighted row, sensitivity is 90% but specificity is only 72.7% for k = 1. A further
investigation was carried out using the same set of 6 genes and 22 different classifiers
from WEKA software (Hall et al., 2009) to classify the unseen test dataset. WEKA is a
data mining software program that has been developed and maintained by WEKA team
since 1994 (Markov & Russell, 2006). WEKA consists of a large number of classifiers
that can be used to analyse datasets and perform classification. WEKA classifiers used
in the thesis are categorized into six types of classifiers including Function, Bayes,
Lazy, Meta, Rules and Tree classifiers (Hall et al., 2009). Function classifiers are
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simple and used for attributes with all numeric values, and a “linear boundaries between
classes” strategy is used for classifying data. Bayes classifiers are implemented based
on Bayes’s rule for probability and use density estimators to map attributes to the
probability. Lazy classifiers are simple and use a distance function to measure the
distance between data points and classify data. Meta classifiers use weighting or voting
or ensemble schemes to classify data, for example, AdaBoost classifier classifies data
based on the class with highest total weight (Witten & Frank, 2005). Rules classifiers
use “a separate-and-conquer” strategy to identify rules for classifying data (Beasley,
Martin, & Bull, 1993, p. 171). Tree classifiers use “the simple divide-and-conquer”
strategy to generate decision trees for classifying data (Beasley et al., 1993, p. 159) .
Further details of WEKA classifiers can be found in Witten and Frank (2005) and Hall
et al. (2009). The aim here is to see if this trend (as in the case of k-NN) in terms
sensitivity and specificity is a result of using a specific classifier, in this case k-NN
classifiers. The classification results for the 22 classifiers constructed using the same set
of 6 features as that in training the k-NN classifiers are shown in Table 4-4. Note that
Multilayer Perceptron, Decorate, Random Committee and Random Forest are classifiers
that may return (slightly) different results from different runs, thus, these classifiers
were executed 10 times with different seeds and results with * is an average on these 10
executions.
As seen in Table 4-4, mixed results were obtained. Using KStar (in bold) on the unseen
test set produced results showing high sensitivity and high specificity (90%). However,
there are also other classifiers showing behaviour similar to that of the k-NN classifiers.
Also interestingly, there are a number of classifiers demonstrating higher specificity
(shaded cells) than sensitivity. These results demonstrated that the use of specific
classifiers may have an impact on the sensitivity and specificity. Thus in a DM analysis
for finding suitable sets of biological markers, a number of classifiers should be used
instead of just using one. This will avoid cases of missing out on sets of features with
high discriminatory capabilities that should be further investigated in early diagnostic
test developments but have been rejected on the basis of their sensitivity/specificity
relating to a specific classifier.
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Table 4-4 Results of classification for the 6 selected genes (highlighted in blue in Table
4-2) with 22 WEKA classifiers on the Colon unseen test set
Classifier

Set of 6 genes
C1

C2

SMO

70

81.8

Simple Logistic

65

100

Logistic

65

100

Multilayer Perceptron

83.5*

89*

Bayes Net

85

18.2

Naïve Bayes

80

63.6

Naïve Bayes Simple

80

63.6

Naïve Bayes Up

80

63.6

IB1

90

72.7

KStar

90

90.9

LWL

70

63.6

AdaBoost

80

63.6

ClassVia Regression

80

63.6

Decorate

85*

58.2*

Multiclass Classifier

65

100

Random Committee

77.5*

55.4*

j48

90

54.5

LMT

65

100

NBTree

80

54.5

Part

90

54.5

Random Forest

79*

59.9*

Ordinal Classifier

90

54.5
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4.2.2.

Leukemia cancer data

Using the same approach as outlined in Section 4.2, 15 independent runs involving
RST-GA were carried out using the parameter settings in Table 4-1 and the Leukemia
training dataset. The optimal subsets of features were obtained and evaluated using 10
fold CV evaluation strategy described in Section 3.2, as well as tested on the unseen test
dataset. The k-NN classifier associated with each of the optimal subsets of features and
with k values of 1, 3, 5 and 7 were used to classify the Leukemia cancer unseen dataset.
A convergence plot from one of the 15 independent runs is shown in Figure 4-12 and
the classification results of the 15 runs are shown in Table 4-5.

Figure 4-12 A typical state of convergence plot for maximum fitness and (fmax – favg )
values associated with the Leukemia cancer dataset
As seen in Figure 4-12, the algorithm converged to a global optimum with the maximum
fitness value of 0.928. The value for (fmax – favg ) was relatively high (values shown on
the right-hand vertical axis) in the earlier generations (<7) and it decreases to values
approximately close to zero around 64 generations. This value coincides with the
98

maximum fitness having a value of 0.928 (1 is the maximum). Similar to the Colon
dataset, the convergence is also quick although it occurred after 64 generations in
comparison with 17 generations for the Colon dataset. This is due to the fact that samples
in the Leukemia dataset have a larger number of genes (features), 7129, compared to
2000 features for the Colon cancer data. The 15 optimal sets of features obtained from
15 runs for the Leukemia cancer data using RST-GA, consisted of 2 sets of 4, 6, 7, 10
and 14 features, 3 sets of 5 features, 1 set of 11 features, and 1 set of 12 features. Each
row in Table 4-5 is associated with classification results for the unseen test dataset using
the k-NN classifier constructed from one of the 15 sets of features. The proposed
algorithm found a set of 5 and 14 genes (rows highlighted in blue and green in the table,
respectively) that gave a similar classification accuracy compared to those involving
the larger set of 19 genes reported by Banerjee, et al.(2007). It is not possible to
evaluate whether there are any commonality in the sets of features found by RST-GA,
with the set obtained by Banerjee et al. as the list of their 19 features is not listed in
their paper. Table 4-5 shows the classification accuracy for the unseen test data for the
classifier associated with each of the 15 sets. The lists of genes associated with each set
are shown in Table 4-6 by their accession number. Again, the differences between the
sets of selected features from each of the 15 runs are due to the same reasons as outlined
in the analysis of the Colon Cancer dataset.
As seen from Table 4-5, the k-NN classification accuracies associated with classifiers of
the set of 5 genes (the row highlighted in blue) and 14 genes (the row highlighted in
green) obtained from RST are compatible with the classification accuracies associated
with classifiers of the set of 19 features reported in Banerjee, et al. (2007).
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Table 4-5 Results for RST-GA (proposed approach) and Banerjee, et al.(2007) using for
k-NN classifier with k=1, 3, 5, and 7 on the Leukemia unseen test set. The column
heading “Net” stands for the overall classification (%) for all classes on the Leukemia
unseen test dataset and “Net” is calculated using Equation (4.3).
Approach
Banerjee
et
al.
(2007)

RST-GA

k=1

#

k=3

k=5

k=7

attr

C1

19

90

50 73.5 90 57.1 76.5 95 14.3 61.7 100 14.3 64.7

4

70

7.1 44.1 55 21.4 41.2 55 14.3 38.2

4

85 35.7 64.7 85 35.7 64.7 90 28.6 64.7

5

90 28.6 64.7 100 21.4 67.6 100 35.7 73.5 100 35.7 73.5

5

65 42.9 55.9 90 14.3 58.8 95 21.4 64.7

5

100 35.7 73.5 100 28.6 70.6 100 21.4 67.6 100 14.3 64.7

6

75 42.9 61.8 85

6

80

50 67.6 95 42.9 73.5 95 35.7 70.6 100 28.6 70.6

7

70

50 61.8 95 28.6 67.6 80 35.7 61.8

7

95 35.7 70.6 100

10

95 28.6 67.6 95 14.3 61.8 95 21.4 64.7 96.3 27.3 61.7

10

85

11

75 42.9 61.8 95 35.7 70.6 95 35.7 70.6

95 28.6 67.6

12

65 57.1 61.7 75 57.1 67.7 70

50 61.7

90

50 73.5

14

85

50 70.6 95 57.1 79.4 95

50 76.5

95

50 76.5

14

75 64.3 70.6 85 64.3 76.5 85

50 70.6

85 57.1 73.5

C2

Net C1

50 70.6 90

C2

0

Net C1

50

95

21 67.6 100

7.1 55.8 85

C2

0

Net C1

90

C2

0

Net

51.9

95 35.7 70.6

95 21.4 64.7

55.9 96.3 45.5 55.9

85

7.1 52.9

28 70.6 100 21.4 67.6

7.1 52.9

95

0

55.9

100

Table 4-6 List of 15 sets of genes selected for the Leukemia cancer dataset using RSTGA.

Table 4-6 lists the selected genes by accession numbers for the 15 sets found by RST.
The highlighted columns (“Set #5” in blue and “Set #14” in green) in the table are the
corresponding set of 5 and 14 genes associated with classifiers that produced
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compatible unseen test classification accuracies in rows highlighted in blue and green,
respectively, in Table 4-5. As seen from the table, some genes are common across a
number of these sets, e.g., D64158 are found in Set# 3, 8, 10, 11, 12 and 14 (shaded
cells). These common genes are coded in the same colour in the table for ease of
identifying them in the different sets.
As seen in from Table 4-6, Set #5 (“Set #5” column highlighted in Table 4-6) is one of
the 15 sets obtained using the proposed approach, which gave a high classification
accuracy with a smaller number of features. This set consists of 5 genes which have
been reported in the literature as being associated with cancer: D10495 (protein kinase
C delta-type) is the gene whose expression is commonly down-regulated in acute Adult
T-cell leukemia (ATL) (Tsukasaki et al., 2004), D13628 (Angiopoietin 1) is the gene
that is over-expressed in extramedullary plasmacytomas (Hedvat et al., 2003), D42072
(Neurofibromatosis type 1 (NF1)) is known as an autosomal disorder gene and highly
associated with malignancy (Suzuki et al., 1995), D50683 (Alteration of the
tra sfor i g growth factor β ( G B)) is a down-regulated gene that

modifies

expression and effects of TGFB in pancreatic carcinomas (Albrechtsson, Axelson,
Heidenblad, Ludmilagorunova, & Höglund, 2001) and D83004 (ubiquitin-conjugating
enzyme E2) is one of Atherosclerotic phenotype determinative genes that can be used in
diagnosis, treatment and drug screening methods for Atherosclerosis (West, Nevins,
Goldschmidt, & Seo, 2005). No existing information found to indicate its role in terms
of this disease.
Also seen in Table 4-5, similar to the Colon cancer data, the k-NN classification results
associated with the selected set of 5 and 14 genes mostly showed high sensitivity but
low specificity when classifying the unseen test data. For example, the k-NN classifier
involving the set of 5 selected genes showed 100% classification accuracy for C1 and
35.7% for C2 ( i.e. high sensitivity and low specificity) . Further investigation, similar
to that conducted with the Colon cancer dataset, was also carried out here using the sets
of 5 and 14 genes to train 22 classifiers from WEKA and then to use them to classify
the Leukemia unseen test dataset. The classification results of 22 classifiers are shown
in Table 4-7.
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Table 4-7 Results of classification for the 5 and 14 selected genes (highlighted in blue
and green, respectively, in Table 4-6) with 22 WEKA classifiers on the Leukemia
unseen test set
Classifier

Set of 5 genes

Set of 14 genes

C1

C2

C1

C2

SMO

100

14.3

95

64.3

Simple Logistic

100

14.3

80

50

Logistic

100

14.3

90

64.3

Multilayer Perceptron

100*

7.1*

85*

64.3*

Bayes Net

95

42.9

75

71.4

Naïve Bayes

100

14.3

80

57.1

Naïve Bayes Simple

100

14.3

80

57.1

Naïve Bayes Up

100

14.3

80

57.1

IB1

100

35.7

85

50

KStar

95

14.3

100

42.9

LWL

95

42.9

70

35.7

AdaBoost

100

42.9

95

50

ClassVia Regression

95

42.9

80

57.1

Decorate

100*

24.6*

86.7*

62.7*

Multiclass Classifier

100

14.3

90

64.3

Random Committee

100*

13.4*

95.5*

45*

j48

100

14.3

70

57.1

LMT

100

14.3

80

50

NBTree

100

14.3

80

57.1

Part

100

14.3

70

57.1

Random Forest

100*

17.3*

95.5*

46.4*

Ordinal Classifier

100

14.3

70

57.1

Again, it can be seen that the classification results of 22 WEKA classifiers constructed
using the selected set of 5 and 14 genes showed mixed results in terms of sensitivity and
specificity. The 22 classifiers associated with the set of 5 genes showed that they can
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classify the diseased instances (C1) very well and are very poor in classifying the nondiseased cases (C2) (i.e. high sensitivity and low specificity). For the classifiers
associated with the set of 14 genes, most showed similar trends as the k-NN classifiers
but one classifier (Bayes Net) showed similar specificity and sensitivity.
4.3. Discussion
As described in the previous section, the optimal set of features, generated from each
independent RST-GA run, is then used with the training set to produce the various kNN classifiers. These classifiers are then used to classify the unseen test set, with the
classification results reported in Table 4-2 and Table 4-5 for the Colon cancer and the
Leukemia datasets respectively. As shown in Table 4-3 and Table 4-6
Table 4-6, the optimal set of features obtained from each independent run of RST-GA
has differences and varying degrees of overlap in terms of the selected features. This is
a typical outcome when using a non-deterministic approach such as RST-GA. Potential
benefits include: 1) the generations of smaller sets of features, (e.g. sets ranging from 4
to 14 features in comparison to the original dimensionality such as 7129 features in the
Leukemia dataset), with high discriminatory capabilities that can be further investigated
for early diagnostic test developments, and 2) examination of the overlap between the
sets of features which then can lead to construction of feature sets for further
investigations.
A number of observations emerged from examining the classification results in Table 42 and Table 4-5 relating to the issues of sensitivity and specificity of a classifier
associated with selected set of features. First, it can be seen that different classifiers,
trained using the same set of features, can produce different values for these two
measures in their evaluation of a test dataset. Second, as demonstrated in the analysis
involving the Leukemia dataset, sets with different number of features (e.g. set of 5 and
set of 14 genes) when used to train the same classifier will also produce different values
for these two measures in their evaluation of a test dataset. For example in the case of
the Bayes Net classifier, when trained with the set of 5 genes, the classification result
showed high sensitivity (95%) and low specificity (42.9%) and when trained with the
set of 14 genes, the sensitivity and specificity is not too different (75% versus 71.4 %).
Yet, most of the remaining 21 classifiers when trained with the same set produced
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classification results that showed high sensitivity and low specificity. This implies that
decisions, in terms of evaluating sets of features to be further investigated in early
diagnostic test developments, need to take into consideration these observations - to
avoid eliminating potential sets of features during an early stage of investigation.
The proposed approach, RST-GA can be used as an exploratory tool in terms of the
generation of multiple optimal sets with the most relevant features. By utilizing these
sets of features to train multiple classifiers and followed by classification on unseen test
datasets would provide biomedical researchers with more information about selecting
potential sets for further investigation. The comparison of classification results of these
different optimal sets with different classifiers in conjunction with domain knowledge
could be the starting basis for further investigations and developments leading to
development of panels of biomarkers related to a disease.
However, given the feature instability nature associated with RST-GA, resulting in
feature sets obtained from each different runs of the RST-GA on a specific dataset being
different and only having a small number of common features across the different sets.
From examining the analysis involving two datasets, it was obvious that the degree of
feature instability across different runs could be significant and the approach may not be
most ideal to explore biomedical data for finding potential biomarkers. The decision
was then to explore approaches that could work better with evolutionary approaches and
with minimal feature instability.
4.4. Summary
This chapter describes the proposed approach of a hybrid algorithm (RST-GA) which
incorporates GA and RST for finding the optimal subset of significant features. The
approach utilizes the k-means clustering for getting the initial cluster centroids of each
attribute for RST, the rough set-based approach for generating sets of good candidate
solutions, and GA for finding the reducts (optimal subsets of features). The evaluation
process used the same Colon and Leukemia cancer datasets as in Banerjee, et al. (2007).
The set of 6 genes and 5 genes for Colon and Leukemia cancer data respectively,
produced from the proposed approach, have similar classification results in comparison
to those obtained by Banerjee, et al. (2007) using a larger number of features.
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In the next chapter, an approach of incorporating the NSC algorithm with GA for
searching for an optimal shrinkage threshold value that leads to the selection of an
optimal set of features will be described.
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5. Incorporating NSC and GA, NSC-GA
5.1. Introduction
Chapter 4 described an initial attempt in this study to develop FS techniques
incorporating the use of evolutionary algorithms and RST for analysis of highdimensional biomedical data. One limitation of this approach is that the result of the
optimal set of features obtained is not constant in every independent run. This is a
typical issue when employing a non-deterministic algorithm such as GA. To ensure less
variability in the optimal set of features from each independent run, a deterministic
method can be incorporated in the approach. This chapter is an extended version of the
paper “NSC-GA: Search for Optimal Shrinkage Thresholds for Nearest Shrunken
Centroid” (Dang, Lam, & Lee, 2013). It describes the second approach in this study that
incorporates EA and a deterministic algorithm for analysing biological data. This
hybrid approach incorporates the NSC method (Tibshirani et al., 2002) and GA to
automatically search for an optimal range of shrinkage threshold values for the NSC.
The optimal shrinkage thresholds obtained are used in NSC to obtain a set of features.
The feature sets obtained using this hybrid approach has less variability as in NSC,
shrinkage threshold values with small differences map to the same feature set .
The NSC method, with its most well-known software implementation being known as
Prediction Analysis for Microarrays (PAM), has been widely used as a FS and
classification method for high dimensional biomedical data in numerous studies (Bair &
Tibshirani, 2004; Klassen & Kim, 2009; Lee et al., 2005; Ravetti & Moscato, 2008; Ray
et al., 2007; K. Y. Yeung & R. E. Bumgarner, 2003). A shrinkage threshold value must
also be provided to the NSC method as input and normally, this is selected manually by
executing the NSC method many times using a number of predetermined shrinkage
threshold values. The optimal shrinkage threshold value is then obtained by minimizing
the cross-validated error rate on the training data. This process can be time-consuming
and the optimal shrinkage threshold value may be limited by the granularity of the
predetermined values.
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The selection of a shrinkage threshold value is crucial as the NSC works on the
principle of shrinking the relative difference between the class centroid and the overall
centroid of all classes, moving the class centroid towards the overall centroid of all
classes using the shrinkage threshold value.

(dik1 - ∆)

(dik2 - ∆)

Relative

Relative

difference

difference

(dik1)

(dik2)

Figure 5-1 Shrinkage of threshold of 2 class centroid toward overall centroid in NSC
As seen in Figure 5-1, the class centroid

ik1 and

ik2

(associated with Class 1 and Class

2 respectively) of attribute i are shrunk toward overall class centroid (

K)

by a shrinkage

threshold (∆) value iteratively. The relative difference, dik1and dik2, is the distance
between the class centroid,

ik1

and

ik2,

and the overall centroid,

k,

respectively. If the

relative difference of an attribute is shrunk to zero for all associated classes, then it is
considered as not an important attribute and is eliminated (i.e. class centroids and
overall class centroid are not different). Attributes with at least one positive relative
shrunken class centroid are considered as important attributes and are selected (i.e. class
centroids and overall class centroid are different).
The shrinkage threshold value for NSC is important in terms of FS and classification as
it affects the selection of features. Using inaccurate shrinkage threshold values will lead
to irrelevant features being selected and subsequently will lead to a lower classification
accuracy. Two approaches, CV (Tibshirani et al., 2002; S. Wang & Zhu, 2007; K.
Yeung & R. Bumgarner, 2003) and empirical approach (Klassen & Kim, 2009; Levner,
2005; Ray et al., 2007) are normally used to find the shrinkage threshold values. With
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the CV approach such as 10 fold CV, the dataset is divided randomly equal into 10
parts, each part consists of approximate proportion of a number of samples and classes.
One part takes turn to be the test set while the other 9 parts are used as the training set.
The procedure is repeated 10 times to obtain the prediction error rate for each time. The
overall prediction error rate is then calculated by averaging the errors from all iterations.
The selected optimal shrinkage threshold value is based on the CV prediction errors
associated with the different shrinkage threshold values. The shrinkage threshold value
that gives the minimum CV prediction error is selected as the optimal shrinkage
threshold value. For example, in Tibshirani, Hastie, Narasimhan and Chu’s study (2002)
the optimal shrinkage threshold value was chosen based on the average errors of a 10
fold CV resulting in a set of 43 genes that was associated with the minimum CV errors.
With the empirical approaches (Klassen & Kim, 2009; Levner, 2005; Ray et al., 2007),
the optimal shrinkage threshold was selected based on the lowest classification error
over a range of shrinkage thresholds. For example, in Levner’s study (2005),
experiments were first carried out with 20 different shrinkage threshold values in the
range of [0.5, 10] with increments of 0.5. This study also experimented with another
200 different shrinkage threshold values in the range of [0.5, 10] with increments of
0.05, and obtained the same classification results. In general, CV and empirical
approaches for determining the optimal shrinkage threshold value are based on “trial
and error”. However, such shrinkage threshold values may not be precisely tuned for
the specific dataset for obtaining optimal classification results. This is due to the fact
that it is limited in terms of exploring the search space of shrinkage threshold values in
relation to the dataset. It is vital to address the issues described above. Thus, a new
approach incorporating GA for automatically searching for the optimal shrinkage
threshold for the NSC is proposed in this study.
Besides investigating evolutionary approaches for obtaining the shrinkage threshold
values, similarity measures used in NSC is another area of investigation. The
investigation is structured in the following way: the investigation of evolutionary
approaches for the NSC and followed by investigation of the impact of different
similarity measures. Chapter 5 and 6 described investigations involving GA and
Memetic algorithm and followed by the description of investigations if similarity
measures in Chapter 7.
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The following section describes the proposed approach (NSC-GA) involving GA.
Section 5.3 describes the parameter settings for GA. Using seven datasets described in
Section 3.1, the performance of the proposed approach is examined using the evaluation
strategy as described in Section 3.2. The evaluation results are reported in Section 5.4
and the summary is in Section 5.5.
5.2. The proposed approach, NSC-GA
Figure 5-2 illustrates the framework of the proposed approach, NSC-GA that
incorporates NSC and the GA to search for the best optimal range of shrinkage
thresholds for the NSC algorithm. The basic concepts of NSC (Tibshirani et al., 2002)
and GA (Goldberg, 1989) algorithms have already been reviewed in Section 2.3.3, and
2.3.4.1, respectively.
The two main steps are:
Step 1: This step carries out the procedure of automatic calculation of Thmax. This
procedure is performed once only at the beginning of the proposed approach, NSC-GA,
to obtain Thmax.
Step 2: The GA is employed in this step as an optimization method to search for optimal
sets of shrinkage thresholds for NSC algorithm that lead to the selection of optimal
subsets of features. Also in this step, the NSC algorithm is employed as a fitness
evaluator to evaluate the fitness of each chromosome in terms of the number of selected
features and its training classification accuracy.
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Figure 5-2 Framework of the proposed approach, NSC-GA
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5.2.1. Issues related to the proposed approach, NSC-GA
Encoding chromosomes, estimating the initial range of values for the shrinkage threshold
and fitness evaluation are the issues that need to be first addressed in NSC-GA. The
following section describes these issues.
5.2.1.1.

Encoding chromosomes

The aim of the proposed approach is to optimize a range of shrinkage threshold values
consisting of real numbers for NSC. The most appropriate encoding representation for
chromosomes in this study would be real-encoding. Each chromosome, consists of
number of genes, representing a range of n shrinkage threshold values, e.g. {1.23 0.56
4.23 5.32 6.0 0.87 in the case of n = 6}. This allows the optimization of a range of
shrinkage threshold values and the use of the GA crossover operator. Without using
crossover to recombine chromosomes, GA would rely solely on a mutation operator and
has a higher probability of being stuck in a local optimum (Back et al., 1991).
5.2.1.2.

Estimate initial range of values for shrinkage thresholds

Shrinkage threshold values of chromosomes are generated randomly using a RNG.
Theoretically, shrinkage thresholds can be in the range [0, ∞]. However, in practice,
there is a finite number of attributes associated with the dataset to be analysed. The
lower limit (Thlower) associated with shrinkage thresholds is a value where all attributes
from the dataset are selected and the maximum value (Thmax) is a value where only 1
attribute is selected. The value Thlower is 0. Thus shrinkage threshold values in the range
[0, Thmax] map to the search space of sets of features in NSC. In the proposed approach,
a chromosome is a range of shrinkage thresholds, each shrinkage threshold maps to a
subset of features, therefore each chromosome maps to a number of subsets of features.
This mapping is different from the commonly used binary representation in FS in
which, a chromosome is a string of binary (bit) of 0 and 1, and each gene (bit) value
maps to 1 feature, with each chromosome mapping to only 1 set of selected features.
To illustrate the impact of Thmax in the “time-to-convergence” in NSC-GA, Figure 5-3
and Figure 5-4, respectively, showed examples of convergence plots of fitness from
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executing NSC-GA with and without employing Thmax when analysing the AD training
data.

Convergence occurs
0.9
0.88
0.86
0.84

Fitness

0.82
0.8
0.78
0.76
0.74
1
7
13
19
25
31
37
43
49
55
61
67
73
79
85
91
97
103
109
115
121
127
133
139
145

0.72

Generations
max fitness

Figure 5-3 Example of convergence plot for AD training dataset with the application of
Thmax calculation using NSC-GA

Convergence occurs
0.9
0.8
0.7
0.6

Fitness 0.5
0.4

max fitness

0.3
0.2
0.1

1
65
129
193
257
321
385
449
513
577
641
705
769
833
897
961
1025
1089
1153
1217
1281
1345
1409

0

Generations

Figure 5-4 Example of convergence plot for AD training dataset without the application
of Thmax calculation and Thupper > Thmax
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As seen in Figure 5-3 and Figure 5-4, the algorithm achieved the same maximum fitness
of 0. 887. However, it can be also seen that, with the application of the Thmax, the
algorithm reached convergence much quicker, at the 47th generation in comparison to
the 916th generation for the algorithm that did not use Thmax. In this instance, the
approach that did not use Thmax required more than 20 times the number of generations
compared to the one using Thmax. The approach with the application of Thmax reached
the fitness of 0.78 in the 1st generation, while the other approach (without Thmax
calculation) required 820 generations before reaching the same fitness value of 0.78.
The algorithm without the application of Thmax spent much more computational time to
obtain the same result as that of the one with Thmax calculation. This is not only
unnecessary but also contradictory to attempts by many previous researchers whom
have tried to develop algorithms or strategies to improve computational time for GA (Li
and Love (1997), Ahujaa and Orlinb (2000), Ilonen, Kamarainen and Lampinen (2003),
and Snyder and Daskin (2006).

Convergence occurs
0.74
0.72
0.7
0.68
0.66
0.64
0.62
0.6
0.58
0.56
1.......48..............................................................................................100000

Generations
Max fitness
Figure 5-5 Example of convergence plot for AD training dataset without the application
of Thmax calculation and the value of Thupper < Thmax
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Figure 5-5 shows an example of the convergence plot of fitness for analysing the impact
of Thmax, using the same Ray et al. training dataset as before and where the upper limit
of shrinkage threshold value is less than the associated of Thmax value (i.e. the initial
population of chromosomes is initialized to be in the range [0, thupper] (i.e. thupper <
Thmax). As seen in this figure, the algorithm is stuck in a local optima and premature
convergence occurred. A maximum fitness of 0.727 is obtained after running for a very
large number of generations (100,000). The optimal shrinkage threshold obtained has
resulted in a set of 48 features with corresponding classification accuracy of 86.95% on
the unseen test set. In comparison, as demonstrated in Figure 5-3, a fitness of 0.887
resulting in a set of 11 features with corresponding classification accuracy of 89.49% on
unseen test data in the case involving the use of Thmax.
Thmax is a simple procedure that involved a single iteration to calculate Thmax and the
computational time to obtain Thmax is up to around 1 second for each of seven datasets
using a personal computer i7, CPU speed of 3.4 GHz with 16 GB memory, Windows 7
and NetBeans 7.2. The calculation of Thmax needed to be carried out once only for each
dataset. For example, it took 0.0105 seconds to obtain Thmax for the Ray et al. AD
training dataset, 0.167 seconds for the Colon cancer dataset, 0.41 second for Leukemia,
0.180 second for Lymphoma, 0.95 second for Lung cancer, 0.971 second for Prostate
cancer and 1.06 seconds for Ovarian cancer dataset. It can also be seen that the
application of Thmax in the proposed GA based approach maximizes the performance of
the algorithm, resulting in a global convergence using less computational time.
5.2.1.3.

Fitness evaluation using NSC as a fitness evaluator

The NSC algorithm as described in Section 2.3.3 was implemented and employed as a
fitness evaluator in this approach to evaluate the fitness of the chromosomes using the
training dataset.
5.2.2. Steps in the proposed approach, NSC-GA
The following sections describe the steps in NSC-GA.

115

5.2.2.1. Step 1: Thmax calculation
To find the value of Thmax for the dataset in question, the approach estimates the value
of Thmax using the procedure shown in Figure 5-6.
Input
Training dataset (Ts)
Output
Thmax value
Steps
1. Generate a real random number (Rn) in the range [0,1] as an initial shrinkage
threshold seed using RNG
2. Set Thmax = Rn
3. Perform NSC FS on Ts using Thmax to select a number of features (N)
4. Loop while n ≠ 1
a. If no feature selected n = 0
 Generate Rn
 Decrease Thmax by Rn, Thmax = Thmax - Rn
 Perform NSC FS on Ts using updated Thmax to select n
b. Else
 Generate Rn
 Increase Thmax by Rn, Thmax = Thmax + Rn
 Perform NSC FS on Ts using updated Thmax to select N
5. Return Thmax

Figure 5-6 Algorithm for calculating Thmax
As seen in the algorithm in Figure 5-6, the value of Thmax is adjusted up or down using
steps of values associated with random numbers in the range [0, 1]. This process repeats
until Thmax reaches the value that results in only one feature being selected using NSC,
i.e., Thmax of the training dataset has been determined.
5.2.2.2.

Step 2: GA search optimization

The following section describes steps involving the application of GA in NSC-GA.
a)

Population initialization

After Thmax has been calculated, a population of chromosomes is then initialized. Each
shrinkage threshold in a chromosome (essentially each chromosome represents a range
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of values for shrinkage thresholds) is initialized to a real number, generated randomly in
the range of [0, Thmax] using a RNG. The number of shrinkage threshold values in the
chromosome equals to the length (n) of the chromosome, i.e. the number of genes in the
chromosome. Theoretically, n can be as large as ∞, but in this proposed approach, n =
10 is chosen. That is, each chromosome consists of 10 shrinkage thresholds. The size of
10 is chosen empirically to balance the computational time and obtaining the optimal
shrinkage threshold. For example, a chromosome of size 10 is illustrated as a range of
10 real numbers, as follows.
2.312

3.523

1.133

1.034

2.334

9.234

0.211

5.354

8.142

10.299

Figure 5-7 describes the algorithm used to initialize the population and Figure 5-8
shows an example of an initial population.
Input:
Thmax
Length of chromosome, n
Size of population, p
Output:
An initialized population of p rows and n columns
Steps:
1. Set population (Ip) as a 2 dimensional array of p rows and n columns of real
numbers
2. Set Ip = { }
3. For counter1 from 1 to p
3.1 For counter2 from 1 to n
a. Generate a real random number (Rn) in the range [1, Thmax] using a
RNG
b. Store Rn to Ip[counter1][counter2]
Figure 5-7 Initial population algorithm using RNG
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Figure 5-8 An example of an initial population
Figure 5-8 shows an example of an initial population of N chromosomes by M
shrinkage threshold values. That is, each chromosome consists of M shrinkage
thresholds. After the population has been initialized, the next step is to employ the NSC
algorithm as a fitness evaluator to evaluate the fitness of each chromosome.
b) Fitness evaluation
GA was described in Section 2.4.4 and implemented, and employed in this study. The
GA here uses an objective function to optimize the search for finding optimal shrinkage
thresholds that leads to the selection of the smallest set of features with the highest
classification accuracy. The objective function, f, is an aggregation of two fitness
functions, f1 and f2, calculated using Equations (5.1), (5.2) and (5.3).
f = f1 + f2
f1 = (Ntotal - Natt) / Ntotal

(5.1)
(5.2)
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f

(5.3)

where Ntotal is the total number of attributes (features) of the dataset
Natt is the number of attributes selected by NSC
f2 is an overall training classification accuracy for the selected set of attributes
using NSC.
TP is true positive for correct prediction to the disease class
TN is true negative for correct prediction to the normal class
FP is false positive for incorrect prediction to disease class
FN is false negative for incorrect prediction to normal class
f1 is computed based on the number of attributes selected over the total of number of
attributes in the training dataset. That is, the smaller the set of features, the higher the
fitness value for f1. Thus f1 is designed for evaluating the fitness of a shrinkage
threshold that leads to a minimum number of attributes.
f2 is computed based on the classification accuracy, associated with the training data, in
the form of TP and TN over a total number of samples in the training dataset (i.e. TP,
FP, TN and FN). Thus f2 is designed for evaluating the fitness of a shrinkage threshold
that leads to the maximum classification accuracy.
Since each chromosome (range) consists of a number of shrinkage threshold values,
therefore the overall fitness of a chromosome is calculated, as the average of fitness
values associated with each of the shrinkage thresholds in the chromosome, using
Equation (5.4).
FitnessInd= ∑

th

/M

(5.4)

where M is the number of shrinkage thresholds in a chromosome.
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c)

GA operators

Selection, crossover and mutation operators for real encodings are used in NSC-GA.
The same tournament selection procedure employed in the RST-GA approach proposed
in Chapter 4 is also employed here to select the parent chromosomes for crossover.
The same single point crossover employed in Chapter 4 is used here to recombine the 2
selected parent chromosomes to produce 2 offspring chromosomes using the probability
of crossover (Pc) listed in Table 5-4.
Uniform mutation (Eiben & Smith, 2007) is used for real-encoded chromosomes.
Uniform mutation has been described in Section 2.4.4.1 and is employed here to modify
offspring chromosomes using the mutation rate (Pm) listed in Table 5-4. Uniform
mutation modifies a chromosome by replacing its gene value with a mutated number,
Nmut , which is calculated using Equation (5.5).
Nmut = Lb + (Rn * (Ub - Lb))

(5.5)

where Lb is lower bound of chromosome, Rn is a random number generated by RNG, Ub
is upper bound of chromosome.
d) Generation of New population
Two parents and 2 offspring chromosomes from the previous step involving selection,
crossover and mutation are evaluated for their fitness and the best 2 chromosomes are
selected and placed into the new population. A single elitist strategy is also employed to
allow the best candidate solution in the previous generation to be retained and placed
into the new generation to improve the search in evolutionary algorithms (Ahn &
Ramakrishna, 2010). The process of selection, crossover and mutation iterates until the
generation of the new population is completed. The procedure for generating a new
population in NSC-GA is the same as the one in RST-GA (Figure 4-8), except that
uniform mutation instead of the bit flip mutation is employed here.
The following figure shows an example of the process of selection, crossover, mutation,
in new population generation.
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Figure 5-9 An example of creating a new population
e)

Checking for convergence in NSC-GA

The process of fitness evaluation, selection, crossover, mutation and new population
generation is repeated until the convergence of fitness takes place or if a predefined
maximum number of generations have been executed. The procedure of verifying the
convergence status and terminating the GA have been described in Section 3.3 and 3.4,
respectively. Upon convergence, the fittest chromosome (optimal solution) is selected.
The process of determining parameter settings used in NSC-GA is described in Section
5.3.
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5.3. Parameter settings for GA
As discussed previously, one of the aims of this study is to investigate the incorporation
of evolutionary algorithms in developing techniques for analysing high dimensional
biological datasets. An aspect associated with the use of evolutionary algorithms
involves finding appropriate values for its parameters (Eiben & Smith, 2003).
Population size, crossover and mutation probability rate are some of the crucial
parameters which affect the performance of evolutionary algorithms where their specific
values may cause the algorithm either to converge to a local (premature convergence) or
global optimal solution. This process is known as parameter tuning, in which
appropriate parameter settings are determined to ensure that the algorithm will perform
at its best (M. Srinivas & Patnaik, 1994).
A traditional parameter tuning approach empirically finds a set of parameter values
which is then subsequently applied to the evolutionary algorithm for processing the
various problem instances. This is usually a very time-consuming and hard task
(Nannen, Smit, & Eiben, 2008) as there are many choices of values associated with the
parameters and little is known about the effect of these parameter values on the
performance of the algorithm. Often this process is guided by conventions (e.g. low
mutation rate), ad hoc choices and experimental comparisons carried out on a limited
scale. Dovgan, Tu ar and Filipic (2011) carried out experiments, comparing parameter
tuning methods for evolutionary algorithms and their findings showed that “there is no
best value for each parameter, but there are wide ranges of good parameter values”
(Franken et al., 2011, p. 2), and that there’s some value in conducting parameter tuning.
Recently a study by Fraser and Arcuri (2011) confirmed that parameter tuning can have
an impact on the performance of the evolutionary algorithm but if this is not performed
properly, it is highly likely to result in obtaining parameter configurations which are
worse than values already found in the literature. One of the main conclusions from
their study is that “using default values coming from the literature is a viable option”
(Fraser & Arcuri, 2011, p. 26), specifically in the case where parameter tuning is
expensive and the investigation is focused on examining the performance of new
techniques (rather than comparisons between techniques). They argued that it would
make more sense to use the available time for analysing a larger number of case studies
than to spend that time on parameter tuning.
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Section 5.3.1 describes the procedure for selection of the parameter settings which will
be employed in approaches in the remaining part of this thesis. The outcomes of this
process are presented in Section 5.3.2 with a summary of the results listed in Table 5-3.
5.3.1. Parameter settings
In order to find an appropriate set of values for the GA parameters, empirical parameter
tuning involving 4 sets of commonly used parameter settings from the literature are
conducted. The parameters that are tuned (highlighted in blue in Table 5-2) include
population size, crossover probability rate (Pc), and mutation probability rate (Pm), with
each set of these values being taken from DeJong (1975), Grefenstette (1986), Goldberg
(1989), and Alander (1992) respectively (Table 5-2). These sets of parameter settings
have been widely used in applications involving the GA and have been considered as
“standard parameter values” for the GA (Harik & Lobo, 1999). The aim of the
parameter tuning process in this study is to determine which of these four sets of
“standard parameter values”, will encourage more exploration and less exploitation in
the population, and achieves an appropriate balance between selection pressure and
diversity so that global convergence can be achieved in a reasonable amount of time.
In other words, during parameter tuning, the evaluation is on the suitability of each the
sets of parameter values for one algorithm using specific datasets and the end product is
a specific set of parameter values. Suitability is measured in terms of achieving
maximum fitness at convergence and the required computation time. For example, we
can have the situation where there are two sets where the algorithm can converge to the
same maximum fitness but one set provides a lower selection pressure than the other and
so may take a longer computation time to reach convergence. Obviously in this case, the
set of parameter values that allowed the algorithm to converge to the same maximum
fitness and using a shorter computation time will subsequently be chosen in the
application of the algorithm to solve the specific problem. Thus, computation time in
obtaining maximum fitness at convergence is used to evaluate one set of parameter
values against another set.
The tuning process involved separate trials that employ each of the 4 sets of parameter
settings in the NSC-GA and for all the seven datasets described in Section 3.1. The
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results obtained from these experiments are analyzed and the set of parameter values
which gave the best results in terms of computational time for convergence and
maximum fitness were then selected to be used in the proposed approaches in this study.
An entire tuning trial involving each of the 4 parameter sets using each of the 7 datasets
(i.e. 4 x (1 x7) = 28 runs) takes 119,339 minutes to complete. Owing to this lengthy
computational time, three independent trials of the tuning process are carried out. The
following table, Table 5.1, shows the computational time of using a personal computer
i7, CPU speed of 3.4 GHz with16 GB memory, Windows 7 and NetBeans 7.2 for one
trial involving each parameter setting for each dataset.
Table 5-1 Computational time spent for one trial involving the 4 parameter settings
Running time (minutes)

Datasets

Dejong (1975) Grefensette (1986) Goldberg (1989) Alander (1992)
64
Ray et al. AD 102
45
45
Alon et al.
795
Colon
2241
644
724
4895
Leukemia
2844
2314
1969
10816
Lung
11288
7721
6764
1625
Lymphoma
3377
1456
1086
Ovarian

11180

7721

8596

Prostate

5473

5352

3436

10026
6740

Table 5-2 Four sets of parameter settings used in the tuning process
Dejong

Grefensette

Goldberg

Alander

Population size
Pc

50
0.06

30
0.9

30
0.6

50
0.5

Pm

0.001

0.01

0.033

0.002

Maximum generations

5000

Selection

Tournament

Crossover

Single point

Mutation

Uniform

Elitist

One
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5.3.2. Results of parameter tuning
The following section presents the results from one typical independent trial. For each of
the seven datasets, NSC-GA is applied using each of the 4 sets of parameter settings
shown in Table 5-2 for one typical trial. Plots demonstrating convergence of fitness
associated with each of the 4 sets of parameter settings as well as a typical plot of the
state of convergence associated with one set of parameter settings is shown for each
dataset. A summary of the results for the 3 independent trials is also shown in Table 5-3.
5.3.2.1.

Ray et al. AD data
DeJong (197th)

Goldberg's ConvergenceGrefenstette (64th)
(35th generation)
Alander ( 162nd)

Fitness
1.78
1.76
1.74
1.72
1.7
1.68

1
10
19
28
37
46
55
64
73
82
91
100
109
118
127
136
145
154
163
172
181
190
199
208
217
226
235
244
253
262

1.66

Generations
Dejong

Grefenstette

Goldberg

Alander

Figure 5-10 Typical convergence of fitness plots for AD data associated with each of
the 4 different parameter settings from DeJong, Genfenstette, Goldberg and Alander
Figure 5-10 shows the convergence of fitness plots from running NSC-GA on the AD
dataset using each of the 4 parameter settings from Table 5-2. The algorithm converged
to the maximum fitness of 1.775 for each of the 4 sets of parameter settings. However,
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the convergence associated with each of the 4 sets of parameter settings occurred at
different generations. With DeJong’s set of parameter settings, convergence occurred
after 197 generations and with Grefensette’s and Alander’s set of parameter settings, the
convergence occurred after 64 and 162 generations, respectively. Whilst with
Goldberg’s set of parameter settings, convergence occurred after 35 generations. With
this dataset, the algorithm using Goldberg’s parameter settings outperformed the other 3
sets of parameter settings in terms of obtaining the global optimum with the same
maximum fitness value and a quicker convergence.
The state of convergence associated with each run of the algorithm using one of the 4
sets of parameter settings is monitored using Srinivas and Patnaik (1994)’s method, see
Section 3.3. The red line plot in Figure 5-11 shows the difference between the maximum
and average fitness of the population (i.e. fmax – favg ) and demonstrates the state of
convergence of the algorithm associated with using Goldberg’s parameter settings. The
value of (fmax – favg ) is expected to be very small for a population that has converged to a
global optimum than for a population with members spread over the entire search space.
That is, a value closer to 0 would imply a convergence closer to the global optimum.

Max Fitness

Convergence occurred

1.8

fmax - favg
0.25

1.78

0.2

1.76

0.15

1.74
0.1

1.72

0.05

1.7

0
1
6
11
16
21
26
31
36
41
46
51
56
61
66
71
76
81
86
91
96
101
106
111
116
121
126
131
136
141
146

1.68

Generations
Max fitness
fmax - favg

Figure 5-11

An example plot of the state of convergence: (fmax – favg ) versus

generations (using Goldberg’s set of parameter settings)
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As seen in Figure 5-11, the value for (fmax – favg ) was relatively high (values shown on
the right-hand vertical axis) in the earlier generations (<10) and it decreases to values
very close to zero around 35th generations. This coincides with the maximum fitness of
1.775.
The following figure shows the state of convergence associated with one run of the
algorithm for each of the 4 sets of parameter settings using Srinivas and Patnaik
(1994)’s method.

Goldberg's Convergence
Alander's Convergence ( 162nd)
th
(35 generation)
th
fmax-favg
Grefenstette's Convergence (64th) DeJong's Convergence (197 )
0.1
0.09
0.08
0.07
0.06
0.05
0.04
0.03
0.02
0.01

1
10
19
28
37
46
55
64
73
82
91
100
109
118
127
136
145
154
163
172
181
190
199
208
217
226
235
244
253
262

0

Dejong

Generations
Grefensette
Goldberg

Alander

Figure 5-12 An example plot of the state of convergence: (fmax – favg ) versus generations
for 4 sets of parameter settings
As seen in Figure 5-12, the value for (fmax – favg ) was relatively high for each set of
parameter settings in the earlier generations (<10) and it decreases to 0 around 35
generations for Goldberg’s parameter settings, 64 generations for Grefensette’s, 162
generations for Alander’s and 197 generations for Dejong’s .
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5.3.2.2.

Alon et al. Colon cancer data

Grefenstette (28th generation)
Alander (63rd)
Goldberg (238th)

Fitness
1.84

DeJong (2199th)

1.83
1.82
1.81
1.8
1.79
1.78
1.77
1.76
1.75
1
83
165
247
329
411
493
575
657
739
821
903
985
1067
1149
1231
1313
1395
1477
1559
1641
1723
1805
1887
1969
2051
2133
2215
2297
2379
2461
2543
2625

1.74

Generations
Dejong

Grefensette

Goldberg

Alander

Figure 5-13 Typical convergence of fitness plots for Colon cancer data associated with
each of the 4 different parameter settings from DeJong, Grefenstette, Goldberg and
Alander.
Figure 5-13 shows the convergence of fitness plots of running NSC-GA on the Colon
cancer dataset for each of the 4 sets of parameter settings. The algorithm converged
with different maximum fitness values and involved a different number of generations
for each of the 4 sets. With Goldberg’s parameter settings, convergence occurred after
238 generations with the maximum fitness of 1.833, whilst with the other 3 sets of
parameter settings,

their maximum fitness at convergence is lower than Goldberg’s

value. In terms of the number of generations required for convergence, the algorithm
took 2199 generations using DeJong’s set of parameter settings. In the case of using
Grefenstette’s and Alander’s set of parameter settings with the Colon cancer dataset,
the algorithm required a smaller number of generations (in comparison to Goldberg’s
set) to converge. Therefore the algorithm with Goldberg’s set of parameter settings
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outperformed the other 3 sets of parameter settings in terms of obtaining a higher
maximum fitness.
5.3.2.3.

Leukemia cancer data

Goldberg's (42nd)
Fitness

DeJong's (732nd)

Grefensette's (129th)

Alander's (1050th)

1.975
1.973
1.971
1.969
1.967
1.965
1.963
1.961
1.959
1.957
1
42
83
124
165
206
247
288
329
370
411
452
493
534
575
616
657
698
739
780
821
862
903
944
985
1026
1067
1108
1149
1190
1231
1272

1.955

Generations
Dejong

Grefensette

Goldberg

Alander

Figure 5-14 Typical convergence of fitness plots for Leukemia cancer data associated
with parameter settings from DeJong, Grefenstette, Goldberg and Alander
Figure 5-14 shows the convergence of fitness plots of running NSC-GA on the
Leukemia cancer dataset for each of the 4 sets of parameter settings. The algorithm
converged to the global optimum with the same maximum fitness of 1.973 for each of
the 4 sets of parameter settings. However, the number of generations that the algorithm
has to run to achieve convergence is different.

With Goldberg’s set of parameter

settings, convergence occurred after 42 generations, with Grefenstette’s set of parameter
settings, convergence occurred after 129 generations, with DeJong’s set, convergence
occurred after 732 generations and lastly with Alander’s set, convergence occurred after
1050 generations. Therefore the algorithm with Goldberg’s parameter settings
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outperformed the other parameter settings in terms of obtaining the global optimum
with the same maximum fitness but used less computational time.
The state of convergence associated with each run of the algorithm using one of the 4
sets of parameter settings for the Leukemia cancer data is also monitored using the
method proposed by Srinivas and Patnaik (1994). The plots obtained here for each of
the 4 sets of parameters are similar in nature to that shown in Figure 5-11 and Figure
5-12.
5.3.2.4.

Fitness

Lung cancer data

Goldberg's convergence (32nd generation)
Grefensette's (60th) Alander's (155th) DeJong's (212nd)

1.999
1.997
1.995
1.993
1.991
1.989
1.987

1
11
21
31
41
51
61
71
81
91
101
111
121
131
141
151
161
171
181
191
201
211
221
231
241
251
261
271
281
291
301

1.985

Generations
Dejong

Grefensette

Goldberg

Alander

Figure 5-15 Typical convergence of fitness plots for Lung cancer data with 4 different
parameter settings from DeJong, Grefenstette, Goldberg and Alander
The convergence of fitness plots from running NSC-GA on the Lung cancer dataset for
each of the 4 sets of parameter settings is shown in Figure 5-15. It can be seen that the
algorithm converged with the same maximum fitness of 1.999 for each of the 4 sets of
parameter settings. However, these convergence started at different generations; with
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Goldberg’s set of parameter settings, the convergence occurred after 32 generations,
with Grefenstette’s set of parameters, the convergence occurred after 60 generations,
DeJong’s set parameters, the convergence occurred after 212 generations and Alander’s
set of parameters, the convergence occurred after 155 generations. With this dataset, the
algorithm using Goldberg’s set of parameter settings achieved the global optimum with
the same maximum fitness.
The state of convergence associated with each run of the algorithm using one of the 4
sets of parameter settings for the Lung cancer data is again monitored. The plots
obtained here for each of the 4 sets of parameters are similar in nature to that shown in
Figure 5-11 and Figure 5-12.
5.3.2.5.

Fitness

Lymphoma cancer data

Goldberg's convergence (133rd)
Alander's (312nd)
Genfenstette's (387th)

DeJong's (1217th)

1.97
1.96
1.95
1.94
1.93

1
50
99
148
197
246
295
344
393
442
491
540
589
638
687
736
785
834
883
932
981
1030
1079
1128
1177
1226
1275
1324
1373
1422
1471
1520
1569

1.92

Generations
Dejong

Grefensette

Goldberg

Alander

Figure 5-16 Typical convergence of fitness plots for Lymphoma cancer data for each of
the 4 sets of parameter settings: DeJong, Grefenstette, Goldberg and Alander.
Figure 5-16 shows the convergence of fitness plots of running NSC-GA on the
Lymphoma cancer dataset and each of the 4 sets of parameter settings. The algorithm
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converged, producing the same maximum fitness of 1.968 for each of the 4 sets of
parameter settings. However, the number of generations required for convergence
differs, with Goldberg’s set of parameter settings, convergence occurred after 133
generations, with Alander’s set of parameter settings, convergence occurred after 312
generations, with Grefensette’s set of parameter settings, convergence occurred after
387 generations and lastly with DeJong’s, the convergence occurred after 1217
generations. Again, running the algorithm with Goldberg’s set of parameter settings on
this dataset resulted in obtaining the global optimum.
5.3.2.6.

Ovarian cancer data

Alander's convergence (47th generation)
Goldberg's (120th)
Fitness

DeJong's (180th)

Grefensette's (573rd)

1.995
1.99
1.985
1.98
1.975
1.97
1.965
1.96
1.955
1
32
63
94
125
156
187
218
249
280
311
342
373
404
435
466
497
528
559
590
621
652
683
714
745
776
807
838
869
900
931
962
993

1.95

Dejong

Generations
Grefensette
Goldberg

Alander

Figure 5-17 Typical convergence of fitness plots for Ovarian cancer data using each of
the 4 different parameter settings from DeJong, Grefenstette, Goldberg and Alander
From Figure 5-17, it can be seen that the algorithm converged to different maximum
fitness values for each of the 4 sets of parameter settings on the Ovarian cancer dataset.
With Goldberg’s and Grefensette’s set of parameter settings, both achieved a maximum
fitness of 1.989 but convergence occurred after 120 and 573 generations, respectively.
Whilst with DeJong’s and Alander’s sets of parameter settings, convergence occurred
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after 180 and 47generations, respectively and both with a maximum fitness value
smaller than 1.989. In this instance, the algorithm using Goldberg’s set of parameter
settings obtains a higher fitness value.
5.3.2.7.

Prostate cancer data

Goldberg's convergence (82nd)
Fitness

th
Grefensette's (304th) DeJong's (686 )
Alander's (836th)

1.95
1.94
1.93
1.92
1.91
1.9
1.89

1
47
93
139
185
231
277
323
369
415
461
507
553
599
645
691
737
783
829
875
921
967
1013
1059
1105
1151
1197
1243
1289
1335
1381
1427
1473

1.88

DeJong

Generation
s
Grefensette
Goldberg

Alander

Figure 5-18 Typical convergence of fitness plots for Prostate cancer data with 4
different parameter settings from DeJong, Grefenstette, Goldberg and Alander
As seen in Figure 5-18, the algorithm converged to the global optimum with the same
maximum fitness of 1.94 for each of the 4 sets of parameter settings. Again, the
algorithm using Goldberg’s set of parameter settings outperformed the other three sets
of parameter settings in terms of computational time (faster convergence).
The results of parameter settings using the 4 parameter settings of DeJong, Grefensette,
Goldberg and Alander are summarized in Table 5-3.
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Table 5-3 Summary of results of running the algorithm using each of the 4 sets of
parameter settings for 3 independent runs

From Table 5-3, it can be seen that the algorithm, using Goldberg’s set of parameter
settings, consistently achieves maximum fitness in each of the three runs for all of the
seven datasets. In comparison, the algorithm using any one of the remaining three sets
of parameters only achieve similar results in some of the runs for some of the seven
datasets. In addition, on examining Table 5-1, the algorithm using Goldberg’s set of
parameter settings also consistently used least computation time to achieve
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convergence. Based on these observations, Goldberg’s set of parameter settings is
considered to be more suitable than the other three sets of parameter values.
Note that while the number of generations has been provided in terms of when
convergence starts to occur, it is not used to measure the performance of the algorithm.
It is only used as an indicative measure of computation time associated with a set of
values for GA parameters used by the algorithm against the seven datasets in this study
as these seven datasets are of different complexity (varying from 120 variables in the
AD dataset to 15154 in Ovarian cancer dataset).
Given the lengthy computational time associated with the tuning process (see Table 5-1)
and the aim of the study is to explore the feasibility of incorporating evolutionary
approaches for finding interesting biomarkers that can differentiate between two classes
(e.g. diseased vs. healthy) of biological data, a “near optimal” set of parameter settings
that can be applied across a range of datasets and algorithms is acceptable. This is
unlike the case where the aim is related to comparisons between the performances of
one evolutionary algorithm against another evolutionary algorithm (that is, to show the
performance of one evolutionary algorithm as being superior), where it is then
important to ensure parameters associated with each of these algorithms are optimally
tuned. Arcuri and Fraser (2011) has argued that, in the case where parameter tuning is
expensive and the investigation is focused on examining the performance of new
techniques, using a set of default values is acceptable. Hence, Goldberg’s set of
parameter settings will subsequently be used in the evolutionary-based approaches
described in Chapter 5, 6 and 7 in this study. The following table shows the complete
set of parameter settings.
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Table 5-4 Parameter settings used in Chapter 5, 6 and 7
Parameters

Values/operators

Population Size

30

Chromosome length
-

Real encoding

10

Crossover probability (Pc)

0.6

Mutation Probability (Pm)

0.033

Maximum generations

1000

Selection

Tournament

Crossover

Single Point

Mutation

Uniform

Elitist

Single

Note that the set of parameters shown in Table 5-4 is the same as the one (Goldberg’s)
in Table 5-2, except for the maximum number of generations which is now set for 1000
instead of 5000. This is due to the fact that with the Goldberg’s parameter settings, the
algorithm obtains the global optimum with the maximum fitness in less than 1000
generations for all seven datasets, thus allowing some savings in computational time. As
the approach also checks the state of convergence, the number of generations in specific
instances can be varied if required. The set of parameter setting is to be selected on the
basis that it consistently allows the algorithm to converge with maximum fitness using
less computation time.
5.4. Experiment results
The proposed approach was evaluated using seven datasets: AD, Colon, Leukemia,
Ovarian, Lymphoma, Lung and Prostate cancer datasets. For each dataset, 15
independent runs of NSC-GA were executed using the respective training data and
parameter values shown in Table 5-4. For each run, 10 fold CV strategy described in
Section 3.2 was employed to evaluate the selected feature sets. The optimal set of
features was then used to construct the NSC classifier to classify the unseen test data
associated with the dataset. The classification results for classifying the unseen test data
were recorded and the average classification result from 15 independent runs was
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calculated. The following sections detail the results obtained from applying NSC-GA on
each of the seven datasets. Where appropriate, the comparison of the performance of the
proposed algorithm with existing work is based on classification accuracy and the
selected feature sets.
5.4.1. Ray et al. Alzheimer’s Disease (AD) data
As mentioned previously in Section 3.1.1, this dataset consists of 120 attributes. The
training set consists of 43 AD and 40 NDC samples and 2 test sets: the AD test set
consists of 42 AD, 50 NAD samples and the MCI test set consists of 22 AD and 25
NAD samples. More details about this dataset can be found in Section 3.1.
The optimal shrinkage thresholds obtained upon convergence were used to evaluate the
training dataset first, and then applied to the unseen test dataset using the NSC
classifier. A convergence plot from one of the typical runs is shown in and results are
in Table 5-5.
Table 5-5 Classification results for the AD data using NSC-GA approach and from Ray
et al. (2007)
Alzheimer
AD
Approach

No of
attributes

MCI

Average classification Average

classification

accuracy on unseen accuracy on unseen test
test dataset (%)

dataset (%)

Proposed approach
11
NSC-GA

89.49

79

NSC (Ray et al.,
18
2007)

89

81
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Convergence occurs
1.79
1.77
1.75
1.73

Fitness

1.71
1.69
1.67
1.65
1
8
15
22
29
36
43
50
57
64
71
78
85
92
99
106
113
120
127
134
141
148
155
162
169
176

1.63

Generations
Max fitness
Figure 5-19 A typical convergence of fitness plot for the training set of AD
As seen in Figure 5-19, convergence occurred after 28 generations with the maximum
fitness of 1.775. Although convergence was achieved in 28 generations, the optimal
solution actually involved a total of 8400 evaluations which is not a small number given
that this dataset with only 120 variables is considered to be of “low dimensionality”
relative to most other biological datasets. The length of chromosomes is 10,
representing 10 shrinkage threshold values. With a population size of 30, the evaluation
in each generation involved 30* 10 shrinkage threshold values. Convergence after 28
generations would mean that a total of 8400 evaluations.
The optimal chromosome obtained for each of the runs had the same maximum fitness
of 1.775, which resulted in a set of 11 features. This set of 11 features (proteins) is a
subset of the 18 biomarkers (proteins) found in Ray et al. (2007)’s experiment and is
shown in Table 5-6 .
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Table 5-6 List of 11 proteins selected using NSC-GA
Features (Proteins)
PDGF-BB_1

RANTES_1

IL-1a_1

TNF-a_1

EGF_1

ICAM-1_1

IL-11_1

IL-3_1

GCSF_1

ANG-2_1

M-CSF_1

The same set of 11 proteins was obtained from each of the 15 independent runs. The
average classification accuracy from 15 runs for the unseen AD test set was 89.49% and
for the unseen MCI test set was 79% using the set of 11 proteins found in this study.
These are similar to the result of 89% for unseen AD test set and 81% for the unseen
MCI test dataset using 18 proteins obtained in Ray et al. (2007)’s study. The remaining
7 proteins excluded here from the original 18 protein signatures (Ray et al., 2007) were
also not included in the 6 and 5 protein signatures found in Ravetti and Moscato
(2008)’s study. According to Ray and Wyss-coray (2010), TRAIL-R4 and IGFBP-6
proteins from the 7 excluded proteins are optional in the list of biomarkers for a
diagnostic analysis of AD.
5.4.2. Alon et al. Colon cancer data
The Colon dataset consists of 2000 attributes, 40 Tumour (T) and 22 Normal (N)
samples. The training set consists of 30 T and 16 N samples, and the test set consists of
10 T and 6 N samples. More details about this dataset can be found in Section 3.1.
Using the same procedure, 15 independent runs of NSC-GA was executed with 10 fold
CV using the Colon dataset with the GA parameter setting listed in Table 5-4. The
optimal shrinkage threshold value from the fittest chromosome upon convergence was
used to evaluate on the training dataset first, and then applied to the unseen test dataset
using the classifier in the NSC. A convergence of fitness plot from one of the typical
runs is shown in Figure 5-20 and classification results using the optimal sets of features
are in Table 5-7.
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Table 5-7 Classification results, for the Colon data using NSC-GA approach, and from
Klassen and Kim (2009)
Colon
No of attributes

Approach

Average

classification

accuracy on unseen test
dataset (%)

Proposed approach NSC-GA
NSC (Klassen & Kim, 2009)

28

100

6

93.75

16

75

Convergence occurs
1.84
1.83
1.82

Fitness

1.81
1.8
1.79

1
22
43
64
85
106
127
148
169
190
211
232
253
274
295
316
337
358
379
400
421
442
463
484
505
526
547

1.78

Generations
Max fitness
Figure 5-20 A typical convergence plot for the training set of Colon cancer data
As seen in Figure 5-20, the convergence of fitness occurred after 362 generations with
the maximum fitness of 1.833. Nine runs had the maximum fitness of 1.833 which gave
the same set of 28 features (genes) for the Colon dataset. Six runs had the maximum
fitness of 1.823 which gave the same set of 6 genes which is a subset of the 28 gene set.
The average classification accuracy from 15 independent runs was 97.5% on the unseen
test set (93.75% for 6 gene set and 100% for 28 gene set) in comparison to 75%
classification accuracy using 16 genes reported in Klassen and Kim (2009)’s
experiments. It is not possible to check the set of 28 and 6 genes found by the proposed
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approach against the set of 16 genes from Klassen and Kim (2009) as these were not
listed in their study. The set of 28 genes from this study are listed by their accession
number in Table 5-8 (the highlighted genes belong to the set of 6 genes).
Table 5-8 Twenty eight genes selected for Colon cancer data using NSC-GA
Gene accession numbers
T95018

X55715

M63391

H40560

T92451

T57619

R78934

T58861

M26697

M76378

R87126

H43887

H64489

M22382

T71025

Z24727

Z50753

X12671

T47377

L05144

H55758

M64110

M76378

T60155

M76378

J02854

X86693

T60778

5.4.3. Leukemia cancer data
The Leukemia dataset consists of 7129 attributes, 47 ALL and 25 AML samples. The
training set consisting of 27 ALL and 11 AML samples, and the test set consisting of 20
ALL and 14 AML samples. More details about this dataset can be found in Section 3.1.
Similar to the experiments above, 15 independent runs with 10 fold CV were carried out
using the Leukemia dataset. A convergence of fitness plot from one of the typical runs
is shown in Figure 5-21 and classification results on unseen test dataset are in Table 5-9.
Table 5-9 Classification results for the Leukemia data using NSC-GA approach and
from Tibshirani et al. (2002), Klassen and Kim (2009), S. Wang and Zhu (2007) and J.
Fan and Fan (2008)
Leukemia
Approach

No of
attributes

Average classification
accuracy on unseen
test dataset (%)

Proposed approach NSC-GA

9

97.05

NSC (Tibshirani et al., 2002)

21

94.12

NSC (Klassen & Kim, 2009)

21

94.12

ALP-NSC, AHP-NSC (S. Wang & Zhu, 2007)

16

94.12

FAIR (Fan & Fan, 2008)

11

97.05
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Convergence occurs
1.976
1.974
1.972
1.97

Fitness 1.968
1.966
1.964
1.962
1
10
19
28
37
46
55
64
73
82
91
100
109
118
127
136
145
154
163
172
181
190
199
208
217

1.96

Generations
Max fitness
Figure 5-21 A typical convergence plot for the training set of Leukemia cancer data.
As seen in Figure 5-21, the convergence occurred after 109 generations with the
maximum fitness of 1.973. The optimal shrinkage thresholds obtained from each of the
15 independent runs had the same maximum fitness of 1.973 which produced the same
set of 9 features (genes) for the Leukemia cancer dataset. The set of nine features gave
the classification accuracy of 97.05% on the unseen test dataset. Seven out of the nine
genes listed in Table 5-10 (highlighted genes) are a subset of the 16 genes reported in S.
Wang and Zhu’s study (2007). Two genes having accession numbers M96326 and
M28310 are not present in that set of 16 genes. It is not possible to check the set of 9
genes found using NSC-GA against the set of 11 genes in J. Fan and Fan (2008) as
these were not listed in their study.
The proposed approach achieved a higher classification accuracy 97.05% using a
smaller number of genes, 9, as compared to 94.12% classification accuracy with 21
genes reported in Tibshirani et al. (2002) and Klassen and Kim (2009), and 94.12%
using 16 genes reported in S. Wang and Zhu (2007), and achieved the same
classification accuracy of 97.05 but using the smaller set of 9 features compared to J.
Fan and Fan (2008). The set of 9 genes from this study are listed by their accession
number in Table 5-10. An interesting point here is, when comparing the results obtained
via NSC-GA with those reported by Tibshirani et al. (2002), Klassen and Kim (2009),
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and S. Wang and Zhu (2007); all involved the same method, NSC, with S. Wang and
Zhu (2007) having made attempts to improve the the original NSC approach via
adaptive L1-norm penalized NSC (ALP-NSC) and adaptive hierarchically penalized
NSC (AHP-NSC). The results reported for NSC-GA is an average of 15 runs and is
obtained by trying to automatically find the optimal value for the shrinkage threshold
for the original NSC method. The NSC-GA results lends support to the hypothesis, “ an
automatic approach that can effectively explore the search space to find a more precise
shrinkage threshold value for NSC may result in an optimal value leading to a better
classification result”, as it produced a shrinkage threshold value that leads to the
selection of 9 genes with a classification accuracy of 97.05%.
Table 5-10 Nine genes selected by the proposed NSC-GA for Leukemia cancer data
Gene
accession

Gene definition

number
M27891

CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)

M84526

Human adipsin/complement factor D mRNA, complete cds

M96326

Human azurocidin gene, complete cds

U46751

Phosphotyrosine independent ligand p62 for the Lck SH2 domain
mRNA

U50136

Leukotriene C4 synthase (LTC4S) gene

X17042

Human mRNA for hematopoetic proteoglycan core protein

X95735

Homo sapiens mRNA for zyxin

M28310

Mus musculus 3/10 metalloproteinase inhibitor gene, exon 3

Y00787

Human

mRNA

for

MDNCF

(monocyte-derived

neutrophil

chemotactic factor)
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5.4.4. Ovarian cancer data
The Ovarian dataset consists of 15154 attributes, 162 Disease (D) and 91Normal (N)
samples. The training set consists of 81 D and 45 N samples, and the test set consists of
81 D and 46 N samples. More details about this dataset can be found in Section 3.1.
Similar to the experiments above, 15 independent runs with 10 fold CV were carried out
using the Ovarian dataset. A convergence of fitness plot from one typical run is shown
in Figure 5-22 and classification results on the unseen test dataset are in Table 5-11.
Table 5-11 Classification results for the Ovarian data using NSC-GA approach and
from Foss (2010)
Ovarian
Average classification

Approach

No of attributes

accuracy on unseen test
dataset (%)

Proposed approach NSC-GA

7

96.06

GCLUS and SERA (Foss, 2010)

47

97.63

Convergence occurs
1.995
1.99
1.985
1.98

Fitness 1.975
1.97
1.965
1
12
23
34
45
56
67
78
89
100
111
122
133
144
155
166
177
188
199
210
221
232
243
254
265
276

1.96

Generations
Max fitness
Figure 5-22 A typical convergence plot for the training set of Ovarian cancer data
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As seen in Figure 5-22, the convergence occurred after 115 generations at the maximum
fitness of 1.989. The optimal shrinkage thresholds obtained for each of the 15
independent runs had the same maximum fitness of 1.989 which produced the same set
of 7 features (peptides), MZ244.36855, MZ244.66041, MZ244.95245, Z245.24466,
MZ245.8296, MZ245.53704 and MZ246.12233. These 7 peptides are a subset of 47
peptides reported in Foss (2010). Six peptides (in bold) are among the top 10 peptides
reported in Yap, Tan and Pang (2013). The average classification accuracy from 15
independent runs on the Ovarian unseen test dataset using this set of 7 selected peptides
was 96.06%, compared to 97.63% using the set of 47 peptides using the Implementation
of the MAXCLUS framework (GCLUS) and Statistical Error Rate estimation
Algorithm (SERA) in Foss (2010).
5.4.5. Lymphoma cancer data
The Lymphoma dataset consists of 4026 attributes, 24 GGL and 23 ACL samples. The
training set consisting of 17 GCL and 17 ACL samples, and the test set consisting of
seven GGL and six ACL samples. More details about this dataset can be found in
Section 3.1.
Fifteen independent runs with 10 fold CV were carried out using the Lymphoma
dataset. A convergence of fitness plot from one of the typical runs is shown in Figure
5-23 and classification results on unseen test dataset are in Table 5-12.
Table 5-12 Classification results for the Lymphoma data using NSC-GA approach and
from Klassen and Kim (2009)
Lymphoma
Approach

Average
No of attributes

classification

accuracy on unseen test
dataset (%)

Proposed approach NSC-GA
NSC (Klassen & Kim, 2009)

7
12
128
129
132
25

95.45
95.45
100
100
100
86.6
145

Convergence occurs
1.98
1.97
1.96

Fitness

1.95
1.94
1.93
1.92
1
14
27
40
53
66
79
92
105
118
131
144
157
170
183
196
209
222
235
248
261
274
287
300
313
326
339

1.91

Generations
Max fitness
Figure 5-23 A typical convergence plot for the training set of Lymphoma cancer data
As seen in Figure 5-23, the convergence occurred after 145 generations with the
maximum fitness of 1.968. From the 15 independent runs, 10 runs resulted in a
shrinkage threshold that mapped to the same set of 128 features, one run resulted in a
set of 129 features, one run resulted in a set of 132 features, one run gave a set of 7
features, and one run gave a set of 12 features. The set of 128, 129 and 132 features
leads to the same classification accuracy of 100% and the set of 7 and 12 features
resulted in the same classification accuracy of 95.45 on the unseen test set. The average
classification accuracy from 15 runs was 99.39% on the unseen test set. The smaller set
of features is a subset of the larger set, e.g., set of 7 features is a subset of the set of 12
features and both are subsets of the set of 128 features. Biomedical domain knowledge
can be used to examine these sets further to make better informed decision for
subsequent diagnostic test development. The set of 7 and 12 genes are listed by their
accession number in Table 5-13.
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Table 5-13 The sets of 7 and 12 genes selected by NSC-GA for Lymphoma cancer data
Set

Gene accession
number

12 genes

7 genes

GENE3327X

√

√

GENE3329X

√

√

GENE3330X

√

√

GENE3332X

√

√

GENE3361X

√

√

GENE3258X

√

√

GENE3256X

√

√

GENE3328X

√

GENE3314X

√

GENE3260X

√

GENE1252X

√

GENE3967X

√

5.4.6. Lung cancer data
The Lung dataset consists of 12533 attributes, 150 ADCA and 31 MPM samples. The
training set consisting of 134 ADCA and 15MPM samples, and the test set consisting of
16 ADCA and 16 MPM samples. More details about this dataset can be found in
Section 3.1.
Fifteen independent runs with 10 fold CV were carried out using the Lymphoma
dataset. A convergence of fitness plot from one of the typical runs is shown in Figure
5-24 and classification results on unseen test dataset are in Table 5-14.
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Table 5-14 Classification results for the Lung data from NSC-GA approach and from
Klassen and Kim (2009), Tai and Pan (2007) and J. Fan and Fan (2008)
Lung
No of attributes

Average
classification

Approach

accuracy
unseen

on
test

dataset (%)
8
Proposed approach NSC-GA

9
10

100

11
NSC (Klassen & Kim, 2009)

5

93.7

Weighted NSC (Tai & Pan, 2007)

6

99.99

FAIR (Fan & Fan, 2008)

31

95.3

Convergence occurs
2
1.999
1.998
1.997
1.996

Fitness 1.995
1.994
1.993
1
8
15
22
29
36
43
50
57
64
71
78
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148
155
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1.992

Generations
Max fitness
Figure 5-24 A typical convergence plot for the training set of Lung cancer data
As seen in Figure 5-24, the convergence occurred after 88 generations with the
maximum fitness of 1.999. Three runs resulted in the same set of 8 features for the Lung
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cancer dataset, 6 runs resulted in a set of 9 features, 2 runs resulted in a set of 10
features and 4 runs resulted in a set of 11 features. The average classification accuracy
of the sets of 8, 9, 10 and 11 features is 100% on the unseen test set. The set of 8, 9, 10
and 11 listed by their accession genes are number in Table 5-15.
Table 5-15 The sets of 8, 9, 10 and 11 genes selected by NSC-GA, for Lung cancer data
Set

Gene accession number
11 genes

10 genes

9 genes

8 genes

32551_at

√

√

√

√

33328_at

√

√

√

√

34320_at

√

√

√

√

36533_at

√

√

√

√

37157_at

√

√

√

√

37716_at

√

√

√

√

37954_at

√

√

√

√

40936_at

√

√

√

√

33833_at

√

√

√

33327_at

√

√

35823_at

√

5.4.7. Prostate cancer data
The Prostate dataset consists of 12600 attributes, 77 Tumour (T) and 59 Normal (N)
samples. The training set consisting of 52 T and 50N samples, and the test set consisting
of 25 T and 9 N samples. More details about this dataset can be found in Section 3.1.
Fifteen independent runs with 10 fold CV were carried out using the Prostate dataset. A
convergence of fitness plot from one of the typical runs is shown in Figure 5-25 and
classification results on the unseen test dataset are in Table 5-16.
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Convergence occurs
1.95
1.94
1.93
1.92
1.91
1.9

Fitness 1.89
1.88
1.87
1.86
1
8
15
22
29
36
43
50
57
64
71
78
85
92
99
106
113
120
127
134
141
148
155
162
169
176
183
190
197

1.85

Generations
Max fitness
Figure 5-25 A typical convergence plot for the training set of Prostate cancer data
As seen in Figure 5-25, the convergence occurred after 99 generations with the
maximum fitness of 1.94. The optimal shrinkage thresholds obtained for each of the 15
independent runs had the same maximum fitness of 1.94 which produced the same set
of 6 genes, 31444_s_at, 41468_at, 37639_at, 38406_f_at, 769_s_at and 556_s_at. The
average classification accuracy using the 6 gene set from 15 runs on the unseen test set
was 90.2%, as shown in Table 5-16.
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Table 5-16 Classification results for the Prostate data from NSC-GA approach and from
Klassen and Kim (2009), Tai and Pan (2007) and J. Fan and Fan (2008)
Prostate
No
Approach

of

Average

attributes

C1

C2

(Tumour)

(Normal)

classification
accuracy
unseen

on
test

dataset (%)
Proposed approach NSC-GA
NSC

(Klassen & Kim,

2009)
Weighted NSC (Tai & Pan,
2007)
FAIR (Fan & Fan, 2008)

6

80

100

90.2

6

90.91

10

60.51

2

73.52

The column headings C1 and C2 in the table stand for average classification accuracy
(%) on the Prostate unseen test dataset for the Tumour class and Normal class,
respectively. The column heading “Average Test” stands for the overall average
classification accuracy (%) on the Prostate unseen test dataset for the 15 independent
run. “Average Test” is calculated using Equation (5.3).
A summary of the results for the AD, Colon, Leukemia, Ovarian, Lymphoma, Lung and
Prostate cancer datasets are shown in Table 5-17.
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Table 5-17 Classification results for AD, Colon, Leukemia, Ovarian, Lymphoma, Lung and Prostate cancer data using NSC-GA
Approach

Proposed
NSC-GA

Alzheimer
AD
No
Test
attr
(%)

MCI
Test
(%)

11

79

89.49

approach

NSC (Ray et al., 2007)
NSC (Tibshirani et al.,
2002)
NSC (Klassen & Kim,
2009)
ALP-NSC, AHP-NSC
(S. Wang & Zhu, 2007)
Weighted NSC
(Tai & Pan, 2007)
FAIR
(Fan & Fan, 2008)
GCLUS & SERA (Foss,
2010)

18

89

Colon

Leukemia

Ovarian

Lymphoma

Lung

No
attr

Test
(%)

No
attr

Test
(%)

No
attr

Test
(%)

No
attr

No
attr

Test
(%)

No
attr

Test
(%)

28

100

9

97.05

7

96.06

6

90.2

93.75

8
9
10
11

100

6

7
95.45
12
128 100
129
132

21

94.12

21

94.12

25

5

93.7

6

90.91

16

94.12
6

99.55

10

60.51

31

95.3

2

73.52

Test
(%)

Prostate

81

16

75

11

97.05
47

86.6

97.63
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5.5. Discussion
Table 5-17 shows a summary of experimental results achieved by the proposed
approach, NSC-GA in comparison to existing work that used the same datasets. The
classification accuracy rate reported for each dataset for NSC-GA is based on the
average classification accuracy of 15 independent runs. NSC-GA achieved similar
classification results as in Ray et al. (2007) on AD and MCI independent test datasets,
and also improved FS and/or classification accuracy on the other 6 datasets in terms of
obtaining smaller sets of features and higher or similar classification accuracy on unseen
test sets compared to the existing results (as reported in Klassen and Kim (2009), S.
Wang and Zhu (2007), J. Fan and Fan (2008), Foss (2010), and Tai and Pan (2007)).
For example, for the Leukemia cancer dataset, NSC-GA obtained a smaller set of 9
features and higher classification accuracy of 97.05% and for the Ovarian cancer
dataset, a smaller set of 7 features was obtained with the similar classification accuracy
of 96.06%. In terms of the Lung cancer dataset, Tai and Pan (2007) achieved 99.55
using a set of 6 features whereas in NSC-GA using 8 features to obtain 100%
classification accuracy. However, as the actual features used have not been listed in Tai
and Pan’s paper. It is not possible to compare the results in terms of the actual features.
When comparing results obtained via NSC-GA with other NSC-based approaches
(Tibshirani et al. (2002), Klassen & Kim (2009), S. Wang & Zhu (2007)), it can be seen
that NSC-GA generally found optimal feature sets that have a smaller number of
features and better classification results. This outcome is achieved by using GA to
automatically explore the search space to find a more precise shrinkage threshold value
for NSC, thus overcoming limitations typically associated with “trial and error”
approaches. Unlike approaches (e.g. S. Wang & Zhu (2007)) that attempts to improve
the performance of NSC by modifying it, this result is obtained using the original NSC
algorithm, thus potentially the proposed approach can also be incorporated into
modified NSC for further improvements.
Having information as shown in Table 5-17, with the Colon, Lymphoma and Lung
cancer datasets, each are associated with multiple sets of features which are subsets of
each other. This allows the domain expert to make informed decision in terms of sets of
features that could be selected for further investigations. For example, in the case of the
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Colon cancer dataset, one can make decisions based on the tradeoffs between
classification accuracy and size of feature set. It can be seen that in the case of the
Lymphoma cancer dataset, the set of 6 features resulted in the same classification
accuracy as the set of 12 features (i.e. 95.45%). The domain expert can examine the 6
additional features in the set of 12 and use domain knowledge to decide on their
potential relevance and make decision on subsequent analysis. Equally it is interesting
to further analyse the Lung cancer dataset where sets with 8, 9, 10 and 11 features
respectively resulted in classifiers producing the same classification accuracy on the
unseen test dataset (100%). It appears that a major contributing factor relates to 8
features and thus may warrant further investigations into the relevance of the remaining
features. This sort of information for analysis in bioinformatics is important as reducing
the number of features to a smaller promising set for further investigations would
reduce costs associated with future experiments and analysis. The set of selected
features from a biological perspective implies that the level of expressions associated
with the selected biomarkers differ significantly between disease and non-disease.
From Table 5-16, the NSC classification results associated with the set of 6 features
mostly showed high specificity but low sensitivity, e.g., sensitivity (C1) is 80% but
specificity (C2) is 100%, implying the majority of the truly not-at-risk cases will be
correctly identified, but some of the truly at-risk cases will also be incorrectly identified
as not-at-risk. Continuing the investigation about classifier bias that was initiated in
Chapter 4, further analysis is carried out using the Prostate cancer data and the
corresponding set of 6 genes identified via NSC-GA. This set of features are used to
construct 22 different classifiers from WEKA software (Hall et al., 2009) for
classifying the unseen test dataset. The aim here is to further examine the trend
observed in Chapter 4 in terms sensitivity and specificity being associated with specific
classifiers (in this case NSC). The classification results from 22 different classifiers are
shown in Table 5-18.
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Table 5-18 Results of classification for the 6 selected genes with 22 WEKA classifiers
on the Prostate unseen test set
Classifier

Set of 6 genes
C1 (%) C2 (%) Average (%)

SMO

80

96.2

88.2

Simple Logistic

88

100

94.1

Logistic

80

92.3

86.3

Multilayer Perceptron* 88.8

98.8

93.9

Bayes Net

80

88.5

84.3

Naïve Bayes

92

92.3

92.2

Naïve Bayes Simple

92

88.5

90.2

Naïve Bayes Up

92

92.3

92.2

IB1

84

92.3

88.2

KStar

68

96.2

82.4

LWL

84

92.3

88.2

AdaBoost

92

92.3

92.2

ClassVia Regression

92

92.3

92.2

Decorate*

82

94.35

88.2

Multiclass Classifier

80

92.3

86.3

Random Committee*

92

88.8

90.4

j48

92

88.5

90.2

LMT

96

88.5

92.2

NBTree

72

92.3

82.4

Part

92

88.5

90.2

Random Forest*

92.8

91.55

92.2

Ordinal Classifier

92

88.5

90.2

Mixed results, with regards to the classifiers used and their corresponding sensitivity
and specificity, were obtained. Naïve Bayes, Naïve Bayes Updateable, AdaBoost and
ClassVia Regression (in bold) produced results showing high sensitivity (92%) and high
specificity (92.3%). However, there are also other classifiers showing behaviour similar
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to that of the NSC classifiers (i.e. lower sensitivity and higher specificity). Also
interestingly, there are a number of classifiers demonstrating higher sensitivity (shaded
cells) than specificity. These results demonstrated that the use of specific classifiers may
have an impact on the sensitivity and specificity obtained using a set of features in
classification. Thus in a DM analysis for finding suitable sets of biological markers, a
number of classifiers should be used instead of just using one. This will avoid missing
out on sets of features with high discriminatory capabilities that should be further
investigated in early diagnostic test developments.
5.6. Summary
This chapter describes the proposed approach of incorporating NSC and a single
objective algorithm, GA, to overcome the limitations of previous approaches such as
empirical methods with NSC, by 1) searching automatically for the optimal shrinkage
threshold value for NSC, and 2) obtaining the optimal set of minimal number of features
for higher classification results. This advantage here is due to the fact that the proposed
approach employs GA as a search algorithm to find optimal shrinkage thresholds based
on the fitness evaluation from the NSC. An additional advantage of the proposed
approach is the use of computers to run the algorithm for finding the optimal shrinkage
threshold values automatically. This is unlike the traditional NSC approach involving
manual shrinkage threshold value selection where the user spends a lot of time and
effort to choose the optimal shrinkage threshold value via trial and error.
A further analysis was also carried out on the Prostate cancer data using the same set of
6 genes to construct 22 different classifiers from WEKA software (Hall et al., 2009) to
investigate the impact of using different classifiers on sensitivity and specificity.
To continue the exploration of evolutionary approaches for FS in biological data, the
following chapter describes an approach incorporating MA for automatically finding
optimal shrinkage thresholds for NSC, an attempt to further improve upon the NCS-GA
approach described in this chapter.
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6. Incorporating the NSC algorithm into MA
Chapter 5 described an approach incorporating NSC into GA (NSC-GA) to
automatically search for optimal shrinkage thresholds in NSC leading to the selection of
optimal sets of features with better classification accuracy. According to Elbeltagi,
Hegazy, & Grierson (Elbeltagi et al., 2005), computation time associated with GA
processing is intensive. One of the factors that contribute to the quality of optimal
solutions in EA is the evaluation of fitness of individuals in the population. That is, the
better the fitness evaluation the better the quality of the optimal solution. One of the
approaches to improve GAs both in processing time and quality of optimal solutions is
the use of a MA (Elbeltagi et al., 2005). MA (Albrechtsson et al., 2001) is a hybrid
algorithm that incorporates an EA and a local search (LS) to search for a local optimum
to further improve its fitness (Elbeltagi et al., 2005; Krasnogor & Smith, 2005; Wu,
2001b). As a result of increased exploitations, fitness of each chromosome is improved
significantly in each generation, leading to a faster convergence in population fitness,
and subsequently, computation time for the evolutionary process is reduced. The quality
of the optimal solution could also be improved owing to the fact that chromosomes have
already been evaluated locally by LS before being subjected to a global search for the
optimal solution.
In this chapter, an approach of incorporating the NSC algorithm into a MA, namely
NSC-MA, for automatically searching for an optimal range of shrinkage threshold
values is proposed. The aim here is to explore how to improve the NSC-GA approach.
MA has been described in Section 2.3.5. The following section describes the proposed
approach of incorporating the NSC algorithm and MA, the results are reported in
Section 6.2, the discussion is in Section 6.3 and the summary is in Section 6.4.
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6.1. The proposed approach, NSC-MA.
The combination of EA and LS makes MA more efficient and effective in terms of
processing time for convergence to optimal solutions, finding smaller sets of features,
and improving classification accuracy in comparison to other traditional EAs such as
GA (Elbeltagi et al., 2005; Zhu et al., 2007). Different LS strategies such as pair-wise
LS (Merz & Freisleben, 1999), Adding Subtracting LS, Improvement First Strategy LS
and greedy LS (Zhu et al., 2007) have been incorporated into GA in different
approaches. For example, a LS strategy can be applied to elite chromosomes only or to
the entire population or only to chromosomes that have been modified by crossover
and/or mutation operation, etc.
Adding Subtracting LS strategy is carried out to search for a better chromosome in
terms of fitness by adding or subtracting a small random value generated by a RNG to a
meme (gene) value in the chromosome to create a new chromosome. The fitness of the
new chromosome is then evaluated, if improved (i.e. better fitness) the new
chromosome is retained, otherwise discarded. The process continues for the rest of the
memes in the chromosome (Elbeltagi et al., 2005). This strategy has been known as a
greedy search strategy (Zhu et al., 2007) or a hill climbing search strategy where the
search progresses from the current best chromosome to the one that has a better fitness
(Kohavi & John, 1997; H. Wang et al., 2009). MA with the greedy search strategy LS
outperformed GA in terms of achieving better classification accuracy and processing
time (Elbeltagi et al., 2005). However, according to Zhu, et al. (2007)’s study, the LS
with Improvement First Strategy outperformed the greedy search strategy LS. Their
study also found that the Improvement First Strategy LS when applied to a few of the
elite chromosomes resulted in better solutions when compared to the approach that
applied the Improvement First Strategy LS to all chromosomes in the population.
Improvement First Strategy LS was also employed as a LS to find a local optimum for
offspring generated from crossover and mutation operation. That is, after the application
of crossover and mutation operators on chromosomes, Improvement First Strategy LS is
then applied to offspring for searching for a local optimum. According to Krasnogor
and Smith (2005)’s experiments, MA with Improvement First Strategy LS outperformed
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other LS strategies such as Multi Start Local Search (MSLS) (Marchiori, 2002), Genetic
Local Search (Aarts, 1997) and the general procedure of MA (Elbeltagi et al., 2005).
Motivated by the performance of the MA that incorporated the adding and subtracting
Improvement First Strategy LS (Krasnogor & Smith, 2005), it is combined with the
NSC algorithm in the development of a hybrid approach for finding optimal threshold
values in NSC automatically. The basic concepts of NSC (Tibshirani et al., 2002) and
GA have been reviewed in Section 2.4.3 and Section 2.4.4.1, respectively. The
following sections describe the NSC-MA approach.
6.1.1. NSC-MA proposed approach
Similar to the NSC-GA approach proposed in Chapter 5, the proposed approach, NSCMA, consists of 2 major steps:
Step 1:

This step involved the automatic calculation of Thmax. This procedure is

performed once only at the beginning of the proposed approach, NSC-MA, to obtain
Thmax.
Step 2: MA (Albrechtsson et al., 2001) is employed in this step as an optimization
method to search for optimal sets of shrinkage thresholds for NSC algorithm that lead to
the selection of optimal sets of features. Also in this step, NSC algorithm is employed as
a fitness evaluator to evaluate the fitness of each chromosome in terms of the number of
selected features and its corresponding training classification accuracy.
The framework of the proposed approach, NSC-MA, is illustrated in Figure 6-1 and is
described in the following section.
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Training dataset
Automatic Thmax calculation
Thmax
MA

GA
Population initialization
Shrinkage
Fitness evaluation
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accuracy
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No

Converged?

Yes

Optimal threshold range
Figure 6-1 Framework of the proposed approach, NSC-MA, using MA with adding and
subtracting Improvement First Strategy LS
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The same concepts associated with chromosome encoding, estimation of the initial
range of values for the shrinkage threshold and fitness evaluation as previously
discussed in NSC-GA in Chapter 5 also applies in NSC-MA.
6.1.2. Steps of the proposed approach, NSC-MA
In examining Figure 6-1 and Figure 5-2, it can be seen that the only difference between
NSC-GA and NSC-MA is an additional component for MA, that is, the incorporation of
LS into the GA thus converting the GA into a MA. Since the core components of the
algorithm are essentially steps associated with the GA, many of these have been
discussed in Chapter 5 and are applicable here. These include the calculation of Thmax
and some of the steps associated with the GA (i.e. population initialization, fitness
evaluation, selection, crossover, mutation). The step “new population generation” used
in NSC-GA are also used in NSC-MA, but has an addition, the incorporation of the
“adding and subtracting LS with Improvement First Strategy”. This additional step is
applied to offspring chromosomes after crossover and mutation to further improve the
quality of chromosome. Figure 6-2 describes the procedure of adding and subtracting
LS with Improvement First Strategy.
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Input:
Chromosome (chrom)
Chromosome length (len)
Output:
An improved local search chromosome (chromls)
Steps:
1. Generate a real random number (Rn) in the range [0, 1] using RNG
2. Evaluate fitness of chrom
3. For counter from 1 to len
a. Add Rn to chrom[counter] to create a new chromosome (chromls)
b. Evaluate the fitness of chromls
c. If fitness of chromls > chrom
 Retain chromls as an improved local search chromosome
 Exit the loop
d. Else
 subtract Rn to chrom[counter] create a new chromosome
(chromls)
 evaluate the fitness of chromls
 If fitness of chromls > chrom
o retain chromls as an improved local search
chromosome
o exit the loop
 else
o discard chromls
Figure 6-2 Procedure of adding and subtracting LS with Improvement First Strategy
The procedure for generating a new population in NSC-MA is described in Figure 6-3.
A single elitist strategy is also employed in this study. The best candidate solution
(elite) from the previous generation is retained and placed into the new generation to
improve the search in evolutionary algorithms (Ahn & Ramakrishna, 2010). Also in the
step of generating a new population, two best offspring chromosomes produced from
the previous steps via selection, crossover, mutation and LS strategy are placed into the
new population. These steps are repeated until the generation of the new population is
completed.
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Input:
Chromosome population (p)
Fitness population (Fp)
Crossover probability (Pc)
Mutation probability (Pm)
Elite chromosome (Elite)
Chromosome length (lenC)
Output:
New population (Np)
Steps:
1. Set Size = size of population, p
2. Set new population (Np) = { }
3. Store Elite into Np
4. For counter from 1 to ½ Size
a. Select 2 parent chromosomes using binary tournament selection
i. Select 2 chromosomes randomly from p
 Select the best fit chromosome as 1st parent (parent1)
ii. Select 2 chromosomes randomly from p
 Select the best fit chromosome as 2nd parent (parent2)
b. Create 2 offspring chromosomes using parent1 and parent2
i. Generate a random number (Rn) in the range [0, 1] using RNG
ii. If Rn ≤ Pc
 Perform one point crossover on 2 parents to produce
offspring1 and offspring2
 Perform adding and subtracting LS with Improvement First
Strategy on offspring1 and offspring2 to produce 2 new
offspring (offspring1lscross and offspring2lscross)
iii. If Rn ≤ Pm
For counter from 1 to lenC
 Generate a random number (Rn) in the range [0, 1] using
RNG
If Rn ≤ Pm
 Perform uniform mutation on each bit of offspring1 to
generate offspring1mut
 Perform uniform mutation on each bit of offspring2 to
generate offspring2mut
 Perform adding and subtracting LS with Improvement
First Strategy on offspring1mut and offspring2mut to produce
2 new offspring (offspring1lsmut and offspring2lsmut)
iv. Evaluate fitness of offspring1lscross, offspring2lscross,
offspring1lsmut and offspring2lsmut chromosomes
c. Store the best 2 chromosomes into Np
Figure 6-3 Algorithm for generating a new population using MA incorporated adding
and subtracting LS with Improvement First Strategy
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6.1.3. Parameter settings
The parameter settings for running NSC-MA are shown in Table 6-1. The parameters
used here are the same as those used in NSC-GA (described in Chapter 5), except for an
additional parameter “Local Search”.
Table 6-1 Parameter settings used in the proposed approach, NSC-MA
Parameters

Values/Algorithm

Population size

30

Chromosome length
-

Real encoding

10

Crossover rate

0.6

Mutation rate

0.033

Maximum generation

1000

Selection

Tournament

Crossover

Single point

Mutation

Uniform

Elitist

Single

Local search

Adding and subtracting with First Improvement Strategy

6.2. Experiment results
Similar to the experiments for the NSC-GA approach described in Chapter 5, NSC-MA
was evaluated using seven datasets: AD, Colon, Leukemia, Ovarian, Lymphoma, Lung
and Prostate cancer datasets as described in Section 3.1. For each dataset, 15
independent runs of NSC-MA were executed using the respective training data and
parameter values shown in Table 6-1. For each run, 10 fold CV strategy described in
Section 3.2 was employed to evaluate the selected feature sets. The optimal set of
features was then used to construct the NSC classifier to classify the unseen test data
associated with the dataset. The classification results for classifying the unseen test data
were recorded and the average classification result from 15 independent runs was
calculated. The following sections detail the results obtained from applying the
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approach on each of the seven datasets. Where appropriate, the comparison of the
performance of the proposed algorithm with existing work is based on classification
accuracy and the selected feature sets.
6.2.1. Ray et al. Alzheimer’s Disease data
As mentioned previously in Section 3.1.1, this dataset consists of 120 attributes. The
training set consists of 43 AD and 40 NDC samples and 2 test sets: the AD test set
consists of 42 AD, 50 NAD samples and the MCI test set consists of 22 AD and 25
NAD samples.

Convergence (NSC-MA)
1.8

Convergence (NSC-GA)

1.78
1.76
1.74
1.72

Fitness

1.7
1.68
1.66
1.64
1.62
1.6
1
6
11
16
21
26
31
36
41
46
51
56
61
66
71
76
81
86
91
96
101
106
111
116
121
126

1.58

Genertions

NSC-MA

NSC-GA

Figure 6-4 A comparison convergence of fitness plot for AD training dataset using
NSC-MA and NSC-GA associated with one typical run
Figure 6-4 shows a plot of convergence of fitness associated with one typical run for
NSC-MA and NSC-GA. Both algorithms converged to the global optimum with the
same maximum fitness of 1.775. However, the number of generations that the
algorithms have to run to achieve convergence of fitness is different. With the proposed
approach, NSC-MA, convergence occurred after 14 generations, and with NSC-GA,
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convergence occurred after 28 generations in this case. From Table 6-2, it can be seen
that on average NSC-MA takes 18 +/- 2.97 runs to converge versus NSC-GA requiring
28 +/- 4.68 runs for convergence of fitness. Therefore the NSC-MA takes less
computational time to obtain the same global optimum as NSC-GA. This is due to the
fact that, with NSC-MA, chromosomes in the population have been subjected to the
local search to further improve the fitness in each generation and subsequently, the
optimal fitness is obtained in a shorter time.
The same set of 11 features is obtained from 15 independent runs using NSC-MA.
Classifier constructed from this set of features gave an average classification accuracy
of 89.34% for the unseen AD test dataset and 76.59% for the unseen MCI test dataset,
compared to 89.49% and 79%, respectively, using NSC-GA. Although the same set of
11 features was obtained using the proposed approach, the resulting classification
accuracy is slightly different from the value obtained using NSC-GA. This is due to the
fact that the optimal shrinkage threshold values obtained from NSC-MA are only
slightly different from those using NSC-GA. The nature of shrinkage thresholds
associated with NSC is that rather than an exact value, a narrow range of values maps to
the same set of features. Since the optimal threshold value from NSC-GA and NSC-MA
is only slightly different, both mapped to the same set of 11 features but still produced
slight differences in classification accuracy. The classification results of NSC-MA in
comparison to NSC-GA are shown in Table 6-2.
Table 6-2 Classification results and time to converge for NSC-GA and NSC-MA using
AD data
Alzheimer

Average number of

AD
Approach

No

of

attributes

Unseen

MCI

generations

for Standard

Unseen

convergence of fitness deviation

test data test data over 15 independent (Stdev)
(%)

(%)

runs

11

89.34

76.59

18

2.97

11

89.49

79

28

4.68

Proposed
approach
NSC-MA
NSC-GA
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6.2.2. Alon et al. Colon cancer data
Details about the Colon dataset can be found in Section 3.1.

Convergenge (NSC-MA)

Convergence (NSC-GA)

1.84
1.83
1.82
1.81
Fitness 1.8
1.79
1.78
1
27
53
79
105
131
157
183
209
235
261
287
313
339
365
391
417
443
469
495
521
547

1.77
Generations
NSC-MA

NSC-GA

Figure 6-5 Plots for convergence of fitness from a typical run for Colon training dataset
using NSC-MA and NSC-GA
As seen in Figure 6-5, both algorithms converged to the global optimum with the same
maximum fitness of 1.883. However, the number of generations that the algorithms
have to run to achieve convergence of fitness is different. With NSC-MA convergence
occurred after 259 generations, and with NSC-GA, convergence occurred after 363
generations in this sample run. From Table 6-3, it can be seen that on average NSCMA takes 274 +/- 178.84 runs to converge versus NSC-GA requiring 309 +/- 194. 98
runs for convergence of fitness. The same set of 28 features is obtained from each of 15
independent runs using NSC-MA and resulted in an average classification accuracy of
100% for the unseen test cancer dataset. In comparison, sets of 6 and 28 features were
obtained using NSC-GA with 93.75% and 100% for average classification accuracy on
the same unseen test dataset, respectively. This shows that the proposed approach NSCMA selects sets of features consistently for all 15 independent runs (i.e. the same set of
28 features is obtained for every run) compared to NSC-GA where 2 sets, one of 6 and
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one of 28 features were obtained from 15 runs. The classification results of NSC-MA in
comparison to those associated with NSC-GA are shown in Table 6-3.
Table 6-3 Classification results and time to converge for NSC-GA and NSC-MA using
the Colon cancer data
Colon
Average
Approach

No

of Unseen test data

attributes

(%)

number

generations
convergence

of
for

of

fitness

over 15 independent runs

Standard
deviation
(Stdev)

Proposed
approach

28

100

28

100

6

93.75

271

178.84

309

194.89

NSC-MA
NSC-GA
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6.2.3. Leukemia cancer data
Details about the Leukemia dataset can be found in Section 3.1.

Convergenge (NSC-MA)

Convergence (NSC-GA)

1.975
1.973
1.971
1.969

Fitness

1.967
1.965
1.963
1.961

1
7
13
19
25
31
37
43
49
55
61
67
73
79
85
91
97
103
109
115
121
127
133
139
145
151
157

1.959

Generations
Max fitness (NSC-MA)

Max fitness (NSC-GA)

Figure 6-6 Plots for convergence of fitness from a typical run for Leukemia training
dataset using NSC-MA and NSC-GA
As seen in Figure 6-6, both algorithms converged to the global optimum with the same
maximum fitness of 1.973. In terms of convergence of fitness, NSC-MA took 73
generations, and NSC-GA took 91 generations for this sample run. From Table 6-4, it
can be seen that on average NSC-MA takes 54 +/- 38.73 runs to converge versus NSCGA requiring 82 +/- 43.57 runs for convergence of fitness. The same set of 9 features is
obtained from each of the 15 independent runs using NSC-MA, resulting in an average
classification accuracy of 97.05% on the Leukemia unseen test dataset. The
classification results of NSC-MA in comparison to those of NSC-GA are shown in
Table 6-4.
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Table 6-4 Classification results and time to converge for NSC-GA and NSC-MA using
the Leukemia cancer data
Leukemia
Average
Approach

No

of Unseen

attributes

data (%)

number

test generations

of
for

convergence of fitness
over 15 independent runs

Standard
deviation
(Stdev)

Proposed
approach

9

97.05

54

38.73

9

97.05

82

43.57

NSC-MA
NSC-GA

6.2.4. Ovarian cancer data
Details about this dataset can be found in Section 3.1.

Convergence (NSC-GA)

Convergence (NSC-MA)

2
1.99
1.98
1.97
Fitness

1.96

1.95
1
46
91
136
181
226
271
316
361
406
451
496
541
586
631
676
721
766
811
856

1.94
Generations
NSC-GA
NSC-MA
Figure 6-7 Plots for convergence of fitness from a typical run for Ovarian training
dataset using NSC-MA and NSC-GA
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As seen in Figure 6-7, both algorithms converged to the global optimum with the same
maximum fitness of 1.99. With NSC-MA, convergence occurred after 452 generations,
and with NSC-GA, convergence occurred after 124 generations in this sample run.
From Table 6-5, it can be seen that on average NSC-MA takes 177 +/- 160.78 runs to
converge versus NSC-GA requiring 86.88 +/- 24.5 obvious from runs for convergence
of fitness. NSC-MA found the same set of 7 peptides resulting in the same average
classification accuracy of 96.06% on the Ovarian cancer unseen test dataset as that
obtained via NSC-GA. The classification results of NSC-MA in comparison to those of
NSC-GA are shown in Table 6-5.
Table 6-5 Classification results and time to converge for NSC-GA and NSC-MA using
the Ovarian cancer data
Ovarian
Approach

No

of

attributes

Unseen test
data
(%)

Average

number

generations for

of

convergence

of fitness over 15 independent
runs

Standard
deviation
(Stdev)

Proposed
approach

7

96.06

177

160.78

7

96.06

86.88

24.5

NSC-MA
NSC-GA
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6.2.5. Lymphoma cancer data
Details about this dataset can be found in Section 3.1.

Convergence NSC-MA

Convergence NSC-GA

1.98
1.97
1.96

Fitness 1.95
1.94
1.93
1.92

1
14
27
40
53
66
79
92
105
118
131
144
157
170
183
196
209
222
235
248
261
274
287
300
313
326
339

1.91

Generations
Max fitness (NSC-MA)
Max fitness (NSC-GA)
Figure 6-8 Plots for convergence of fitness from a typical run for Lymphoma training
dataset using NSC-MA and NSC-GA
As seen in Figure 6-8, both algorithms converged to the global optimum with the same
maximum fitness of 1.968. With NSC-MA, convergence occurred after 92 generations,
and with NSC-GA, convergence occurred after 144 generations in this typical run.
From Table 6-6, it can be seen that on average NSC-MA takes 88 +/- 8.91 runs to
converge versus NSC-GA requiring 100 +/- 62.42 runs for convergence of fitness. The
same set of 128 features obtained for each of the 15 independent runs using NSC-MA
gave the same average classification accuracy of 100% on the Lymphoma unseen test
dataset. This shows that the proposed approach NSC-MA selects features consistently
for all 15 independent runs (i.e. the same set of 128 features is obtained for every run)
compared to the approach NSC-GA where 5 different sets of 128, 129, 132, 7 and 12
features were selected from the independent 15 runs. The classification results of NSCMA in comparison to NSC-GA are shown in Table 6-6.
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Table 6-6 Classification results and time to converge for NSC-GA and NSC-MA using
the Lymphoma cancer data
Lymphoma
Approach

No

of

Unseen test Average number of generations Standard
data

for convergence of fitness over deviation

(%)

15 independent runs

(Stdev)

128

100

88

8.91

7

95.45

12

95.45

128

100

100

62.42

129

100

132

100

attributes
Proposed
approach
NSC-MA

NSC-GA

6.2.6. Lung cancer data
Details about this dataset can be found in Section 3.1.
As seen in Figure 6-9, both algorithms converged to the global optimum with the same
maximum fitness of 1.999. With NSC-MA, convergence occurred after 27 generations,
and with NSC-GA, convergence occurred after 88 generations in this sample run. From
Table 6-7, it can be seen that on average NSC-MA takes 41 +/- 9.5 runs to converge
versus NSC-GA requiring 68 +/- 53.08 runs for convergence of fitness. The same set of
8 features obtained from each of the 15 independent runs using NSC-MA gave the same
average classification accuracy of 100% on the Lung unseen test dataset. In comparison,
NSC-GA produced 4 different sets consisting of 8, 9, 10, and 11 features from 15 runs.
The classification results of NSC-MA in comparison to NSC-GA are shown in Table
6-7.

173

Convergence NSC-GA

Convergence NSC-MA
1.999
1.997
1.995

Fitness

1.993
1.991
1.989
1.987

1
5
9
13
17
21
25
29
33
37
41
45
49
53
57
61
65
69
73
77
81
85
89
93
97
101
105
109
113
117

1.985

Generations
Max fitness (NSC-MA)

Max fitness (NSC-GA)

Figure 6-9 Plots for convergence of fitness from a typical run for Lung training dataset
using NSC-MA and NSC-GA
Table 6-7 Classification results and time to converge for NSC-GA and NSC-MA using
the Lung cancer data
Lung
Approach

No

of

attributes

Unseen test Average number of generations Standard
data

for convergence of fitness over deviation

(%)

15 independent runs

(Stdev)

100

41

9.5

100

68

53.08

Proposed
approach

8

NSC-MA
8
NSC-GA

9
10
11
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6.2.7. Prostate cancer data
Details about this dataset can be found in Section 3.1.
As seen in Figure 6-10, both algorithms converged to the global optimum with the same
maximum fitness of 1.973. With NSC-MA, convergence occurred after 62 generations,
and with NSC-GA, convergence occurred after 99 generations in this sample run. From
Table 6-8, it can be seen that on average NSC-MA takes 65 +/- 23.62 runs to converge
versus NSC-GA requiring 82 +/- 32.26 runs for convergence of fitness. The same set of
6 features obtained from each of the 15 independent runs using NSC-MA gave the same
average classification accuracy of 90.2% on the Prostate unseen test dataset. The
classification results of NSC-MA in comparison to NSC-GA are shown in Table 6-8.

Convergence NSC-MA

Convergence NSC-GA

1.95
1.94
1.93
1.92
1.91

Fitness 1.9
1.89
1.88
1.87
1.86

1
8
15
22
29
36
43
50
57
64
71
78
85
92
99
106
113
120
127
134
141
148
155
162
169
176
183
190
197

1.85

Generations
Max fitness (NSC-MA)

Max fitness (NSC-GA)

Figure 6-10 A comparison convergence of fitness plot for Prostate training dataset using
NSC-MA and NSC-GA associated with one typical run
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Table 6-8 Classification results and time to converge for NSC-GA and NSC-MA using
the Prostate cancer data
Prostate
Approach

No

of

Unseen test Average number of generations Standard
data

for convergence of fitness over deviation

(%)

15 independent runs

(Stdev)

6

90.2

65

23.62

6

90.2

80

32.26

attributes
Proposed
approach
NSC-MA
NSC-GA
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Table 6-9 Summary of results obtained from the NSC-GA and NSC-MA approach

Dataset

No of
attributes

NSC-GA
Unseen
Average number Standard
test data of generations for deviation
(%)
convergence of (Stdev)
fitness over 15
independent runs

No of
attributes

NSC-MA
Unseen
Average number Standard
test data of generations for deviation
(%)
convergence of (Stdev)
fitness over 15
independent runs

AD

11

89.49

28

2.97

11

89.34

18

4.68

Colon

28
6

100
93.75

309

194.9

28

100

271

178.84

Leukemia

9

97.05

82

43.57

9

97.05

54

38.73

Lymphoma

7
12
128
129
132

95.45
95.45
100
100
100

100

62.42

128

100

88

8.91

Ovarian

7

96.06

86

24.5

7

96.06

177

160.78

Lung

8
9
10
11

100

68

53.08

8

100

41

9.5

Prostate

6

90.2

80

32.26

6

90.2

65

23.62

177

6.3. Discussion
Table 6-9 shows a summary of experimental results obtained using NSC-MA, in
comparison to results from NSC-GA on the same datasets. The proposed approach
achieved the same classification results in terms of the sets of selected features and
classification accuracy on unseen test sets for the seven datasets. However, the NSCMA approach has generally improved performance in terms of computational time for
all datasets except for the Ovarian and Lymphoma datasets. That is, the NSC-MA
approach, on average over 15 independent runs, required a smaller number of
generations for convergence of fitness.
Another difference from NSC-MA when compared to NSC-GA is that, NSC-MA
consistently obtained the same set of features for each of the 15 independent runs. This
highlights the advantage of incorporating LS into the previous approach NSC-GA to
further improve the fitness of candidate solutions and subsequently, that leads to only
one constant optimal solution being obtained for all the independent runs for the
respective dataset. For example, for the Lung cancer dataset, the proposed approach
NSC-MA obtained the same set of 8 genes for each of the 15 independent runs, whilst
the NSC-GA approach obtained sets with 8, 9, 10, and 11 features from the 15
independent runs.
Overall, the impact of incorporating MA with NSC for finding shrinkage threshold
values automatically are (1) reduced computational time and (2) obtaining the same
feature set over different runs of NSC-MA.
6.4. Summary
This chapter has described the proposed approach of incorporating the NSC and MA to
automatically search for optimal threshold values for the NSC, and subsequently to be
used for FS and classification. The approach incorporated the adding and subtracting LS
with Improvement First Strategy in a MA to optimize the optimal threshold value
automatically for NSC, and to obtain the sets of relevant features. The results obtained
shows that with NSC-MA, convergence of fitness is quicker while obtaining the same
feature set and similar classification accuracy, compared to those obtained via NSC-GA.
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In Chapter 7, the investigation of incorporating different similarity distance measures
into the NSC algorithm in NSC-GA will be described.
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7. Incorporating different similarity distance measures into the NSC
algorithm in the NSC-GA approach
The NSC classifier uses Euclidean distance as a measure to assign data points to
different classes. Each data point is assigned to the class that it has the shortest
Euclidean distance. The classification accuracy is calculated based on correct class
assignment. The higher the number of data points correctly assigned to its class, the
higher the resulting classification accuracy. According to Bandyopadhyay and Saha
(2013, p. 60), “similarity measurement is essential for performing classification”,
therefore employing a different similarity distance measure in the NSC classifier would
impact its class prediction of data points and consequently the classification accuracy.
The aim of this chapter is to investigate the impact of employing different similarity
distance measures (Mahalanobis, Pearson and Mass distance (MD) measure) in the NSC
classifier on FS and classification using the same NSC-GA approach, which has been
proposed and implemented in Chapter 5. Subsequently the impact of incorporating
different distance measures in NSC*-GA (with * representing M or P or MD) is
evaluated using the seven biomedical datasets described in Chapter 3. Section 7.1.1
describes the proposed approaches, NSCM-GA, NSCP-GA and NSCMD-GA, the results
are reported in Section 7.2, discussion is in Section 7.3 and summary is in Section 7.4.
*

7.1. NSC -GA proposed approach
Similar to the NSC-GA approach where Euclidean distance is employed in the NSC, the
proposed approach NSC*-GA consists of the same 2 major steps that have been
described in Section 5.2.
Considerations for chromosomes encoding, estimation of the initial range of values for
the shrinkage threshold and fitness evaluation in NSC*-GA are also the same as NSCGA and have been discussed in Section 5.2.1. The basic concepts of NSC algorithm
(Tibshirani et al., 2002) have been reviewed in Section 2.3.3 and different distance
measures, Euclidean, Mahalanobis (Mahalanobis, 1936), Pearson (Pearson, 1895) and
MD (Yona et al., 2006) have been reviewed in Section 2.3.6. The following sections
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describe the proposed approach which incorporates NSC with different similarity
distance measures, Mahalanobis, Pearson and MD, into GA, denoted as NSCM-GA,
NSCP-GA and NSCMD-GA, respectively.
7.1.1. NSC-GA with Mahalanobis (NSCM-GA), Pearson (NSCP-GA) and Mass
distance measure (NSCMD-GA)
Training dataset
Automatic ThMax calculation

NSCM

NSC

NSCMD

Mahalanobis
distance
measure

Pearson
P
distance
measure

Mass
distance
measure

Shrinkage thresholds
GA
Features selected and
classification accuracy

NSC classifier
(fitness
evaluator)

Optimal shrinkage
threshold range

Figure 7-1 Framework of NSC*-GA

As seen in Figure 7-1, the core of the framework of NSC*-GA is the same as of the
framework of NSC-GA. The only difference between the 2 approaches is the different
distance measure method employed in the NSC classifier. That is, instead of using the
Euclidean distance as a distance measure in the original implementation of NSC,
Mahalanobis distance (green box), Pearson (yellow box) and Mass distance (blue box)
are employed in the NSC classifier to measure the distance between data points and
classes when performing classification. The modified NSC * classifiers (NSC with a
different distance measure) are NSCM, NSCP and NSCMD with M, P and MD denoting
Mahalanobis distance, Pearson and Mass distance respectively. These modified
classifiers are detailed in the following sections.
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A number of calculations in the original NSC algorithm still apply in NSCM, NSCP and
NSCMD. These include the calculations of class centroid, overall centroid, relative
difference, shrunken relative difference, updated class centroid and classification.
Equations for these calculations are shown in Equation (7.1), (7.2), (7.3), (7.4), (7.5),
and (7.6), respectively. More details about these equations can be found in Section
2.4.3.


Class centroid :

∑
̅

(7.1)


Overall centroid: ̅i

∑

i

(7.2)



̅i - ̅i

Relative difference:
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Shrunken relative difference:
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(7.3)
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Updated class centroid: ̅



Classification:

i

̅i

(si

so ) d’i

(7.5)
(7.6)

The following sections describe the specific distance measure employed in NSC M,
NSCP and NSCMD classifiers respectively.
 NSCM classifier
The difference between the NSC and NSCM classifier is the calculation of discriminant
scores for data points, where each data point is assigned to the class that it has the
closest distance, i.e., the distance is based on a minimal discriminant score.
In NSCM, the calculation of the discriminant score is now obtained using the calculation
of Mahalanobis distance (

) as defined by Equation (7.8) and (7.9). Descriptions of

Mahalanobis distance and associated equations are found in Section 2.3.6.2.

√

(7.7)
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where

is a data point
µ is a class centroid
superfix T is a matrix transpose
Σ-1 is an inverse covariance matrix

Hence the calculation of discriminant scores using Mahalanobis distance measure is
defined by Equation (7.8) as follows.
( )

(7.8)

 NSCP classifier
In NSCP, the calculation of the discriminant score is now obtained using Pearson
Correlation. These calculations are defined by Equation (7.9), (7.10) and (7.11).
Descriptions of Pearson Correlation and associated equations are found in Section
2.3.6.3.



Correlation coefficient

r=

∑ (x- ̅ ) (y- ̅ )
√(x- ̅ )2 √(y- ̅ )2

(7.9)

where x is variable value
̅


̅ are class centroids
| |

Pearson correlation measure

(7.10)

Hence the calculation of discriminant scores using Pearson correlation is defined by
Equation (7.11) as follows.
( )

(7.11)

 NSCMD classifier
In NSCMD, the calculation of the discriminant score is now obtained using MD. These
calculation are defined by Equation (7.12), (7.13), 7.14), (7.15) and (7.16) in the
calculations for Mass Distance. These equations have been described in Section 2.3.6.4.
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∫
(

(7.12)
√

)

(7.13)
(7.14)

(∫

(

√

)

) (

)

(7.15)

Hence the calculation of discriminant scores using mass distance is defined by Equation
(7.16) as follows.
(7.16)

As mentioned previously, NSC*-GA comprised of the same 2 major steps as NSC-GA.
These steps include the automatic Thmax calculation, GA search optimization including
population initialization, fitness evaluation, GA operators and new population
generation steps which have been described in Section 5.2.1 and will not be repeated
here. The same parameter settings used in NSC-GA (Table 5-4) are also used to run
NSCM-GA, NSCP-GA and NSCMD-GA.
7.2. Experiment results
Similar to the experiments for NSC-GA described in Chapter 5, NSCM-GA, NSCP-GA
and NSCMD-GA, were evaluated using the same seven datasets. For each dataset, 15
independent runs of NSC*-GA (i.e. 15 runs for each of NSCM-GA, NSCP-GA and
NSCMD-GA) were executed using the respective training dataset and parameter settings
shown in Table 5-4. For each independent run, 10 fold CV strategy described in Section
3.2 was employed to evaluate the proposed approaches. The optimal set of features
obtained for each dataset was then used to construct the respective NSC * classifier to
evaluate the corresponding unseen test dataset. The classification results for the unseen
test data were recorded and the average classification result from 15 independent runs
was calculated. The following sections report the results of experiments for each
approach on each of the seven datasets. Where appropriate, the comparison of the
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performance of the proposed algorithm with existing work is based on classification
accuracy and the selected feature sets.
7.2.1. NSCM-GA
7.2.1.1.

Ray et al. AD data

Convergence occurs
1.82
1.81
1.8
1.79
1.78

Fitness 1.77
1.76
1.75
1.74
1.73
1.72
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58 61 64 67 70

Generations
Max fitness
Figure 7-2 A typical plot for convergence of fitness for the training data of AD using
NSCM-GA
As seen in Figure 7-2, convergence in this sample run occurred after 28 generations
with the maximum fitness of 1.81. The optimal shrinkage threshold obtained for each of
the runs had the same maximum fitness of 1.81 which produced the set of 18 proteins
with resulting 97.82% classification accuracy on the unseen test data (Figure 7-1). The
18 proteins selected by NSCM-GA, for the AD dataset are the same set of 18 proteins
found by Ray et al. (2007).
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Table 7-1 Comparison of classification results between NSC-GA and NSCM-GA for AD
data
NSC-GA (Euclidean dist.)

Proposed NSCM-GA (Mahalanobis dist.)

Number of
Unseen Test (%)
proteins

Number
proteins

11

18

7.2.1.2.

90.21

of

Unseen Test (%)
97.82

Alon et al. Colon cancer data

Convergence occurs

Fitness

2
1.98
1.96
1.94
1.92
1.9
1.88
1.86
1.84
1.82
1.8
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58 61 64 67 70

Generations
Max fitness
Figure 7-3 A typical plot for convergence of fitness for the training data of Colon using
NSCM-GA
As seen in Figure 7-3, convergence in this sample run occurred after 37 generations
with the maximum fitness of 1.99. The optimal shrinkage threshold obtained for each of
the runs had the same maximum fitness of 1.99 which produced the set of 7 genes with
93.54% classification accuracy on the unseen test set. The gene accession numbers of 7
genes selected by NSCM-GA for Colon dataset are T71025, M76378, M63391, T92451,
H64489, M76378 and J02854. This set of 7 genes is a subset of the set of 28 genes and
the superset of the 6 genes which have been found by NSC-GA. As seen in Table 7-2,
the classification accuracy using the set of 6 and 7 genes are very similar.
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Table 7-2 Comparison of classification results between NSC-GA and NSCM-GA for
Colon cancer data
NSC-GA (Euclidean dist.)

Proposed NSCM-GA
(Mahalanobis dist.)

Number of
Unseen Test (%)
genes
28
100
6
93.75

Number of
Unseen Test (%)
genes

7.2.1.3.

7

93.54

Leukemia cancer data

Convergence starts
2
1.95
1.9

Fitness
1.85
1.8

1
6
11
16
21
26
31
36
41
46
51
56
61
66
71
76
81
86
91
96
101
106
111
116

1.75

Generations

Max fitness
Figure 7-4 A typical plot for convergence of fitness for the training data of Leukemia
using NSCM-GA
As seen in Figure 7-4, convergence in this sample run occurred after 69 generations
with the maximum fitness of 1.99. The optimal shrinkage threshold obtained for each of
the 15 independent runs had the same maximum fitness of 1.99 which produced the
same set of 9 genes for the Leukemia cancer dataset. As shown in Table 7-3, this set of
9 genes produced the average classification accuracy of 94.12% on the unseen test set.
The classification accuracy is slightly different from those obtained using NSC-GA.
Owing the fact that the optimal shrinkage threshold value obtained from NSCM-GA is
slightly different from that of NSC-GA. These two slightly different optimal thresholds
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still mapped to the same set of 9 genes but produced slightly different classification
accuracy on the same unseen test dataset.
Table 7-3 Comparison of classification results between NSC-GA and NSCM-GA for
Leukemia data
NSC-GA (Euclidean dist.)

Proposed NSCM-GA
(Mahalanobis dist.)

Number of
Unseen Test (%)
genes

Number of
Unseen Test (%)
genes

9

9

7.2.1.4.

97.05

94.12

Lymphoma cancer data

As seen in Figure 7-5, convergence in this sample run occurred after 31 generations
with the maximum fitness of 1.99. The optimal shrinkage threshold obtained for each of
the 15 independent runs had the same maximum fitness of 1.99 which produced the
same set of 3 genes for the Lymphoma cancer dataset. This set of 3 genes produced the
average classification accuracy of 100% on the unseen test set. The 3 gene set with gene
accession numbers, GENE3327X, GENE3329X and GENE3361X, selected by NSCMGA for Lymphoma dataset, is a subset of the following sets consisting of 7, 12, 128,
129 and 132 genes found using NSC-GA. For this dataset, the proposed approach
selected a smaller set of genes resulting in a higher classification accuracy on the same
unseen test dataset.
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Convergence starts
2.1
2
1.9
1.8

Fitness

1.7
1.6
1
7
13
19
25
31
37
43
49
55
61
67
73
79
85
91
97
103
109
115
121
127
133
139
145

1.5

Generations
Max fitness

Figure 7-5 A typical plot for convergence of fitness for the training data of Lymphoma
using NSCM-GA
Table 7-4 Comparison of classification results between NSC-GA and NSCM-GA for
Lymphoma data
NSC-GA (Euclidean dist.)
Number of
Unseen Test (%)
genes
7
95.45
12
95.45
128
100
129
100
132
100

Proposed NSCM-GA
(Mahalanobis dist.)
Number of
Unseen Test (%)
genes
3

100
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7.2.1.5. Lung cancer data

Convergence starts
2
1.998
1.996
1.994

Fitness

1.992
1.99
1.988

1
5
9
13
17
21
25
29
33
37
41
45
49
53
57
61
65
69
73
77
81
85
89
93
97
101
105
109

1.986

Generations
Max fitness
Figure 7-6 A typical plot for convergence of fitness for the training data of Lung using
NSCM-GA
As seen in Figure 7-6, convergence in this sample run occurred after 10 generations
with the maximum fitness of 1.998. The optimal shrinkage threshold obtained for each
of the 15 independent runs produced the set of 9 and 11 genes for the Lung cancer
dataset. As shown in Table 7-5, the set of 9 and 11 genes resulted in the average
classification accuracy of 98.88% on the unseen test set. These sets of 9 and 11 genes
selected by NSCM-GA are the same set of 9 and 11 genes found by using NSC-GA with
the classification accuracy of 100%.
Table 7-5 Comparison of classification results between NSC-GA and NSCM-GA for
Lung data
NSC-GA (Euclidean dist.)

Proposed NSCM-GA (Mahalanobis dist.)

Number of

Number of

genes
7, 8, 9, 10

Unseen Test (%)
100

genes
9, 11

Unseen Test (%)
98.88
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7.2.1.6.

Ovarian cancer data

Convergence starts
1.99
1.985
1.98

Fitness1.975
1.97
1.965

1
6
11
16
21
26
31
36
41
46
51
56
61
66
71
76
81
86
91
96
101
106
111
116
121
126
131
136
141

1.96

Generations
Max fitness
Figure 7-7 A typical plot for convergence of fitness for the training data of Ovarian
using NSCM-GA
As seen in Figure 7-7, convergence in this sample run occurred after 46 generations
with the maximum fitness of 1.98. The optimal shrinkage threshold obtained for each of
the 15 independent runs had the same maximum fitness of 1.98 which resulted in the set
of 1 peptide for the Ovarian cancer dataset. As shown in Table 7-6, the set of 1 gene
(MZ244.36855) gave the average classification accuracy of 96.06% on the unseen test
set. This set of 1 peptide selected by NSCM-GA is a subset of 7 peptides found using the
NSC-GA approach but gave the same classification accuracy of 96.06%. It appears that
a major contributing factor relates to 1 peptide and thus may warrant further
investigations into the relevance of the remaining features. This sort of information for
analysis in bioinformatics is important as reducing the number of features to a smaller
promising set for further investigations would reduce costs associated with future
experiments and analysis.
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Table 7-6 Comparison of classification results between NSC-GA and NSCM-GA for
Ovarian data
NSC-GA (Euclidean dist.)

Proposed NSCM-GA (Mahalanobis dist.)

Number of genes

Unseen Test (%) Number of genes

Unseen Test (%)

7

96.06

96.06

7.2.1.7.

1

Prostate cancer data

As seen in Figure 7-8, convergence in this sample run occurred after 9 generations with
the maximum fitness of 1.998. The optimal shrinkage threshold obtained for each of the
15 independent runs had the same maximum fitness of 1.998 which produced the sets of
17 genes for the Prostate cancer dataset. As shown in Table 7-7, this set of 17 genes
resulted in the average classification accuracy of 100% on the unseen test set. The gene
accession numbers of 17 genes selected by NSC M-GA for Prostate cancer dataset are:
31444_s_at, 31527_at, 33614_at, 41468_at, 37639_at, 39756_g_at, 40435_at,
40436_g_at, 36587_at, 36666_at, 37720_at, 38406_f_at, 38429_at, 40282_s_at,
769_s_at, 556_s_at and 216_at. The gene accession number, 31444_s_at and 769_s_at
are listed in the prognosis gene patent that indicates high risk for TTD (time to death)
(Liu & Iba, 2002). In comparison, this set of 17 genes is a superset of the 6 genes
obtained using NSC-GA which produced a resulting classification accuracy of 90.2%
on the same unseen test dataset.
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Convergence starts
2
1.99
1.98
1.97

Fitness 1.96
1.95
1.94
1.93
1
5
9
13
17
21
25
29
33
37
41
45
49
53
57
61
65
69
73
77
81
85
89
93
97
101
105
109

1.92

Generations
Max fitness
Figure 7-8 A typical plot for convergence of fitness for the training data of Prostate
using NSCM-GA
Table 7-7 Comparison of classification results between NSC-GA and NSCM-GA for
Prostate data
NSC-GA (Euclidean dist.)

Proposed NSCM-GA (Mahalanobis dist.)

Number of genes

Unseen Test (%)

Number of genes

Unseen Test (%)

6

90.2

17

100

193

7.2.2. NSCP-GA approach
Similar to the experiments for NSCM-GA approach, the same parameter settings,
experimental conditions and evaluation strategy were also used here for evaluating
NSCP-GA. The results from these experiments are reported as follows.
7.2.2.1. Ray et al. AD data

Convergence starts
1.78
1.76
1.74
1.72

Fitness

1.7
1.68
1.66
1.64
1.62
1
25
49
73
97
121
145
169
193
217
241
265
289
313
337
361
385
409
433
457
481
505
529
553
577

1.6

Generations
Max fitness
Figure 7-9 A typical plot for convergence of fitness for the training data of AD using
NSCP-GA
As seen in Figure 7-9, convergence in this sample run occurred after 251 generations
with the maximum fitness of 1.768 in this sample run. The optimal shrinkage threshold
obtained for each of the 15 independent runs had the same maximum fitness of 1.768
which produced the same set of 9 proteins for the AD dataset. As shown in Table 7-8,
the set of 9 proteins resulted in the average classification accuracy of 92.39% on unseen
test dataset, an improvement over the results from the set of 11 proteins obtained via
NSC-GA. The selected 9 proteins, PDGF-BB_1, RANTES_1, IL-1a_1, TNF-a_1,
EGF_1, M-CSF_1, ICAM-1_1, IL-3-1 and GCSF_1, are a subset of the sets of 11 and
18 proteins obtained using NSC-GA and NSCM-GA, respectively, as well as being a
subset of the 18 proteins in Ray et al. (2007).
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Table 7-8 Comparison of classification results between NSC-GA and NSCP-GA for AD
data
NSC-GA (Euclidean dist.)

Proposed NSCP-GA (Pearson dist.)

Number of genes

Unseen Test (%)

Number of genes

Unseen Test (%)

11

89.49

9

92.39

7.2.2.2.

Alon et al. Colon cancer data

Convergence starts
1.84
1.83
1.82
1.81
1.8

Fitness

1.79
1.78
1.77
1.76
1
13
25
37
49
61
73
85
97
109
121
133
145
157
169
181
193
205
217
229
241
253
265
277
289
301
313
325

1.75

Generations
Max fitness
Figure 7-10 A typical plot for convergence of fitness for the training data of Colon
using NSCP-GA
As seen in Figure 7-10, convergence in this sample run occurred after 144 generations
with the maximum fitness of 1.826. Seven runs produced a maximum fitness of 1.826
which gave the same set of 42 genes and other 8 runs produced a maximum fitness of
1.823 which mapped to the same set of 6 genes which is a subset of the 42 gene set. As
shown in Table 7-9, these sets of 42 and 6 genes, each resulted in an average
classification accuracy of 100% on the unseen test dataset. The set of six genes selected
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by the proposed approach is the same set of 6 genes found by the NSC-GA approach
and is also a subset of the sets of 28 genes (from NSC-GA) and 42 genes.
Table 7-9 Comparison of classification results between NSC-GA and NSCP-GA for
Colon data
NSC-GA (Euclidean dist.)

Proposed NSCP-GA (Pearson dist.)

Number of genes

Unseen Test (%)

Number of genes

Unseen Test (%)

28
6

100
93.75

42
6

100

7.2.2.3.

Leukemia cancer data

Convergence starts
2
1.995
1.99
1.985
1.98

Fitness 1.975
1.97
1.965

1
11
21
31
41
51
61
71
81
91
101
111
121
131
141
151
161
171
181
191
201
211
221
231
241

1.96

Generations
Max fitness
Figure 7-11 A typical convergence of fitness plot for the training data of Leukemia data
using NSCP-GA
As seen in Figure 7-11, convergence in this sample run occurred after 91 generations
with the maximum fitness of 1.99. Three different optimal shrinkage thresholds were
obtained from the 15 independent runs, each are associated with 7 sets of 4 genes, 5 sets
of 5 genes and 3 sets of 24 genes respectively. As shown in Table 7-10, these sets of 4,
5 and 24 genes, each resulted in an average classification accuracy of 100% on unseen
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test data. The sets of 4 and 5 genes, each is a subset of the 9 gene set produced from
using NSC-GA.
Table 7-10 Comparison of classification results between NSC-GA and NSCP-GA for
Leukemia data
NSC-GA (Euclidean dist.)

Proposed NSCP-GA (Pearson dist.)

Number of genes

Unseen Test (%)

9

97.05

Number of genes
4
5
24

7.2.2.4.

Unseen Test (%)
100

Lymphoma cancer data

Convergence starts
1.985
1.98
1.975
1.97
1.965
1.96

Fitness 1.955
1.95
1.945
1.94
1
16
31
46
61
76
91
106
121
136
151
166
181
196
211
226
241
256
271
286
301
316
331
346
361
376

1.935

Generations
Max fitness
Figure 7-12 A typical plot for convergence of fitness for the training data of Lymphoma
using NSCP-GA
As seen in Figure 7-12, convergence in this sample run occurred after 91 generations
with the maximum fitness of 1.983. Five different optimal shrinkage thresholds
obtained for the 15 independent runs, each are associated with 5 sets of 72 genes, 3 sets
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of 73 genes, 5 sets of 75 genes, 1 set of 77 and 80 genes respectively. As shown in
Table 7-11, these sets of 72, 73, 75, 77 and 80 genes, each produced an average
classification accuracy of 100% on unseen test data. The sets of 72, 73, 75, 77 and 80
genes are subset of the 128 gene set produced using NSC-GA.
Table 7-11 Comparison of classification results between NSC-GA and NSCP-GA for
Lymphoma data
NSC-GA (Euclidean dist.)

Proposed NSCP-GA (Pearson dist.)

Number of genes

Unseen Test (%)

Number of genes

Unseen Test (%)

7
12
128
129
132

95.45
95.45
100
100
100

72
73
75
77
80

100

7.2.2.5.

Lung cancer data

As seen in Figure 7-13, convergence in the sample run occurred after 36 generations
with the maximum fitness of 1.9996. Three different optimal shrinkage thresholds were
obtained from the 15 independent runs. Each is associated with 8 sets of 4 genes, 5 sets
of 5 genes and 2 sets of 7 genes, respectively. The smaller set is a subset of the larger
set. As shown in Table 7-12, the set of 4, 5 and 7 genes resulted in an average
classification accuracy of 100% on unseen test data. The set of 7 genes, with gene
accession numbers 32551_at, 33328_at, 34320_at, 36533_at, 37157_at, 37716_at and
37954_at. Sets of 4, 5 and 7 genes are each a subset of the sets consisting of 8, 9, 10 and
11 genes produced using NSC-GA.

198

Convergence starts
2
1.999
1.998
1.997

Fitness

1.996
1.995
1.994
1.993
1.992
1.991
1
6
11
16
21
26
31
36
41
46
51
56
61
66
71
76
81
86
91
96
101
106
111
116

1.99

Generations
Max fitness
Figure 7-13 A typical plot for convergence of fitness for the training data of Lung using
NSCP-GA
Table 7-12 Comparison of classification results between NSC-GA and NSCP-GA for
Lung data
NSC-GA (Euclidean dist.)

Proposed NSCP-GA (Pearson dist.)

Number of genes

Unseen Test (%) Number of genes

8
9
10
11

100

4
5
7

Unseen Test (%)
100
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7.2.2.6.

Ovarian cancer data

Convergence starts
1.98405
1.984
1.98395

Fitness

1.9839
1.98385
1.9838
1.98375
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Generations
Max fitness
Figure 7-14 A typical plot for convergence of fitness for the training data of Ovarian
using NSCP-GA
As seen in Figure 7-14, convergence in this sample run occurred after 7 generations
with the maximum fitness of 1.984. Four different optimal shrinkage thresholds were
obtained from the 15 independent runs, each are associated with 2 sets of 2 peptides, 8
sets of 8 peptides, 3 sets of 9 peptides and 2 set of 10 peptides respectively. As shown in
Table 7-13, the set of 2 peptides produced an average classification accuracy of 96.85%
and the set of 8, 9 and 10 genes produced an average classification accuracy of 96.06%
on unseen test data. The set of the 2 peptides, MZ244.95245 and MZ245.24466, is a
subset of 7 peptides found by the approach NSC-GA.
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Table 7-13 Comparison of classification results between NSC-GA and NSCP-GA for
Ovarian data
NSC-GA (Euclidean dist.)

Proposed NSCP-GA (Pearson dist.)

Number of peptides Unseen Test (%) Number of peptides Unseen Test (%)
7

96.06

7.2.2.7.

2
8
9
10

96.85
96.06
96.06
96.06

Prostate cancer data

Convergence starts
1.96
1.94
1.92

Fitness

1.9

1.88
1.86

1
7
13
19
25
31
37
43
49
55
61
67
73
79
85
91
97
103
109
115
121
127
133
139
145

1.84

Generations
Max fitness
Figure 7-15 A typical plot for convergence of fitness for the training data of Prostate
using NSCP-GA
As seen in Figure 7-15, convergence in this sample run occurred after 43 generations
with the maximum fitness of 1.942. The optimal shrinkage threshold obtained for each
of the 15 independent runs had the same maximum fitness of 1.942 which mapped to
the same set of five genes. As shown in Table 7-14, this set of five genes produced an
average classification accuracy of 90.2% on unseen test data. This five gene set, with
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gene accession numbers 41468_at, 37639_at, 38406_f_at, 769_s_at and 556_s_at , is a
subset of six genes found using NSC-GA.
Table 7-14 Comparison of classification results between NSC-GA and NSCP-GA for
Prostate data
NSC-GA (Euclidean dist.)

Proposed NSCP-GA (Pearson dist.)

Number of genes

Unseen Test (%)

Number of genes

Unseen Test (%)

6

90.2

5

90.2

7.2.3. NSCMD-GA approach
Similar to the experiments for NSCM-GA and NSCP-GA, the same parameter settings,
experimental conditions and evaluation strategy were also used here for evaluating
NSCMD-GA. The results from these experiments are reported as follows.
7.2.3.1.

Ray et al. AD data

As seen in Figure 7-16, convergence in this sample run occurred after 51 generations
with the maximum fitness of 1.84. The optimal shrinkage threshold obtained for each of
the 15 independent runs had the same maximum fitness of 1.84 which mapped to the
same set of 4 proteins. As shown in Table 7-15, this set of 4 proteins resulted in an
average classification accuracy of 91.3% on unseen test data. This 4 protein set, PDGFBB_1, RANTES_1, TNF-a_1 and IL-1a_1, is a subset of the following sets with each
comprising of 11, 18 and 9 features selected using NSC-GA, NSCM-GA and NSCP-GA,
respectively, and is also a subset of 18 features in Ray et al. (2007).
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Convergence starts
1.9
1.85
1.8

Fitness1.75
1.7
1.65

1
11
21
31
41
51
61
71
81
91
101
111
121
131
141
151
161
171
181
191
201
211
221
231
241
251

1.6

generations
Max fitness
Figure 7-16 A typical plot for convergence of fitness for the training data of AD using
NSCMD-GA
Table 7-15 Comparison of classification results between NSC-GA and NSCMD-GA for
AD data
NSC-GA (Euclidean dist.)

Proposed NSCMD-GA (Mass dist.)

Number of proteins

Unseen Test (%) Number of proteins

Unseen Test (%)

11

90.21

91.3

4
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7.2.3.2.

Alon et al. Colon cancer data

Convergence starts
1.9
1.85
1.8
1.75

Fitness

1.7
1.65

1
67
133
199
265
331
397
463
529
595
661
727
793
859
925
991
1057
1123
1189
1255
1321
1387
1453
1519
1585
1651
1717
1783

1.6

Generations
Max fitness

Figure 7-17 A typical plot for convergence of fitness for the training data of Colon
using NSCMD-GA
As seen in Figure 7-17, convergence in this sample run occurred after 853 generations
with the maximum fitness of 1.86. The optimal shrinkage threshold obtained from each
of the 15 independent runs had the same maximum fitness of 1.86 which mapped to the
same set of 12 genes. As shown in Table 7-16, this set of 12 genes resulted in an
average classification accuracy of 100% on the unseen test data. The set of 12 genes has
gene accession numbers: T71025, Z24727, M76378, M63391, M76378, R87126,
X12671, M76378, T92451, H43887, T47377 and J02854. This set is also a subset of the
set of 28 genes found using NSC-GA. The interesting point from the perspective of
early diagnostic test developments is a small set with high discriminatory potentials and
here both sets (set of 12 genes and the set of 28 genes) produced the same classification
accuracy on the unseen test dataset.

204

Table 7-16 Comparison of classification results between NSC-GA and NSCMD-GA for
Colon data
NSC-GA (Euclidean dist.)
Number of genes
28
6

7.2.3.3.

Proposed NSCMD-GA (Mass dist.)

Unseen Test (%) Number of genes
100
12
93.75

Unseen Test (%)
100

Leukemia cancer data

Convergence starts
1.94
1.92
1.9
1.88

Fitness 1.86
1.84
1.82
1
6
11
16
21
26
31
36
41
46
51
56
61
66
71
76
81
86
91
96
101
106
111
116
121
126
131

1.8

Generations
Max fitness
Figure 7-18 A typical plot for convergence of fitness for the training data of Leukemia
using NSCMD-GA
As seen in Figure 7-18, convergence in this sample run occurred after 56 generations
with the maximum fitness of 1.92. The optimal shrinkage threshold obtained for each of
the 15 independent runs had the same maximum fitness of 1.92 which mapped to the
same set of 3 genes. As shown in Table 7-17, this set of 3 genes gave the average
classification accuracy of 94.12% on unseen test data. The set of 3 genes selected with
gene accession numbers, M27891, M84526, and X17042, is a subset of 5 features found
in NSCPGA, and also a subset of 9 genes found in NSC-GA.
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Table 7-17 Comparison of classification results between NSC-GA and NSCMD-GA for
Leukemia data
NSC-GA (Euclidean dist.)

Proposed NSCMD-GA (Mass dist.)

Number of genes

Unseen Test (%) Number of genes

Unseen Test (%)

9

97.05

94.12

7.2.3.4.

3

Lymphoma cancer data

Convergence starts
2
1.99
1.98
1.97

Fitness 1.96
1.95
1.94
1
10
19
28
37
46
55
64
73
82
91
100
109
118
127
136
145
154
163
172
181
190
199
208
217
226
235
244
253

1.93

Generations
Max fitness
Figure 7-19 A typical plot for convergence of fitness for the training data of Lymphoma
using NSCMD-GA
As seen in Figure 7-19, the convergence in this sample run occurred after 151
generations with the maximum fitness of 1.997. The optimal shrinkage threshold
obtained for each of the 15 independent runs had the same maximum fitness of 1.997
which produced the same set of 3 genes for the Lymphoma cancer dataset. As shown in
Table 7-18, the set of 3 genes gave the average classification accuracy of 100% on
unseen test data. The set of 3 genes selected with gene accession numbers,
GENE3327X, GENE3329X and GENE3361X, is a subset of 7 features found in NSCGA.
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Table 7-18 Comparison of classification results between NSC-GA and NSCMD-GA for
Lymphoma data
NSC-GA (Euclidean dist.)

Proposed NSCMD-GA (Mass dist.)

Number of genes

Unseen Test (%)

Number of genes

Unseen Test (%)

7
12
128
129
132

95.45
95.45
100
100
100

3

100

7.2.3.5.

Lung cancer data

Convergence starts
2
1.9
1.8
1.7

Fitness 1.6
1.5
1.4
1
6
11
16
21
26
31
36
41
46
51
56
61
66
71
76
81
86
91
96
101
106
111
116
121
126

1.3

Generations
Max fitness
Figure 7-20 A typical plot for convergence of fitness for the training data of Lung using
NSCMD-GA
As seen in Figure 7-20, the convergence in this sample run occurred after 21
generations with the maximum fitness of 1.997. The optimal shrinkage threshold
obtained for each of the 15 independent runs had the same maximum fitness of 1.997
which produced the same set of 2 genes for the Lung cancer dataset. As shown in Table
7-19, the set of 2 genes gave the average classification accuracy of 63.33% on unseen
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test data. The set of 2 genes selected with accession numbers, 33328_at and 40936_at, is
a subset of 8 genes found in NSC-GA.
Table 7-19 Comparison of classification results between NSC-GA and NSCMD-GA for
Lung data
NSC-GA (Euclidean dist.)

Proposed NSCM-GA (Mass dist.)

Number of genes

Unseen Test (%)

Number of genes

Unseen Test (%)

8
9
10
11

100

2

63.33

7.2.3.6.

Ovarian cancer data

Convergence starts

1.98
1.96
1.94
1.92

Fitness 1.9
1.88
1.86
1
7
13
19
25
31
37
43
49
55
61
67
73
79
85
91
97
103
109
115
121
127
133
139
145
151
157

1.84

Generations
Max fitness
Figure 7-21 A typical plot for convergence of fitness for the training data of Ovarian
using NSCMD-GA
As seen in Figure 7-21, the convergence in this sample run occurred after 37
generations with the maximum fitness of 1.964. The optimal shrinkage thresholds
obtained for the 15 independent runs produced the 12 sets of 10 peptides, 2 sets of 11
peptides and 1 set of 20 peptides for the Ovarian cancer dataset. As shown in Table
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7-20, the set of 10, 11 and 20 peptides gave the average classification accuracy of
63.33% on unseen test data. The smaller set is a subset of the larger sets.
Table 7-20 Comparison of classification results between NSC-GA and NSCMD-GA for
Ovarian data
NSC-GA (Euclidean dist.)

Proposed NSCMD-GA (Mass dist.)

Number of peptides Unseen Test (%) Number of peptides
7

7.2.3.7.

96.06

10
11
20

Unseen Test (%)
92.12
92.12
88.97

Prostate cancer data

Convergence starts
1.96
1.94
1.92
1.9
1.88

Fitness 1.86
1.84
1.82
1.8
1
7
13
19
25
31
37
43
49
55
61
67
73
79
85
91
97
103
109
115
121
127
133
139
145

1.78

Generations
Max fitness
Figure 7-22 A typical plot for convergence of fitness for the training data of Prostate
using NSCMD-GA
As seen in Figure 7-22, the convergence occurred after 43 generations with the
maximum fitness of 1.94. The optimal shrinkage threshold obtained for each of the 15
independent runs had the same maximum fitness of 1.94 which produced the same set
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of 5 genes for the Prostate cancer dataset. As shown in Table 7-21, the set of 5 genes
gave the average classification accuracy of 94.12% on unseen test data. The set of 5
genes selected with gene accession numbers are 41468_at, 37639_at, 38406_f_at,
769_s_at and 556_s_at, which is a subset of 6 genes found in NSC-GA.
Table 7-21 Comparison of classification results between NSC-GA and NSCMD-GA for
Prostate data
NSC-GA (Euclidean dist.)

Proposed NSCMD-GA (Mass dist.)

Number of
Unseen Test (%)
genes

Number of genes

Unseen
(%)

6

5

94.12

90.2

Test

7.2.4. Summary: selected feature subsets and corresponding classification results
Table 7-22 to Table 7-30 summarised all the features sets that were obtained using
NSCM-GA, NSCP-GA, NSCMD-GA and NSC-GA on the seven datasets.
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Table 7-22 Summary of the sets of selected features obtained from NSCM-GA, NSCPGA, NSCMD-GA and NSC-GA for AD data
Proposed approaches

NSC-GA
(Euclidean dist.)
Proteins

NSCM-GA

Number of
proteins

NSCP-GA

NSCMD-GA

Number of proteins

11

18

9

4

PDGF-BB_1

√

√

√

√

RANTES_1

√

√

√

√

IL-1a_1

√

√

√

√

TNF-a_1

√

√

√

√

EGF_1

√

√

√

M-CSF_1

√

√

√

ICAM-1_1

√

√

√

IL-3_1

√

√

√

IL-11_1

√

√

√

GCSF_1

√

√

ANG-2_1

√

√

PARC_1

√

GDNF_1

√

TRAIL R4_1

√

IL-8_1

√

MIP-1d_1

√

IGFBP-6_1

√

MCP-3_1

√
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Table 7-23 Summary of the sets of selected features obtained from NSCM-GA, NSCPGA, NSCMD-GA and NSC-GA for Colon data
Proposed approaches
Gene Accession
number

NSC-GA

NSCM-GA

(Euclidean dist.)
Number of genes

NSCP-GA

NSCMD-GA

Number of genes

28

7

6

12

T71025

√

√

√

√

M63391

√

√

√

√

R87126

√

√

√

√

M76378

√

√

√

√

T92451

√

√

√

√

J02854

√

√

√

√

M76378

√

√

R78934

√

M26697

√

Z24727

√

X55715

√

T60778

√

T57619

√

M76378

√

H64489

√

Z50753

√

T60155

√

M64110

√

H40560

√

T58861

√

M22382

√

X12671

√

T95018

√

X86693

√

H43887

√

√

√

√

√

√
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T47377

√

L05144

√

H55758

√

√

Table 7-24 Summary of the sets of selected features obtained from NSCM-GA, NSCPGA, NSCMD-GA and NSC-GA for Leukemia data
Proposed approaches
NSC-GA

Gene
Accession
number

(Euclidean dist.)

NSCM-GA

NSCP-GA

NSCMD-GA

Number of genes

Number of genes

9

9

4

5

24

3

M27891

√

√

√

√

√

√

M84526

√

√

√

√

√

√

M96326

√

√

√

√

√

√

X17042

√

√

√

√

√

U50136

√

√

√

√

U46751

√

√

√

X95735

√

√

√

M28130

√

√

√

Y00787

√

√

√

L08246

√

L16896

√

M11147

√

M16038

√

M19507

√

M55150

√

M57710

√

M62762

√

M63138

√

M69043

√

Y12670

√

X85116

√
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J03801

√

M19045

√

X14008

√

Table 7-25 Summary of the sets of selected features obtained from NSCM-GA, NSCPGA, NSCMD-GA and NSC-GA for Lymphoma data

Gene
accession
number

Proposed approaches

NSC-GA
(Euclidean dist.)

NSCM-GA

NSCP-GA

NSCMD-GA

Number of genes

Number of genes

12

7

3

3

GENE3327X √

√

√

√

GENE3329X √

√

√

√

GENE3361X √

√

√

√

GENE3332X √

√

GENE3330X √

√

GENE3258X √

√

GENE3256X √

√

The list of 80
genes is shown in
Table 7-26

GENE3328X √
GENE3314X √
GENE3260X √
GENE1252X √
GENE3967X √
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Table 7-26 List of 80 genes in the selected set obtained from NSCP-GA for Lymphoma
data
Gene accession numbers
GENE3940
X
GENE3941
X
GENE3939
X
GENE3946
X
GENE3945
X
GENE3947
X
GENE3699
X
GENE3755
X
GENE3556
X
GENE3555
X

GENE3554
X
GENE2496
X
GENE2326
X
GENE2106
X
GENE2066
X
GENE2065
X
GENE3290
X
GENE3347
X
GENE3346
X
GENE3315
X

GENE3325
X
GENE3326
X
GENE3327
X
GENE3328
X
GENE3329
X
GENE3330
X
GENE3331
X
GENE3332
X
GENE3334
X
GENE3335
X

GENE3338
X
GENE3341
X
GENE3314
X
GENE3312
X
GENE3311
X
GENE3309
X
GENE3361
X
GENE3258
X
GENE3257
X
GENE3260
X

GENE3259
X
GENE3256
X
GENE3261
X
GENE3263
X
GENE3264
X
GENE3265
X
GENE3246
X
GENE2760
X
GENE3025
X
GENE1211
X

GENE1212
X
GENE1213
X
GENE1251
X
GENE1252
X
GENE1174
X
GENE1159
X
GENE3988
X
GENE3987
X
GENE3986
X
GENE3965
X

GENE3966
X
GENE3967
X
GENE3968
X
GENE947X
GENE3932
X
GENE3617
X
GENE3815
X
GENE384X
GENE1609
X
GENE1616
X

GENE1693
X
GENE1694
X
GENE1697
X
GENE1719
X
GENE1720
X
GENE3839
X
GENE1349
X
GENE1171
X
GENE1080
X
GENE1556
X

Table 7-27 Summary of the sets of selected features obtained from NSCM-GA, NSCPGA, NSCMD-GA and NSC-GA for Lung data
Proposed approaches

NSC-GA

Gene

(Euclidean dist.)

accession

NSCM-GA

NSCP-GA

NSCMD-GA

Number of genes

Number of genes

11

9

11

4

5

7

2

33328_at

√

√

√

√

√

√

√

40936_at

√

√

√

√

√

√

√

34320_at

√

√

√

√

√

√

32551_at

√

√

√

√

√

√

37157_at

√

√

√

√

√

36533_at

√

√

√

√

37954_at

√

√

√

√

37716_at

√

√

√

33833_at

√

√

√

33327_at

√

√

35823_at

√

√

number
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Table 7-28 Summary of the sets of selected features obtained from NSCM-GA, NSCPGA, NSCMD-GA and NSC-GA for Ovarian data
Proposed approaches

NSC-GA
Gene

(Euclidean dist.)

accession

Number of

number

Peptides

NSCM-GA

NSCP-GA

NSCMD-GA

Number of Peptides

7

1

2

8

9

10

10

11

20

MZ244.36855

√

√

√

√

√

√

√

√

√

MZ244.66041

√

√

√

√

√

√

√

√

MZ244.95245

√

√

√

√

√

√

√

Z245.24466

√

√

√

√

√

√

√

MZ245.8296

√

√

√

√

√

√

√

MZ245.53704

√

√

√

√

√

√

√

MZ246.12233

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

√

MZ246.41524
MZ25.589892
MZ25.49556
MZ25.684398
MZ28.600577

√

MZ220.47402

√

MZ28.700483

√

MZ220.75125

√

MZ29.001246

√

MZ246.70832

√

MZ463.55767

√

MZ463.95962

√

MZ464.36174

√
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Table 7-29 Summary of the sets of selected features obtained from NSCM-GA, NSCPGA, NSCMD-GA and NSC-GA for Prostate data
Proposed approaches

NSC-GA
Gene
Accession

(Euclidean dist.)

NSCM-GA

NSCP-GA

NSCMD-GA

Number of genes

Number of genes

6

17

5

5

41468_at

√

√

√

√

37639_at

√

√

√

√

38406_f_at

√

√

√

√

769_s_at

√

√

√

√

556_s_at

√

√

√

√

31444_s_at

√

√

number

31527_at

√

33614_at

√

39756_g_at

√

40435_at

√

40436_g_at

√

36587_at

√

36666_at

√

37720_at

√

216_at

√

38429_at

√

40282_s_at

√

Table 7-30 shows a summary of classification results associated with using the different
sets of features, obtained from NSC-GA, NSCM-GA, NSCP-GA and NSCMD-P on the
AD, Colon, Leukemia, Lymphoma, Lung, Ovarian and Prostate cancer data, on the
corresponding unseen test dataset.
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Table 7-30 Summary of classification results for the respective unseen test datasets
using the corresponding feature sets obtained using NSC-GA, NSCM-GA, NSCP-GA
and NSCMD-GA for each of the seven datasets

Dataset

Proposed approaches

NSC-GA
(Euclidean dist.)

NSCM-GA

NSCP-GA

NSCMD-GA

No of Test
features (%)

No of Test
features (%)

No of Test
features (%)

No of Test
features (%)

AD

11

90.21

18

97.82

9

92.39

4

91.3

Colon

28
6

100

7

93.54

100

12

100

Leukemia

9

97.05

9

94.12

94.12

3

94.12

95.45
95.45
100
100
100

3

100

100

3

100

100

9
11

98.88

4
5
7

100

2

63.33

96.85
96.06
96.06
96.06

10
11
20

92.12
92.12
88.97

90.2

5

94.12

7
12
lymphoma 128
129
132
8
9
Lung
10
11

6
42
4
5
24
72
73
75
77
80

Ovarian

7

96.06

1

96.06

2
8
9
10

Prostate

6

90.2

17

100

5

As seen in Table 7-30, the columns of “No of features” list the number of selected
features using the different approaches, NSC-GA, NSCM-GA, NSCP-GA and NSCMDGA, with the smaller set being a subset of the larger set of features for the
corresponding dataset. Also seen from the table, for AD data, NSCM-GA approach was
the best in terms of achieving the highest classification accuracy, 97.82%, on unseen
test data compared with NSC-GA, NSCP-GA and NSCMD-GA. However, NSCMD-GA
approach selected a smallest set of features, 4, and classification accuracy of 91.3%, that
was higher than the NSC-GA approach and compatible with the NSCP-GA approach;
for Colon data, NSCP-GA outperformed the other approaches in terms of selecting a
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smallest set of relevant features, 6, with highest classification accuracy of 100%; for
Leukemia data, NSCMD-GA selected a smallest set of relevant features, 3, and still
retained the same classification accuracy of 94.12% as of NSCM-GA and NSCP-GA
using 13, 9 and 5 features respectively, and was compatible with NSC-GA of 97.05
using 9 features. It can be stated that NSCMD-GA approach is able to select a smallest
set of features and still retain compatible classification accuracy compared to the other
approaches for AD and Leukemia data; for Lymphoma data, NSCM-GA and NSCMDGA outperformed the other approaches for both in selecting a smallest feature set, 3,
with the highest classification accuracy of 100%; for Lung and Ovarian data, NSCP-GA
showed its best in overall for selecting small set of 4 and 2 features with the highest
classification accuracy of 100% and 96.85%, respectively; and for Prostate data, NSC MGA selected the larger set of 17 features with the highest classification accuracy of
100%, NSCMD-GA outperformed NSC-GA and NSCP-GA for selecting a smallest set of
5 features with higher classification accuracy of 94.12%.
Again, these results showed that the developed techniques support a comprehensive
analysis, providing a number of multi-variate signatures for each dataset, each with a
varying number of features. Biomedical researchers can make informed decision based
on the tradeoffs between classification accuracy and size of feature sets as well as use
domain knowledge to decide on the potential relevance of features in the different
signatures. An important aspect of the smaller sets being subsets of the larger set also
provides some information about the possible correlations/interactions amongst the
features and the joint behaviour of these features.
7.3. Summary
This chapter has described the proposed approach of implementing different similarity
distance measures in the NSC classifier and incorporating NSC and GA to
automatically search for optimal shrinkage threshold values for NSC. The approach
used the modified NSC classifier with different distance measure as an evaluator to
evaluate the fitness of the candidate shrinkage threshold values, utilized the GA as a
search algorithm to search for optimal shrinkage threshold values, and obtained the sets
of relevant features. The results obtained shows that the new approaches, NSCM-GA,
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NSCP-GA and NSCMD-GA, are able to select smaller set of features and improve
classification accuracy compared to the NSC classifier using Euclidean distance.
In the next chapter, the proposed approach of using a multi-objective algorithm to
incorporate into the NSC algorithm for searching multiple optimal solutions will be
described in details.
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8. Incorporating Nearest shrunken centroid and multi-objective
evolutionary algorithm for searching multiple shrinkage threshold
solutions
8.1. Introduction
In Chapter 5, the approach of incorporating NSC into GA (NSC-GA) was proposed for
finding an optimal shrinkage threshold for NSC automatically (Dang et al., 2013). In
NSC-GA, the approach of aggregating 2 objective functions as a single objective was
implemented for measuring the fitness of chromosomes. In order to optimize a multiobjective problem more effectively and to obtain multiple optimal solutions in a single
run, an approach involving MOEA is developed in this study. The non-dominated
sorting algorithm (NSGA2) algorithm (Deb et al., 2002) is an example of an MOEA
that has been used in bioinformatics. For example, Deb, et al. (2002), Deb and Reddy
(2003), Mitra and Banka (2006), and Banerjee, Mitra and Banka (2007) employed the
NSGA2 algorithm to produce multiple feature sets for Colon, Lymphoma and Leukemia
cancer dataset in their studies. One of the advantages of using MOEAs is its ability to
evaluate multiple objectives simultaneously in order to find optimal solutions showing
good tradeoffs between all objective functions (Deb et al., 2002). For example, Deb and
Reddy (2003) employed NSGA2 to analyse the Leukemia cancer dataset and obtained
352 different three-gene sets that gave 100% classification accuracy.
Motivated by 1) the effectiveness of MOEA (NSGA2) in its potential to find multiple
solutions, 2) the NSC algorithm in FS and classification, and 3) the automated shrinkage
threshold optimization in NSC-GA, a hybrid approach incorporating NSGA2 (Deb et
al., 2002) and NSC algorithm (Tibshirani et al., 2002) is proposed in this chapter to
automatically find the Pareto front associated with optimal shrinkage threshold values
for the NSC. These optimal shrinkage threshold values mapped to potential sets of
relevant features for classification. The aim of this study is to see the impact of
incorporating a MOEA with NSC with the use of multiple objective functions to
evaluate the fitness of chromosomes in the task for obtaining multiple shrinkage
threshold solutions. This chapter is an extended version of the paper “NSC-NSGA2:
Optimal Search for Finding Multiple Thresholds for Nearest Shrunken Centroid” (Dang
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& Lam, 2013). The proposed approach uses NSC as a fitness evaluator in NSGA2 to
measure the goodness of feature sets and NSGA2 optimizes the search for multiple
solutions. Unlike NSC-GA, where the shrinkage threshold value is selected on the basis
of a single objective function which is an aggregation of 2 objective functions, the
proposed approach, NSC-NSGA2, supports finding optimal shrinkage threshold values
while considering different tradeoffs by simultaneously considering multiple objective
functions. The proposed approach is evaluated using the evaluation strategy and the 7
biomedical datasets described in Chapter 3.
Section 8.2, describes the proposed approach, NSC-NSGA2, with evaluation results in
Section 8.3, details and results for NSC-NSGA2 using 3 objective functions are
described in Section 8.4. Section 8.5 describes the investigation of using Mahalanobis
distance in NSC-NSGA2 and followed by the summary in Section 8.6.
8.2. The proposed approach, NSC-NSGA2
Figure 8-1 illustrates the framework of the proposed approach, NSC-NSGA2. There are
2 main steps consisting of:
Step 1: This step carries out the procedure for automatic calculation of Thmax. This
procedure is performed once only at the beginning of NSC-NSGA2.
Step 2: NSGA2 is employed in this step to search for multiple optimal sets of shrinkage
thresholds for NSC algorithm. The NSC algorithm is employed as a fitness evaluator to
evaluate the fitness of each chromosome in terms of the number of features selected and
its training classification accuracy.
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Training dataset
(1)

Thmax calculation

Thmax
NSGA2
Initialization (Pi)
Shrinkage thresholds
Shrinkage thresholds
Fitness evaluation

Selection

NSC classifier
(Fitness evaluator)

svalues
Features selected (f1)
Classification accuracy (f2)

Mutation

Offspring
population (Po)

Population
combination
(Pu = Pi + Po)
Non-dominated
sorting Pu

Fronts

Crowding
distance
sorting

Population
of Fronts
Max
generations?

Yes

Pareto front
Figure 8-1 Framework of the proposed approach, NSC-NSGA2
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8.2.1. Issues related to the proposed approach, NSC-NSGA2
Chromosomes encoding and fitness evaluation are similar to those used in NSC-GA.
The same procedure for estimation of the initial range of values for the shrinkage
threshold described in Section 5.2.1 is also used in NSC-NSGA2. The following section
describes the issues associated with encoding chromosomes and fitness evaluation.
8.2.1.1. Encoding chromosomes
The aim of the proposed approach is to use a MOEA, specifically NSGA2 to find a
Pareto front consisting of multiple shrinkage threshold values that are real numbers for
NSC. Similar to the NSC-GA, the most appropriate encoding representation for
chromosomes in this study would also be a real-encoding. But unlike the NSC-GA
approach in which, each chromosome consists of a number of genes (shrinkage
thresholds), in NSC-NSGA2, each chromosome consists of a single gene only,
representing one shrinkage threshold value.
8.2.1.2. Fitness evaluation using NSC as a fitness evaluator
The NSC algorithm is also employed as a fitness evaluator in the NSC-NSGA2
approach for evaluating the fitness of the chromosomes using the training dataset. The
NSC algorithm uses shrinkage threshold values to perform FS and classification. As a
result, each shrinkage threshold (chromosome) is associated with a set of features and
classification accuracy. To investigate the impact of the approach to using more than 2
objective function, two versions: NSC-NSGA2 and NSC-NSGA2* were implemented
involving two and three objective functions respectively. The first two objective
functions (f1 and f2) have been described in Section 5.3.2.2 and the third objective
function (f3) is defined in Equation 8.6.
The basic concepts of NSC algorithm (Tibshirani et al., 2002) has been reviewed in
Section 2.3.3. The following sections describe the steps associated with the proposed
approach, NSC-NSGA2. The parameters used to run NSC-NSGA2 are also described in
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Table 8-1.
8.2.2. Steps of the proposed approach, NSC-NSGA2
8.2.2.1.

Step 1: Thmax calculation

The same procedure for calculating Thmax described in Section 5.2.2.1 is employed here
to find the Thmax value (upper bound shrinkage threshold value) for the respective
dataset.
8.2.2.2. Step 2: Multi-objective evolutionary algorithm search optimization
The study uses NSGA2 and NSC to automatically obtain multiple optimized shrinkage
threshold values for finding relevant features for classification. The following section
describes Pareto-based MOEA in general and NSGA2 specifically.
The concept of Pareto optimality and dominance as defined by Coello and Lamont
(2004), Ayala and Coelho (2008), and Fonseca and Fleming (1995) is:
X is a Pareto optimal if and only if F( ) = (fi ( ),.., fk ( )) is not dominated by F( )
= (f1 ( ),.., fk ( )) where

X. A solution

1

dominates

2

if and only if f ( 1) less

than or equal f ( 2), which means:
∀i {1..k}, fi ( 1) ≤ fi ( 2) ⋀ ∃i
if no other solutions dominate

1,

{1..k} : fi ( 1) < fi ( 2)
then

1

is non-dominated. Thus the Pareto front is the

set of non-dominated solutions.
Figure 8-2 illustrates the Pareto front with a set of solutions.
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f2
Pareto front solutions
Dominated solutions

f1

Figure 8-2 Pareto front solutions
According to Ayala and Coelho (2008), a good solution obtained from MOEA must be
very close to the Pareto front and is also wide spread. In order to achieve this desire
solution, MOEA first needs to find a solution set that is close to the Pareto front as
possible and then search through the Pareto front to obtain a set of solution which is
more diverse than the other solution sets in the Front.
MOEA selects non-dominated solutions (Pareto front) based on the Pareto ranking. The
population is sorted according to Pareto dominance of individuals, and then all the nondominated individuals are given the same rank which is a higher rank than the
dominated individuals. The same rank is given for all non-dominated individuals so that
they would have the equal probability of being chosen to reproduce offspring.
According to Coello and Lamont (2004), the diversity of the Pareto front is maintained
by different strategies such as fitness sharing and niching, clustering, and use of
entropy. The use of elitist schemes is very popular in MOEA in recent years. With this
elitist approach, a second population is used along with the main population to store the
non-dominated solutions found during the evolutionary process. It is also used to
improve the diversity of the solutions and to adjust the selection rate of the algorithm
(Coello & Lamont, 2004). Another approach of using this elitist approach is to combine
the parent population and its offspring population into a single population as in NSGA2
(Deb et al., 2002) to maintain the elitist solutions (Coello & Lamont, 2004). The
following section describes steps involving NSGA2 in the proposed approach.
NSGA2 incorporates the concept of Pareto front into MOEA (Deb et al., 2002) which
was developed based on NSGA (N. Srinivas & Kalyanmoy, 1994). NSGA2 is an
improved version of NSGA in terms of less computational time, incorporating elitism to
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improve the performance of the algorithm and avoid losing good solutions, and not
using a sharing parameter provided by the user (Deb et al., 2002). The following figure
illustrates the framework of NSGA2 with the major phases.

Figure 8-3 Major steps of NSGA2 adapted from Deb et al. (2002)
a)

Population initialization

After the chromosome representation has been determined and the Thmax value has also
been calculated, a population of chromosomes is then initialized. Each chromosome
(shrinkage threshold value) is initialized to a real value generated randomly in the range
[0, Thmax] using RNG. Figure 8-4 describes the procedure used to initialize the
population and Figure 8-5 shows an example of an initial population.

Input:
Thmax
Size of population, p
Output:
An initialized population of p chromosomes
Steps:
1. Set population (Ip) as 1dimensional array of size p of real numbers
2. Set Ip = { }
3. For counter from 1 to p
a. Generate a real random number (Rn) in the range [1, Thmax] using a
RNG
b. Store Rn to Ip[counter]
Figure 8-4 Initial population algorithm using RNG
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Gene (shrinkage threshold)

Chromosomes

1.153
2.969
1.176
1.932
0.702
1.337
0.247
2.438
0.001
1.872

Associated feature sets
25
1
24
14
45
16
87
4
150
15

Figure 8-5 An example of an initial population with 10 chromosomes with shrinkage
threshold values and the number of features in their corresponding sets
As seen in the example in Figure 8-5, each chromosome consists of only one shrinkage
threshold value which has been initialized to be in the range between 0 and Thmax, that
is [0, 3], Each shrinkage threshold value is associated with a set of features, for
example, shrinkage threshold value of 1.153 resulted in a set of the most relevant 25
features and a value of 0.001 resulted in a set of the entire initial 150 features
(highlighted row 1 and 9, respectively). Once the initial population has been initialized,
the next step is to evaluate the fitness of chromosomes in the population.
b) Fitness evaluation in NSC-NSGA2
In this step, two sub-steps are carried out: firstly, the fitness for each chromosome in the
population is calculated using two objective functions: f1 and f2 (or three objective
functions in the case of NSC-NSGA2*), and secondly, chromosomes in the population
are sorted using the non-dominated sorting algorithm (Deb et al., 2002) shown in Figure
8-8.
The NSC algorithm described in Section 2.3.3 is employed here as a fitness evaluator to
determine the fitness of the chromosomes associated with a training dataset. To obtain
the fitness of the chromosome, firstly, the chromosome (shrinkage threshold) value is
used in the NSC algorithm to obtain the corresponding set of features and secondly, this
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set of features is then used to construct a classifier that is used to classify the training
data. The set of features and its classification result are then used in the calculation of
the fitness of the chromosome. The two objective functions (f1 and f2) have been
described in Section 5.3.2.2 and are shown as follows.
f1 = (Ntotal - Natt) / Ntotal

(8.1)

(8.2)

Objective function f1 is designed for maximizing the fitness of chromosomes (solutions)
that has a minimum number of features, i.e., the smaller the number of features selected
the better the fitness for the chromosome, f2 is designed for maximizing the fitness of
chromosomes that has highest training classification accuracy, i.e., the higher the
training classification accuracy the better the fitness for the chromosome.
c)

Selection and mutation operators

Selection and mutation operators for real encodings are used in NSC-NSGA2. The
crowded tournament selection is employed in NSGA2 for chromosome selection. The
crowded tournament selection is a binary tournament selection with different selection
criteria based on the rank and crowding distance of the chromosomes. That is, two
chromosomes are selected randomly from the population to form a tournament group
(i.e. the size of tournament group is two for a binary tournament) and the best
chromosome of the group is selected based on the fitness ranked by the non-dominated
sorting procedure (Deb et al., 2002; Suzuki et al., 1995). In the case of two
chromosomes with different ranks then choose the one with a better rank. Otherwise, if
the two chromosomes have the same rank, then the crowding distance algorithm is
employed to calculate the crowding distance of the chromosomes and the chromosome
with a smaller crowding distance is chosen (Deb et al., 2002; Suzuki et al., 1995).
Tournament selection has been described in Section 2.4.4.2, the crowded tournament
selection and the crowding distance algorithm (Deb et al., 2002) are described in Figure
8-6 and Figure 8-7, respectively.
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Input:
Population front (P)
Population ranks (Prank)
Output:
Best chromosome (Cbest)
Steps:
1. Set k = size of binary tournament = 2
2. For counter from 1 to k
 Select a chromosome (C1) randomly from P
 Select a chromosome (C2) randomly from P
3. Compare the rank of C1 and C2 using Prank
i. If rank of C1 = rank of C2
 Perform crowding distance algorithm


Select the chromosome (Cbest) with a smaller crowding distance

ii. Else
 Select a chromosome (Cbest) with the best rank
Figure 8-6 Crowded tournament selection algorithm used in Deb et al. (2002)

Input:
Population (P)
Objective functions f [f1..fn]
Number of objective functions (Nf)
Output:
Individual crowding distance
Steps:
1. For each n individual in P
Initialize Individual distance (Id) = 0
2. For counter from 1 to Nf
a. Sort P based on f
b. Set Id1 = Idn ∞
3. For counter = 2 to (n -1)
Idi = Idi+ ((I(i+1).m - I(i-1).m)/ ∫
-∫
(where I(i).m = value of mth objective function of the kth
individual in i)
Figure 8-7 Crowding distance algorithm used in Deb et al. (2002)
Note that in Step 2b, the two boundary solutions, i.e., solutions with smallest and largest
objective function values, are assigned a value of infinite distance (∞) so that the
boundary solutions are always selected. Step 3 in Figure 8-7 is used to calculate the
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Euclidean distance for the remaining solutions, i.e., solutions between the boundary
solutions.
Gaussian distribution probability is employed as the mutation operator to modify the
value of a gene in a chromosome.

When mutating a single real value, Gaussian

probability distribution function is first used to get a number and then adding it to the
value being mutated to produce a new number (Hedvat et al., 2003). The calculation of
probability distribution,
mutation value,

, for a value

is defined by Equation (8.3) and the

, is calculated by Equation (8.4).

(

√

(

)

)

(8.3)

(8.4)
where

is a value of the gene (threshold), σ is a standard deviation, μ is a mean of the

value.
σ 1 and μ 0 when mutating a chromosome with only one gene value, hence Equation
(8.3) can be rewritten using Equation (8.5).
(

√

)

(

)

(8.5)

d) Offspring population (Po) generation
The new offspring produced from one cycle consisting of the selection and mutation
process are then placed into the offspring population. The process of creating new
offspring via the cycle consisting of the selection and mutation process is repeated until
the population for new offspring of size N (the same size of parent population size) is
obtained.
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e)

Union (combination) of two populations (Pi and Po)

Two populations (in the same generation), the first being the parent population (Pi) of
size N and the second being the offspring population (Po) also of the size N, are then
combined to make a larger population of size 2N, Pu.
f) Rank the individuals in the combined population, Pu, using the non-dominated
sorting algorithm (Figure 8-8). All the best chromosomes of rank #1 are placed in Front
#1, all the next best chromosomes of rank #2 are placed in Front #2, etc., and when the
sorting algorithm has found a sufficient number of fronts having a specified number of
chromosomes for the new population, it stops the sorting process (Deb et al., 2002).
For each individual p in population P
Initialise Sp =
np =0
For each individual q in population P
If p dominates q then
Add q to Sp
Else if q dominates p then
np = np+1
if np=0
prank =1
add p to Front1
Set Front counter i =1
While Fronti ≠
Set Q =
For each p in Fronti
For each q in Sp
nq = nq-1
if nq =0
qrank = i+1
add q to Q
i = i+1
set Fronti = Q
Figure 8-8 Non-dominated sorting procedure used in Deb et al. (2002)
g) Generate a new population (Pi+1) of size N
After the ranked chromosomes in Pu were sorted into Fronts on the basis of their
respective ranks, a new population (Pi+1) of size N is then created by populating it,
starting with chromosomes from the front with the highest rank. The process continues
to incorporate chromosomes, taken from a descending order of ranked fronts. In the
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event that there are more chromosomes in the ultimate Front to be included for
completing a population of size N, chromosomes in this front are sorted using the
crowding distance procedure first and the remaining slots in the population are then
filled with the required number of “best chromosomes” from this front. Figure 8-9
showed the steps involved in generating the new population.
Non-dominated

Combined population (2N)

sorting
Front 1 …. Front ith

Population front of
size 2 N
Front1
:
:
:
:
Front ith
Front ith +1
:
:
:
Front xn

New population of
size N

Selected
Highest ranked

chromosomes

fronts

Crowding
distance sorting

Figure 8-9 Steps for generating the new population from the combined population
h) Repeat the process
The new population Pi+1 undergoes the next iteration consisting of all steps described
above, i.e., from fitness evaluation to the step for generation of a new population. These
iterations of steps are repeated until the termination condition is satisfied (i.e. the
predefined maximum number of generations has been executed). A Pareto front is the
output. The following figure shows an example of a Pareto front of shrinkage threshold
solutions with their associated objective function values.
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Pareto front

2.855559333844611
1.2154637472872774
2.194804507510737
2.0993206348249376
1.5086645962070784
1.3642342000485415
1.7379179051564781
1.6187309914352315
1.868299886752155

Objective fitness
f1

f2

0.9916666666666667
0.8416666666666667
0.9666666666666667
0.9583333333333334
0.9083333333333333
0.8666666666666667
0.9333333333333333
0.9166666666666666
0.95

0.6626506024096386
0.9036144578313254
0.7228915662650602
0.7951807228915662
0.8674698795180723
0.8795180722891566
0.8192771084337349
0.8554216867469878
0.8072289156626506

Figure 8-10 An example of Pareto front of 9 shrinkage threshold solutions
Figure 8-10 shows an example of a Pareto front consisting of 9 shrinkage threshold
value solutions listed in the “Pareto front” column with their associated objective
function of f1 and f2 listed in the last 2 columns (Objective fitness column). For example
for the 1st shrinkage threshold value, 2.8555 (highlighted) in the shrinkage threshold
value column having associated f1=0.9916 and f2=0.6626 (highlighted) in the objective
fitness column.
8.2.3. Parameter settings for NSGA2
According to Deb et al. (2002), the mutation rate used in their study was based on 1/n
where n is the number of attributes. In this study, since the chromosome has only one
attribute (shrinkage threshold value), the algorithm relies solely on a mutation operator
to generate new offspring. To adapt to this situation the mutation rate of 1/n is used
where n is the population size (Goldberg, 1989). The algorithm was executed with the
population size of 100, and mutation rate of 0.01, i.e., 1/100. The complete set of
parameter settings used in this study is shown in Table 8-1. As each chromosome
consists of a single gene, crossover operations are not applicable.
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Table 8-1 Parameter set used for NSC-NSGA2
Parameters

Values / Methods

Population Size

100

Chromosome Length

1

-

Real encoding

Mutation Probability

1 / Population size = 0.01

Generation

1000

Selection

Crowded tournament

Mutation

Gaussian probability distribution

8.3. Experiment results
Experiments were carried out to evaluate the proposed approach, NSC-NSGA2, in
terms of obtaining the Pareto front of shrinkage threshold values associated with the
NSC for the datasets described in Section 3.1. For each of the 7 datasets, 15
independent runs of the proposed approach were executed using the respective training
data. For each run, a stratified 10 fold CV described in Section 3.2 was employed. Each
shrinkage threshold solution on the Pareto front obtained from each run is used as input
to the NSC algorithm to obtain its corresponding feature set. This feature set was then
used to construct the corresponding NSC classifier to classify the unseen test data
associated with the dataset. Where appropriate, the comparison of the performance of
the proposed algorithm with existing work is based on classification accuracy and the
selected feature sets.
Two common characteristics are applicable across the results from the evaluation of the
approach using each of the seven datasets. These are:


The classification results using each of the NSC classifiers on the respective
unseen test dataset from each run are first recorded and the reported
classification accuracy in the tables was an average of classification accuracy of
these classifiers over the 15 independent runs.



In terms of the selected feature sets that were obtained as part of the evaluation,
the smaller feature set is a subset of the larger feature set. For example, in Table
235

8-2, the set with 18 features is the subset of the set with 19 features and
similarly, the set with one feature is both a subset of the set of 18 as well as the
set of 19 features.
8.3.1. Ray et al. AD data
The proposed algorithm, NSC-NSGA2, was executed 15 times with 10 fold CV on AD
dataset using the NSGA2 parameter setting listed in Table 8-1. The results obtained
from the 15 independent runs consists of 8 runs where their Pareto fronts has 10
shrinkage thresholds, 3 runs with Pareto fronts of 9 shrinkage thresholds, 3 runs with
Pareto fronts of 8 shrinkage thresholds, and 1 run with Pareto fronts of 7 shrinkage
thresholds. Using these shrinkage thresholds led to selected sets of features consisting of
1, 4, 5, 6, 7, 8, 9, 10, 11, 15, 16, 17, 18 and 19 features. The convergence plot with a
typical Pareto optimal front from one of the 15 runs is shown in Figure 8-11 and the
NSC classification results using each of these sets of features on the unseen test dataset
are shown in Table 8-3.

0.95
f2

0.9
0.85
0.8
0.75
0.7
0.65
0.6
0.8

0.85

0.9
Pareto front

0.95

1
f1

Figure 8-11 A typical Pareto front plot of objective function f1 against f2 for AD dataset
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As seen in Table 8-2, the proposed approach found a set of 18 and 19 features which are
the same set of 18 and 19 features found in (Ray et al., 2007). The approach also found
the same set of 11 features reported in Chapter 5 using the NSC-GA approach.
Table 8-2 Sets of selected proteins using the proposed approach, NSC-NSGA2, for AD
data
Proteins

Protein sets
19

18

17

16

15

11

10

9

8

7

6

5

4

1

PDGF-BB_1

√

√

√

√

√

√

√

√

√

√

√

√

√

√

RANTES_1

√

√

√

√

√

√

√

√

√

√

√

√

√

IL-1a_1

√

√

√

√

√

√

√

√

√

√

√

√

√

TNF-a_1

√

√

√

√

√

√

√

√

√

√

√

√

√

EGF_1

√

√

√

√

√

√

√

√

√

√

√

√

M-CSF_1

√

√

√

√

√

√

√

√

√

√

√

ICAM-1_1

√

√

√

√

√

√

√

√

√

√

IL-3_1

√

√

√

√

√

√

√

√

√

IL-11_1

√

√

√

√

√

√

√

√

GCSF_1

√

√

√

√

√

√

√

ANG-2_1

√

√

√

√

√

√

PARC_1

√

√

√

√

√

GDNF_1

√

√

√

√

√

TRAIL R4_1

√

√

√

√

√

IL-8_1

√

√

√

√

√

MIP-1d_1

√

√

√

√

IGFBP-6_1

√

√

√

MCP-3_1

√

√

MDC_1

√
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Table 8-3 Classification results for the AD data using the sets of selected features from
NSC-NSGA2 approach
Number of proteins

Average classification Accuracy (%)
(Unseen Test data)

1

56.98

4

72.82

5

76

6, 7

81.52

9

82.6

8

82.78

10

83.4

11

87.7

17

91.3

16

91.63

15

92.39

18

93.84

19

94.56

From the results it can also be seen that NSC-NSGA2 produced a number of potential
feature sets that demonstrates the tradeoffs between the numbers of selected features
and the classification accuracy for the unseen test data. For example, the smallest
feature set (with 1 feature), the resulting classifier has the lowest classification accuracy
for the unseen test data (56.98%), whilst the largest feature set (19 features) the
resulting classifier has the highest test classification accuracy (94.56%) on the unseen
test data. This type of analysis provides more information than univariate statistics and
biomedical researchers can use it to gain a better understanding of the possible
correlations amongst the features as well as the joint behaviour of features in their
datasets.
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8.3.2. Alon et al. Colon cancer data

f2

0.95
0.9
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0.8
0.75
0.7
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0.97

0.98

Pareto front

0.99

1
f1

Figure 8-12 A typical Pareto front plot of objective function f1 against f2 for the Colon
cancer dataset
Using the same experimental procedure described above, the proposed algorithm is
evaluated using the Colon dataset. A typical convergence plot with a Pareto optimal
front consisting of 7 solutions is shown in Figure 8-12. NSC-NSGA2 found optimal
shrinkage threshold values from the 15 independent runs that consist of 8 runs with a
Pareto front of 5 shrinkage thresholds, 4 runs with a Pareto front of 6 shrinkage
thresholds, 2 runs with a Pareto front of 4 shrinkage thresholds and 1 run with a Pareto
front of 7 shrinkage thresholds. Using these shrinkage thresholds led to selected sets of
features consisting 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 21, 23, 38, 39, 40, 42, 43, 44, 45, 47, 48,
61, 62, 77, 83, 85, 87, 89 and 92 features (genes). Classification results associated with
classifiers constructed from these sets of selected features are shown in Table 8-4. An
interesting point here is that classifiers constructed using feature sets that are supersets
of the set of 23 features all performed worse than those classifiers constructed from
feature sets that are subsets of the set of 23 features. The set of 9 genes includes known
biomarkers associated with Colon cancer from the literature. These are M76378,
J02854, M63391, Z50753, T71025, R87126, U25138, M82919 and T92451
(highlighted genes in Table 8-4). Note that Table 8-4 lists only the sets that have up to
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23 genes but the evaluation has been done for all sets of features obtained using NSCNSGA2 and shown in Table 8-5.
Table 8-4 Sets of genes selected using the proposed approach, NSC-NSGA2 for Colon
cancer data
Gene accession number

Gene sets
23 21

10

9

8

7

6

5

4

3

2

1

M76378

√

√

√

√

√

√

√

√

√

√

√

√

J02854

√

√

√

√

√

√

√

√

√

√

√

M63391

√

√

√

√

√

√

√

√

√

√

Z50753

√

√

√

√

√

√

√

√

√

T71025

√

√

√

√

√

√

√

√

R87126

√

√

√

√

√

√

√

U25138

√

√

√

√

√

√

M82919

√

√

√

√

√

T92451

√

√

√

√

M76378

√

√

√

Z24727

√

√

M76378

√

√

T56604

√

√

H43887

√

√

R36977

√

√

X86693

√

√

X63629

√

√

M36634

√

√

T67077

√

√

H06524

√

√

T60778

√

√

H67764

√

X12671

√

240

Table 8-5 Classification results for the Colon cancer data using the sets of selected
features from NSC-NSGA2 approach
Number of genes

Average classification Accuracy (%)
(Unseen Test data)

61 , 87, 62, 86

62.5

77, 83, 85, 92, 89

68.75

38 , 48

81.25

39, 40, 42, 43, 44, 45, 47

87.5

1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 21, 23

93.75

8.3.3.

Leukemia cancer data

Using the same experimental procedure as before, the proposed algorithm was evaluated
using the Leukemia cancer dataset. A typical Pareto optimal front from one of the 15
independent runs is shown in Figure 8-13.

Figure 8-13 A typical plot of a Pareto front of objective function f1 against f2 for the
Leukemia cancer dataset
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The Shrinkage threshold solutions obtained from the 15 independent runs led to selected
sets of features consisting 2, 7, 9, 10, 11 and 13 features. The sets of 2, 7, 9, 10, 11 and
13 features are listed in Table 8-6. Five genes are associated with known Leukemia
biomarkers in the literature; namely M84526_at, U50136_mal_at, D49950_at,
M16038_at and X17042_at (highlighted genes in Table 8-6). Classifiers constructed
using the set with 2 and 13 genes produced the same average classification accuracy,
91.18%, on unseen test data, and classifiers constructed using the set of 7, 9, 10 and 11
genes produced the same average classification accuracy of 94.11%. The set of 13
genes having seven genes in common from the set of 9 genes reported in NSC-GA [7].
Table 8-6 Sets of genes selected using the proposed approach, NSC-NSGA2 for
Leukemia cancer data
Gene accession number

Gene sets
13 11 10 9

7

2

M84526_at

√

√

√

√

√

√

U50136_rna1_at

√

√

√

√

√

√

D49950_at

√

√

√

√

√

M16038_at

√

√

√

√

√

M23197_at

√

√

√

√

√

X17042_at

√

√

√

√

√

X95735_at

√

√

√

√

√

M55150_at

√

√

√

√

M57710_at

√

√

√

√

Y00787_s_at

√

√

√

M27891_at

√

√

U82759_at

√

M28130_rna1_s_at

√
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Table 8-7 Classification results for the Leukemia cancer data using the sets of selected
features from NSC-NSGA2 approach
Average classification Accuracy (%)

Number of genes

(Unseen Test data)

2, 13

91.18

7, 9, 10, 11

94.12

8.3.4. Ovarian cancer data
Using the same experimental procedure as before, the proposed algorithm was evaluated
using the Ovarian cancer dataset. A typical convergence plot of Pareto optimal front
with 5 solutions is shown in Figure 8-14.

f2

0.995
0.99
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0.975
0.97
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0.9985

0.999

0.9995

Pareto front

1
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Figure 8-14 A typical Pareto front plot of f1 against f2 for Ovarian cancer dataset
The results obtained from the 15 independent runs consist of 8 runs, each with a Pareto
front of 5 shrinkage thresholds; 4 runs, each with a Pareto front of 3 shrinkage
thresholds and 3 runs, each with a Pareto front of 4 shrinkage thresholds. Using these
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shrinkage thresholds led to selected sets of features consisting 1, 5, 6, 7, 36, 37, 38, 207,
210, 212, 224, 227 and 230 features. The sets of 1, 5, 6, and 7 features are listed in
Table 8-8. Classifiers constructed using the sets with 1, 5 and 6 peptides produced the
same average classification accuracy, 96.85% , on the unseen test data, and the classifier
constructed using the set of 7 peptides gives 96.06%. The approach also found the same
set of 7 features reported in Chapter 5 using the NSC-GA approach, which is associated
with known ovarian peptide biomarkers in the literature.
Table 8-8 Subsets of genes selected using the proposed approach, NSC-NSGA2 for
Ovarian cancer data
Gene accession number

Gene sets
7

6

5

1

MZ245.24466

√

√

√

√

MZ244.66041

√

√

√

MZ244.95245

√

√

√

MZ245.53704

√

√

√

MZ245.8296

√

√

√

MZ244.36855

√

√

MZ246.12233

√

Table 8-9 Classification results for the Ovarian cancer data using the sets of selected
features from NSC-NSGA2 approach
Average classification accuracy (%) Overall
(Unseen Test data)

average
classification

Number of Genes
C1(Disease)

C2 (Normal)

accuracy (%)
(Unseen

Test

data)
207, 210, 212, 224, 227

88.89

91.3

89.76

230

90.06

91.3

90.55

7, 36, 37, 38

97.53

93.48

96.06

1 , 5, 6

97.65

95.65

96.85
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The column headings C1 and C2 in the table stand for average classification accuracy
(%) on the Ovarian unseen test dataset for the Disease class and Normal class,
respectively. The column heading “Overall average classification accuracy” stands for
the overall average classification (%) for both classes on the Ovarian unseen test dataset
for the 15 independent run. “Overall average classification accuracy” is calculated using
Equation (5.3). From Table 8-9, the NSC classification results associated with the sets
of features mostly showed similar levels of specificity and sensitivity, e.g., sensitivity
(C1) is 97.65% and specificity (C2) is 95.65%, implying truly not-at-risk and at-risk
cases will be correctly identified at a very high level of accuracy.
8.3.5. Lymphoma cancer data
Using the same experimental procedure as before, the proposed algorithm was evaluated
using the Lymphoma cancer dataset. A typical convergence plot of Pareto optimal front
with 4 solutions is shown in Figure 8-15.

1
0.98
0.96
0.94
f2

0.92
0.9
0.88
0.86
0.96

0.97

0.98

0.99

1

f1
Pareto front
Figure 8-15 A typical Pareto front plot of f1 against f2 for Lymphoma cancer dataset
The results obtained from the 15 independent runs consist of 14 runs, each with a Pareto
front of 4 shrinkage thresholds and 1 run with a Pareto front of 3 shrinkage thresholds.
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Using these shrinkage thresholds led to selected sets of features consisting 1, 2, 7, 8, 12,
128, 133, 134 137, 139, 140, 141, 146, 149 and 164 features. The sets of 1, 2, 7, 8 and
12 features are listed in Table 8-10. Classifiers constructed using the set with 1 feature
produced 68.18% average classification accuracy for the unseen test data, classifiers
obtained using the set with 2 features produced 77.72%, classifiers constructed using
the set with 7, 8 and 12 features produced the same average classification accuracy of
95.45%, and classifiers obtained using the set with 128, 133, 134, 137, 139, 140, 141,
146, 149 and 164 features produced 100% respectively. The approach also found the
same set of 7, 12 and 128 features reported in Chapter 5 using the NSC-GA approach.
Table 8-10 Subsets of genes selected using NSC-NSGA2 for Lymphoma cancer data
Gene sets

Gene accession number
12

8

7

2

1

GENE3361X

√

√

√

√

√

GENE3329X

√

√

√

√

GENE3327X

√

√

√

GENE3330X

√

√

√

GENE3332X

√

√

√

GENE3258X

√

√

√

GENE3256X

√

√

√

GENE3328X

√

√

GENE3314X

√

GENE3260X

√

GENE1252X

√

GENE3967X

√
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Table 8-11 Classification results for the Lymphoma cancer data using the sets of
selected features from NSC-NSGA2 approach
Average classification Accuracy (%)

Number of genes

(Unseen Test data)

1

68.18

2

72.73

7, 8, 12

95.45

128, 133, 134, 137, 139, 140,
141, 146, 149, 164, 173

100

8.3.6. Lung cancer data
Using the same experimental procedure as before, the proposed was evaluated using the
Lung cancer dataset. A typical convergence plot of Pareto optimal front with 3 solutions
is shown in Figure 8-16.
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Figure 8-16 A typical Pareto front plot of f1 against f2 for Lung cancer dataset
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The results obtained from the 15 independent runs consist of 14 runs, each with a Pareto
front of 3 shrinkage thresholds and 1 run with a Pareto front of 4 shrinkage thresholds.
Using these shrinkage thresholds led to selected sets of features consisting 1, 2, 3, 5, 8,
9 and 11 features. The sets of 1, 2, 3, 5, 8, 9 and 11 features are listed in Table 8-12.
Classifiers constructed using the set with 1 feature produced 93.63% average
classification accuracy for the unseen test data, classifiers obtained using the set with 2
features produced 94.62%, classifiers obtained using the set with 3 features produced
95.93%, and classifiers constructed using each of the sets with 5, 8, 9 and 11 features
respectively, produced 100% respectively. The approach also found the same set of 8, 9
and 11 features reported in Chapter 5 using the NSC-GA approach.
Table 8-12 Subsets of genes selected using the proposed approach, NSC-NSGA2 for
Lung cancer data
Gene accession number

Gene sets
11

9

8

5

3

2

1

40936_at

√

√

√

√

√

√

√

33328_at

√

√

√

√

√

√

32551_at

√

√

√

√

√

34320_at

√

√

√

√

37157_at

√

√

√

√

36533_at

√

√

√

37716_at

√

√

√

37954_at

√

√

√

33833_at

√

√

35823_at

√

33327_at

√
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Table 8-13 Classification results for the Lung cancer data using the sets of selected
features from NSC-NSGA2 approach
Number of genes

Average classification Accuracy (%)
(Unseen Test data)

1

93.63

2

94.62

3

95.93

5, 8, 9, 11

100

8.3.7.

Prostate cancer data

As mentioned previously in Section 3.1.6, the Prostate dataset consists of 12600
attributes, 77 Tumour (T) and 59 Normal (N) samples. The training set consisting of 52
T and 50N samples, and the unseen test set consisting of 25 T and 9 N samples.
Using the same experimental procedure as before, the proposed algorithm was evaluated
using the Prostate cancer dataset. A typical convergence plot of Pareto optimal front
with 4 solutions is shown in Figure 8-17.

Figure 8-17 A typical Pareto front plot of f1 against f2 for Prostate cancer dataset
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The results obtained from the 15 independent runs consist of 3 runs with a Pareto front
of 4 shrinkage thresholds, 4 runs with a Pareto front of 3 shrinkage thresholds and 8
runs with a Pareto front of 2 shrinkage thresholds. Using these shrinkage thresholds led
to selected sets of features consisting 1, 2, 3, 4, 5, 6 and 8 features. The sets of 1, 2, 3, 4,
5, 6 and 8 features are listed in Table 8-14. Classifiers constructed using the set with 1
feature produced 78.43% average classification accuracy for the unseen test data,
classifiers obtained using the set with 2 features produced 82.48%, classifiers
constructed using the set with 3 and 4 features produced 88.24% respectively, classifiers
obtained using the set with 5 features produced 89.8%, classifiers obtained using the set
with 6 features produced 90.2% and classifiers obtained using the set with 8 features
produced 92.16%. The approach also found the same set of 6 features reported in
Chapter 5 using the NSC-GA approach.
Table 8-14 Subsets of features selected using the proposed approach, NSC-NSGA2 for
Prostate cancer data
Gene accession number

Gene sets
8

6

5

4

3

2

1

38406_f_at

√

√

√

√

√

√

√

37639_at

√

√

√

√

√

√

41468_at

√

√

√

√

√

769_s_at

√

√

√

√

556_s_at

√

√

√

31444_s_at

√

√

39532_at

√

31527_at

√
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Table 8-15 Classification results for the Prostate cancer data using the sets of selected
features from NSC-NSGA2 approach
Number of genes

Average classification Accuracy (%)
(Unseen Test data)

1

78.43

2

82.48

3

88.24

4

88.24

5

89.8

6

90.2

8

92.16

The following section compares the NSC-NSGA2 approach with NSC-GA from the
perspectives of potential sets of features obtained via both approaches. Table 8-16 lists
the sets of features (in terms of the number of features) and the average classification
accuracy of their corresponding classifiers for the corresponding unseen test datasets.
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Table 8-16 Summary of results for NSC-GA and NSC-NSGA2
NSC-GA (f = f1+f2)
Dataset

Number
of
features

AD

11

Colon

6

Leukemia

9

Ovarian

7

Lymphoma

7

Lung

8

Prostate

6

NSC-NSGA2 (f1 and f2)

Average
Classification
Number of
Accuracy (%)
features
(Unseen Test
data)
1
4
5
6, 7
9
8
89.45
10
11
17
16
15
18
19
1, 2, 3, 4, 5, 6, 7, 8, 9, 10,
21,,23
38
48
93.75
39, 40, 42, 43, 44, 45, 47
61 , 87, 62, 86
77, 83, 85, 92, 89
2, 13
97.06
7, 9, 10, 11
1 , 5, 6
7, 36, 37, 38
96.06
207, 210, 212, 224, 227
230
1
2
7, 8, 12
95.45
128, 133, 134, 137, 139,
140, 141, 146, 149, 164, 173
1
2
100
3
5, 8, 9, 11
1
2
3, 4
90.2
5
6
8

Average
Classification
Accuracy (%)
(Unseen Test
data)
56.98
72.82
76
81.52
82.6
82.78
83.4
87.7
91.3
91.63
92.39
93.84
94.56
93.75
81.25
87.5
62.5
68.75
91.18
94.12
96.85
96.06
89.76
90.55
68.18
72.73
95.45
100
93.63
94.62
95.93
100
78.43
82.48
88.24
89.8
90.2
92.16
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Table 8-16 shows results obtained in Chapter 5 for NSC-GA where the objective
function was an aggregation of the same two objective functions for NSC-NSGA2, that
is,

f = 0.5 f1 + 0.5 f2. In this formulation, both objective functions were given equal

weightings and using a GA, single optimal sets of relevant features were obtained at the
end of each run for AD, Colon, Leukemia, Ovarian, Lymphoma, Lung and Prostate
cancer datasets. With the proposed approach in this chapter, NSC-NSGA2, two
objective functions (f1 and f2) are assessed simultaneously and multiple optimal sets of
relevant features are obtained for each dataset at the end of each run.
Having information as shown in Table 8-16 with regards to the joint classification
behaviour of various sets of features allows the domain expert to make informed
decision in terms of sets of features that would be selected for further investigations. For
example in the case of the AD dataset, one can make decisions based on the tradeoffs
between classification accuracy and size of feature set. The set of 6 features resulted in
the same classification accuracy as the set of 7 features (i.e. 81.52%). The domain
expert can examine the 7th feature and use domain knowledge to decide on it potential
relevance and make decision on subsequent analysis. Equally it is interesting to further
analyse the Colon cancer dataset where sets with 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 21 and 23
features respectively resulted in classifiers producing the same classification accuracy
on the unseen test dataset (93.75%). It appears that a major contributing factor relates to
1 feature and thus may warrant further investigations into the relevance of the remaining
features. A similar situation can also be seen with the Leukemia cancer dataset where
sets with 7, 9, 10 and 11 features respectively resulted in classifiers returning the same
classification (94.12%) on the unseen test dataset (a major contributing factor relates to
7 features); with Ovarian cancer dataset where sets with 1, 5 and 6 features,
respectively, resulted in classifiers returning the same classification (96.85%) on the
unseen test dataset (a major contributing factor relates to 1 features), and sets with 7, 36,
37 and 38 features, resulted in classifiers returning the same classification (96.06%) on
the unseen test dataset (a major contributing factor relates to 7 features); with
Lymphoma cancer dataset where sets with 7, 8 and 12 features, respectively, resulted in
classifiers returning the same classification (95.45%) on the unseen test dataset (a major
contributing factor relates to 7 features); with Lung cancer dataset where sets with 5, 8,
9 and 11 features, respectively, resulted in classifiers returning the same classification
(100%) on the unseen test dataset (a major contributing factor relates to 5 features), and
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with Prostate cancer dataset where sets with 3 and 4 features, respectively, resulted in
classifiers returning the same classification (88.24%) on the unseen test dataset (a major
contributing factor relates to 3 features). This sort of information for analysis in
bioinformatics is important as reducing the number of features to a smaller promising
set for further investigations would reduce costs associated with future experiments and
analysis.
8.4. NSC-NSGA2 with 3 objective functions
To further examine the proposed approach, the following section detailed work that
investigated the impact of employing more than 2 objective functions for FS. In
addition to

and

, a 3rd objective function (f3) is also employed in NSC-NSGA2, and

this is denoted as NSC-NSGA2*.

is calculated using Equation (8.6).

(∑

where

∑

)

(8.6)

is the positive shrunken relative difference of selected features
n is the total number of features selected
is the number of classes
is an average of

for selected features

f3 is designed for maximizing the fitness of chromosomes that has a maximum shrunken
relative difference,

, for the features selected. As mentioned previously, in NSC, the

class centroid of attributes is shrunk toward the overall class centroid and attributes with
at least one positive relative shrunken class centroid are considered as important and are
selected (i.e. class centroids and overall class centroid are different). The attributes can
be ranked based on the value of

. That is, the larger the value of

the better the

rank of attributes. Therefore, f3 is employed in the proposed approach to maximize the
set that consists of attributes with better ranks, (i.e. the best overall average value of
for the set), with the aim to improve the fitness evaluation for chromosomes that leads
to the selection of smaller feature sets with the same or higher classification accuracy.
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Table 8-17 Result from applying 2 and 3 objective functions for the proposed approach,
NSC-NSGA2, on AD and Leukemia dataset
NSC-NSGA2
(f1, f2)
Dataset

AD

Average
Classification
Number of
Accuracy (%)
features
(Unseen Test
data)
1
56.98
4
72.82
5
76
6, 7
81.52
9
82.6
8
82.78
10
83.4
11
87.7
17
91.3
16
91.63
15
92.39
18
93.84
19
94.56

2, 13
7, 9, 10, 11
Leukemia

NSC-NSGA2*
(f1, f2, f3)

91.18
94.12

1
4
5
6
7
8
9
10
11
12
13, 14
16
17
18, 19
33
38
67
2, 3, 11, 13, 15
7
8, 10
62

Average
classification
Accuracy (%)
(Unseen
Test
data)
56.07
72.83
75.47
79.98
81.52
83.02
82.60
83.52
89.72
90.21
92.39
91.67
91.3
94.56
92.39
90.21
85.86
91.18
92.02
94.12
85.29

176, 336, 884, 889

88.23

Number of features

From the limited analysis using the AD dataset with 120 features and the Leukemia
dataset with 7129 features, it can be seen from Table 8-17 that the NSC-NSGA2*
approach resulted in a bigger number of different sets of selected features when
compared to the approach with 2 objective functions (NSC-NSGA2). Among these
additional sets of selected features, some sets are smaller but have the same average
NSC classification accuracy, e.g., for AD dataset, the sets with 13 and 14 features using
the 3 objective approach that gave the same classification accuracy (92.39%) as that of
the set with 15 features using the 2 objective approach, for Leukemia dataset, the set
with 8 features using the NSC-NSGA2* approach that gave the same classification
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accuracy (94.12%) as that of the sets with 9, 10 and 11 features using the NSC-NSGA2
approach.
8.5. The proposed approach, NSC-NSGA2 with Mahalanobis distance measure
According to Bandyopadhyay and Saha (2013, p. 60), “similarity measurement is
essential for performing classification”, thus in order to investigate the impact of
employing a different similarity distance measure in the NSC classifier on the Pareto
front obtained from NSC-NSGA2, the study carried out a further experiment to replace
Euclidean distance in the NSC classifier with Mahalanobis distance. This is one of the
most common distance measures that has been used for feature-based similarity search,
specifically in datasets where correlation exists between features (Emrich et al., 2013).
Using the same experimental procedure outlined in Section 8.3, NSCM-NSGA2 (NSC
with Mahalanobis distance) was evaluated using the Leukemia cancer dataset and the
NSGA2 parameter settings listed in Table 8-1 as a proof of concept. A typical Pareto
optimal front from one of the 15 runs is shown in Figure 8-18.

f2

1
0.99
0.98
0.97
0.96
0.95
0.94
0.9984

0.9986

0.9988

0.999

0.9992

Pareto front

0.9994

0.9996

0.9998

1

f1

Figure 8-18 A typical Pareto front plot of f1 against f2 for Leukemia cancer dataset using
the NSCM-NSGA2 approach
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The results obtained from running 15 independent runs of NSCM-NSGA2 led to the
selection of sets with 2, 5, 6, 7, 8, 9, 10, 11 features.
Table 8-18 Sets of genes obtained by NSCM-NSGA2 for the Leukemia cancer data
Gene sets
Gene accession number

11

10

9

8

7

6

5

2

M84526_at

√

√

√

√

√

√

√

√

U50136_rna1_at

√

√

√

√

√

√

√

√

D49950_at

√

√

√

√

√

√

√

M16038_at

√

√

√

√

√

√

√

M23197_at

√

√

√

√

√

√

√

X17042_at

√

√

√

√

√

√

X95735_at

√

√

√

√

√

M55150_at

√

√

√

√

M57710_at

√

√

√

Y00787_s_at

√

√

M27891_at

√

As seen in Table 8-18, sets of 2, 5, 6, 7, 8, 9, 10 and 11 genes obtained are the same as
those using NSC-NSGA2. The sets of 5, 6 and 8 genes are additional sets obtained
using NSCM-NSGA2.
Table 8-19 Results from NSC-NSGA2 and NSCM-NSGA2 for Leukemia cancer dataset

Dataset

Euclidean
NSC-NSGA2 (f1 and f2)
Average
Number of Classification
genes
Accuracy (%)
(Unseen Test data)
2, 13

91.18

7, 9, 10, 11

94.12

Leukemia

Mahalanobis
NSCM-NSGA2 (f1 and f2)
Average
Number of Classification
genes
Accuracy (%)
(Unseen Test data)
2,5

88.24

6, 9

94.12

7, 8

97.06

10, 11

100
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The classification results using classifiers constructed using these sets of features on the
unseen test data are shown in Table 8-19. It is interesting to note that NSCM-NSGA2 did
not produce the set of 13 features associated with NSC-NSGA2 and that there are some
differences in the classification accuracy associated with the different classifiers from
the two approaches. For example, the classifiers constructed from the set of 7 and 8
features obtained the same average classification accuracy of 97.06% in comparison to
the classifier constructed using the set of 9 features from NSC-NSGA2 that obtained
94.12% average classification accuracy. Similar to other analysis in this study, the
optimal shrinkage threshold values obtained from NSCM-NSGA2 can be slightly
different from those obtained using NSC-NSGA2 but are still in the range that map to
the same set of features but may slightly impact on the classification accuracy. From
this limited analysis here, it can be seen that the use of another similarity measure in the
approach can produce some different sets of features. This implies that to
comprehensively analyse biological datasets, researchers should examine them using
techniques that support different similarity measures and a number of selection criteria.
Having information in Table 8-19 can help biomedical researchers to make informed
decisions about sets of features that would be selected for further investigations. For
example it will be interesting to examine the set of 6 features obtained via NSCMNSGA2 and the set of 7 features obtained via NSCM-NSGA2 in terms of the 7th feature
(set of 6 being the subset of 7 features) in terms of its known biological relevance to the
specific disease.
8.6. Summary
This chapter has described the proposed approach of incorporating NSC and MOEA
(NSGA2) to automatically search for multiple optimal shrinkage threshold values for
NSC. The approach used NSC as an evaluator to evaluate the fitness of the candidate
shrinkage threshold values, utilized the MOEA (NSGA2) as a multi-objective search
algorithm to search for Pareto front of multiple shrinkage threshold values that lead to
the selection of corresponding sets of relevant features. The proposed approach was
evaluated using 7 public biomedical datasets: AD, Colon, Leukemia, Ovarian,
Lymphoma, Lung and Prostate cancer data. The proposed approach shows the
effectiveness of using a multi objective approach, NSC-NSGA2, over a single
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aggregated objective function used in NSC-GA involving a single objective approach as
described in Chapter 5.
This chapter has also described work that incorporated 3 objective functions in NSCNSGA2 for studying the impact of using more than two objective functions for FS. This
approach was evaluated using the AD and Leukemia dataset. The results from the study
showed that the approach NSC-NSGA2* obtained a bigger number of different sets of
selected features when compared to the approach using 2 objective functions (NSCNSGA2). In some cases, NSC-NSGA2* obtained some sets having a smaller number of
features that produced classifiers that obtained the same average NSC classification
accuracy as those associated with a classifier constructed from a superset of features.
To examine the impact of using a different similarity measure, this study implemented
NSCM-NSGA2 where Mahalanobis distance is used in NSC instead of Euclidian
distance. The approach was evaluated using the Leukemia cancer dataset. The results
showed that some additional sets of features were produced and their corresponding
classifiers produced similar classification results. This implies that to comprehensively
analyse biological datasets, researchers need to examine them using techniques that
support different similarity measures and a number of selection criteria.
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9. Conclusion and Future work
This thesis presented the investigation of evolutionary-based FS techniques for
analysing biological datasets acquired via mass throughput technologies. These
biological datasets are typically high dimensional with only a small number of samples;
making the task of their analysis especially challenging. Section 9.1 summarises the
key findings from this study and Section 9.2 outlines suggestions for future work.
9.1. Conclusion
As the area of bioinformatics become increasingly “data rich”, the need for appropriate
techniques that can be used for a comprehensive analysis of these huge volumes of data
is imperative. This thesis contributed towards a better understanding of the development
of evolutionary-based FS techniques for analysing biological data from mass throughput
technologies. The thesis also demonstrated the impact of employing different similarity
measure in NSC and showed the need to consider classifier-biased when examining the
sensitivity and specificity associated with a specific classifier constructed from a set of
features.
This study has addressed the following aims:


Aim 1: To investigate and develop FS algorithms that incorporates various
evolutionary strategies, specifically investigating the use of

evolutionary

strategies in conjunction with Rough Set Theory and Nearest Shrunken
Centroid;


Aim 2: To evaluate the developed algorithms in terms of finding the “most
relevant” biomarkers contained in biological datasets and



Aim 3: To evaluate the goodness of extracted feature subsets for relevance
(examined in terms of existing biomedical domain knowledge and classification
accuracy form the perspectives of sensitivity and specificity associated with
different classifiers). The project aims to generate sets of features for
construction of good predictive models for classifying diseased samples from
control.
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In addressing Aim 1, this study has developed evolutionary-based FS techniques that
incorporated GA, MA and MOEA. The first approach involved the development of
RST-GA, a hybrid approach involving the GA, RST and k-means. This approach is
described in Chapter 4 and consisted of 3 phases: feature reduction, distinction table
generation and FS via GA optimization. In the first phase, features of high dimensional
data were reduced effectively. In this phase, quartile statistics was employed to generate
initial starting centroids for k-means clustering. The final centroids obtained from kmeans were used for the feature reduction process. In the second phase, the criteria (i.e.
generation rules) used in Banerjee, Mitra, & Banka’s study (2007) was also applied to
generate a distinction table with a smaller dimension. Finally, in the third phase, GA
was employed to search for optimal feature sets based on the distinction table generated
in the previous phase. The study showed that the smaller feature sets obtained using
RST-GA produced classifiers that gave similar classification accuracy for the Colon
cancer dataset and the Leukemia data in comparison to the results reported in Banerjee,
et al. (2007).
A second approach described in Chapter 5, NSC-GA, incorporates NSC and GA to
automatically search for an optimal range of shrinkage threshold values for the NSC.
The NSC is a deterministic FS algorithm which selects the same set of features for
shrinkage threshold values in the same range. The optimal shrinkage thresholds are
used in NSC to obtain the corresponding sets of selected features. The study showed
that the feature sets obtained using NSC-GA are smaller. Corresponding classifiers
constructed from these feature sets produced similar or higher classification accuracy
for seven datasets in comparison with other NSC-based approaches reported in previous
studies. While the sets of relevant features obtained using the NSC-GA from every
independent run is more consistent, multiple sets consisting of features where the
smaller sets are subsets of the bigger sets were also obtained from the runs of the NSCGA. This is important in terms of allowing biomedical researchers to investigate the sets
of features for biological relevance in subsequent clinical studies.
To continue the exploration of evolutionary approaches for FS in biological data,
Chapter 6 described an approach MA for automatically finding optimal shrinkage
thresholds for NSC in an attempt to further improve upon NCS-GA. The aim was to
explore improvements that can be made on the NSC-GA approach. The impact of
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incorporating MA with NSC for finding shrinkage threshold values automatically are
reduced computational time and obtaining the same feature set over different runs of
NSC-MA. Chapter 8 described NSC-NSGA2, a hybrid approach incorporating NSGA2
and NSC to automatically find the Pareto front associated with optimal shrinkage
threshold values for the NSC. Unlike GA which involved a single objective function,
the aim here was to examine the impact of incorporating a MOEA with NSC with the
use of multiple objective functions for obtaining multiple shrinkage threshold solutions.
Unlike existing techniques, the developed approaches here support FS by
simultaneously considering tradeoffs between a number of criteria (e.g. high
classification accuracy and a small number of features). Multiple sets of potential
features (biomarkers) obtained via the developed approach can be further investigated to
explore both diagnostic and biological relevance.
Lastly, this study examined the impact of using different similarity measures in NSCGA and NSC-NSGA2. Euclidean distance is the distance measure originally used in
NSC to assign data points to different classes. Chapter 7 described the approach of
implementing different similarity distance measures (i.e. Mahalanobis, Pearson and
Mass distance) in the NSC classifier and incorporating NSC and GA to automatically
search for optimal shrinkage threshold values for NSC. The use of distance measures
such as Mahalanobis overcomes some of the limitations associated Euclidean distance
(e.g. assumption that the features are uncorrelated). From the perspective of using a
different distance measure in a multi-objective approach, NSCM-NSGA2 was
implemented using Mahalanobis distance in NSC instead of Euclidian distance. As a
proof of concept, it was evaluated using the Leukemia cancer dataset. Additional sets of
selected features were obtained and their corresponding classifiers produced similar
classification results. This implies that to comprehensively analyse biological datasets,
researchers need to examine them using techniques that support different similarity
measures and a number of selection criteria.
In addressing Aim 2 and Aim 3, seven datasets and the evaluation strategy described in
Chapter 3 were used to evaluate the developed approaches in this study. The
dimensionality of these datasets ranged from 120 to 15,154 attributes. In terms the
relevance and the “goodness” of the selected sets of features, these were evaluated by
constructing different classifiers using the suite of classifiers from WEKA and
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examining the corresponding classification accuracy on unseen test datasets (in terms
of diagnostic relevance). From these analyses, the study demonstrated that the use of
specific classifiers may have an impact on the sensitivity and specificity obtained using
a set of features in classification and recommended that in DM for finding suitable sets
of biological markers, a number of classifiers should be employed to examine the
diagnostic relevance. This will avoid incidences of dismissing sets of features with high
discriminatory capabilities that should be further investigated in early diagnostic test
developments. From the perspective of biological relevance, this study is limited to
examining the relevance of the extracted feature sets against known biomarkers from
literature associated with the relevant domains. For example, Table 4-3 listed genes
found by the RST-GA approach which are already known in the biomedical literature to
be associated with the Colon Cancer. The common features selected across different
approaches for the seven datasets are listed in Table 9-1.
Table 9-1 Common features selected across difference approaches
Approaches
Datasets

NSC-GA

NSCM-GA

NSCP-GA

NSCMD-GA

NSC-MA

NSCNSGA2

Common features
AD
Colon
Leukemia
Lymphoma
Lung
Ovarian

PDGF-BB_1, RANTES_1, IL-1a_1, TNF-a_1
T71025, M63391, R87126, M76378, T92451, J02854,
M27891, M84526, M96326
GENE3327X, GENE3329X, GENE3361X
33328_at, 40936_at
MZ244.36855, MZ244.66041, MZ244.95245, Z245.24466, MZ245.8296,
MZ245.53704, MZ246.12233

Prostate

41468_at, 37639_at, 38406_f_at, 769_s_at, 556_s_at

Since the primary theme being the investigation of evolutionary approaches for analysis
of biological datasets, the NSC-GA approach was developed to first explore the use of
GA to find the shrinkage threshold value for NSC. The next logical step from NSC-GA
was to investigate how this technique can be further improved, leading to the
development of NSC-MA, the use of memetic algorithm. Another venue of
improvements for the NSC relates to impact of similarity measures used and the
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investigation here led to the development of NSCM-GA, NSCp-GA and NSCMD-GA.
Finally, NSC-NSGA2 was developed to explore the use of multiple objectives for
feature selection, improving upon the previous approaches in this study that involved a
single objective.
The following table also summarises the advantages and limitations of the proposed
approaches.
Table 9-2 Advantages and limitation of the developed approaches
Proposed
approaches

Advantages

Limitations

RST-GA

 Number of attributes is reduced
before applying the GA.
 Less computational time

Feature instability

NSC-GA
NSC-MA
NSCM-GA
NSCP-GA
NSCMD-GA

 Feature stability
 Explore interaction of features

NSC-NSGA2





More computational time
compared to the RST-GA
approach.

Multiple sets of features
obtained in one run
Feature stability
Explore interaction of features

9.2. Future work
Future directions from this research could examine:


Investigations and development of FS techniques that combines RST and
different evolutionary algorithms such as MA and other MOEA approaches for
analysing biological datasets. Existing work involving evolutionary-based RST
for analysis of biological data is limited, probably owing to its computational
intensiveness.



Incorporation of RST into the developed approaches of NSC-GA, NSCM-GA,
NSCP-GA and NSCMD-GA to reduce computational time of these approaches.
Here, RST can be used as a feature reduction algorithm to reduce the number of
features for high dimensional data as an initial step before the NSC-GA
approach is used to optimize the search of optimal sets of features.
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Due to time constrains, the investigations involving MOEA has only examined
NSGA2 and a maximum of 3 objectives. Subsequent investigations could
examine the use of other MOEAs and the impact of employing more than 3
objective functions.



NSC-based approaches are very much targeted for analysis of bioinformatics
data, extended to being applied to other high dimensional biological data
generated using other techniques. Potentially, the RST-GA approach can be
applied to any domain for feature selection.
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